
<html lang="en"     class="pb-page"  data-request-id="4fac5103-1002-402b-bb1a-b8eb80e0a6a9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/jm701137s;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2007.50.issue-25;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, In Vitro, and In Vivo Characterization of Phenylpiperazines and Pyridinylpiperazines as Potent and Selective Antagonists of the Melanocortin-4 Receptor" /></meta><meta name="dc.Creator" content="Joe A.  Tran" /></meta><meta name="dc.Creator" content="Wanlong  Jiang" /></meta><meta name="dc.Creator" content="Fabio C.  Tucci" /></meta><meta name="dc.Creator" content="Beth A.  Fleck" /></meta><meta name="dc.Creator" content="Jenny  Wen" /></meta><meta name="dc.Creator" content="Yang  Sai" /></meta><meta name="dc.Creator" content="Ajay  Madan" /></meta><meta name="dc.Creator" content="Ta Kung  Chen" /></meta><meta name="dc.Creator" content="Stacy  Markison" /></meta><meta name="dc.Creator" content="Alan C.  Foster" /></meta><meta name="dc.Creator" content="Sam R.  Hoare" /></meta><meta name="dc.Creator" content="Daniel  Marks" /></meta><meta name="dc.Creator" content="John  Harman" /></meta><meta name="dc.Creator" content="Caroline W.  Chen" /></meta><meta name="dc.Creator" content="Melissa  Arellano" /></meta><meta name="dc.Creator" content="Dragan  Marinkovic" /></meta><meta name="dc.Creator" content="Haig  Bozigian" /></meta><meta name="dc.Creator" content="John  Saunders" /></meta><meta name="dc.Creator" content="Chen  Chen" /></meta><meta name="dc.Description" content="Benzylamine and pyridinemethylamine derivatives were synthesized and characterized as potent and selective antagonists of the melanocortin-4 receptor (MC4R). These compounds were also profiled in r..." /></meta><meta name="Description" content="Benzylamine and pyridinemethylamine derivatives were synthesized and characterized as potent and selective antagonists of the melanocortin-4 receptor (MC4R). These compounds were also profiled in r..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 10, 2007" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701137s" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2007 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701137s" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701137s" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701137s" /></link>
        
    
    

<title>Design, Synthesis, In Vitro, and In Vivo Characterization of Phenylpiperazines and Pyridinylpiperazines as Potent and Selective Antagonists of the Melanocortin-4 Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701137s" /></meta><meta property="og:title" content="Design, Synthesis, In Vitro, and In Vivo Characterization of Phenylpiperazines and Pyridinylpiperazines as Potent and Selective Antagonists of the Melanocortin-4 Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0009.jpeg" /></meta><meta property="og:description" content=" Benzylamine and pyridinemethylamine derivatives were synthesized and characterized as potent and selective antagonists of the melanocortin-4 receptor (MC4R). These compounds were also profiled in rodents for their pharmacokinetic properties. Two compounds with diversified profiles in chemical structure, pharmacological activities, and pharmacokinetics, 10 and 12b, showed efficacy in an established murine cachexia model. For example, 12b had a Ki value of 3.4 nM at MC4R, was more than 200-fold selective over MC3R, and had a good pharmacokinetic profile in mice, including high brain penetration. Moreover, 12b was able to stimulate food intake in the tumor-bearing mice and reverse their lean body mass loss. Our results provided further evidence that a potent and selective MC4R antagonist with appropriate pharmacokinetic properties might potentially be useful for the treatment of cancer cachexia." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701137s"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701137s">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701137s&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701137s&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701137s&amp;href=/doi/10.1021/jm701137s" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2007</span><span class="cit-fg-volume">, 50</span><span class="cit-fg-issue">, 25</span><span class="cit-fg-pageRange">, 6356-6366</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/50/25" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701042w" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm0611861" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, In Vitro, and In Vivo Characterization of Phenylpiperazines and Pyridinylpiperazines as Potent and Selective Antagonists of the Melanocortin-4 Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joe+A.++Tran">Joe A. Tran</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wanlong++Jiang">Wanlong Jiang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabio+C.++Tucci">Fabio C. Tucci</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beth+A.++Fleck">Beth A. Fleck</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jenny++Wen">Jenny Wen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Sai">Yang Sai</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ajay++Madan">Ajay Madan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ta+Kung++Chen">Ta Kung Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stacy++Markison">Stacy Markison</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+C.++Foster">Alan C. Foster</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sam+R.++Hoare">Sam R. Hoare</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Marks">Daniel Marks</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Harman">John Harman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Caroline+W.++Chen">Caroline W. Chen</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melissa++Arellano">Melissa Arellano</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dragan++Marinkovic">Dragan Marinkovic</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haig++Bozigian">Haig Bozigian</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Saunders">John Saunders</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chen++Chen">Chen Chen</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 858-617-7634 . Fax: 858-617-7602. E-mail: <a href="/cdn-cgi/l/email-protection#f99a9a919c97b9979c8c8b969a8b90979cd79a9694"><span class="__cf_email__" data-cfemail="85e6e6ede0ebc5ebe0f0f7eae6f7ecebe0abe6eae8">[email protected]</span></a></div><div class="corresp-fn" id="fn1">†Current address: Department of Medicinal Chemistry, Tanabe Research Laboratories, U.S.A., Inc., 4540 Towne Centre Ct., San Diego, CA 92121.</div><div class="corresp-fn" id="fn2">#Department of Pediatrics, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239.</div><div class="corresp-fn" id="fn3">‡Current address: Vertex Pharmaceuticals Inc., 11010 Torreyana Road, San Diego, CA 92121.</div><div class="corresp-fn" id="fnabb">aAbbreviations: MC4R, type 4 melanocortin receptor; MSH, melanocyte-stimulating hormone; AgRP, agouti-related protein; cAMP, cyclic adenosine monophosphate; i.p., intraperitoneal; b/p, brain/plasma.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701137s&amp;href=/doi/10.1021%2Fjm701137s" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2007</span></span><span class="cit-volume">, 50</span><span class="cit-issue">, 25</span><span class="cit-pageRange">, 6356–6366</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 10, 2007</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 September 2007</li><li><span class="item_label"><b>Published</b> online</span>10 November 2007</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 December 2007</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701137s" title="DOI URL">https://doi.org/10.1021/jm701137s</a></div><div class="article_header-article-copyright"><strong>Copyright © 2007 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6356%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJoe%2BA.%2BTran%252C%2BWanlong%2BJiang%252C%2BFabio%2BC.%2BTucci%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D50%26issueNum%3D25%26contentID%3Djm701137s%26title%3DDesign%252C%2BSynthesis%252C%2BIn%2BVitro%252C%2Band%2BIn%2BVivo%2BCharacterization%2Bof%2BPhenylpiperazines%2Band%2BPyridinylpiperazines%2Bas%2BPotent%2Band%2BSelective%2BAntagonists%2Bof%2Bthe%2BMelanocortin-4%2BReceptor%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6366%26publicationDate%3DDecember%2B2007">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701137s"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1085</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701137s" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, In Vitro, and In Vivo Characterization of Phenylpiperazines and Pyridinylpiperazines as Potent and Selective Antagonists of the Melanocortin-4 Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Joe&quot;,&quot;last_name&quot;:&quot;A. Tran&quot;},{&quot;first_name&quot;:&quot;Wanlong&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;C. Tucci&quot;},{&quot;first_name&quot;:&quot;Beth&quot;,&quot;last_name&quot;:&quot;A. Fleck&quot;},{&quot;first_name&quot;:&quot;Jenny&quot;,&quot;last_name&quot;:&quot;Wen&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Sai&quot;},{&quot;first_name&quot;:&quot;Ajay&quot;,&quot;last_name&quot;:&quot;Madan&quot;},{&quot;first_name&quot;:&quot;Ta&quot;,&quot;last_name&quot;:&quot;Kung Chen&quot;},{&quot;first_name&quot;:&quot;Stacy&quot;,&quot;last_name&quot;:&quot;Markison&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;C. Foster&quot;},{&quot;first_name&quot;:&quot;Sam&quot;,&quot;last_name&quot;:&quot;R. Hoare&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Marks&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Harman&quot;},{&quot;first_name&quot;:&quot;Caroline&quot;,&quot;last_name&quot;:&quot;W. Chen&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;Arellano&quot;},{&quot;first_name&quot;:&quot;Dragan&quot;,&quot;last_name&quot;:&quot;Marinkovic&quot;},{&quot;first_name&quot;:&quot;Haig&quot;,&quot;last_name&quot;:&quot;Bozigian&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Saunders&quot;},{&quot;first_name&quot;:&quot;Chen&quot;,&quot;last_name&quot;:&quot;Chen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2007&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;25&quot;,&quot;volume&quot;:&quot;50&quot;,&quot;pages&quot;:&quot;6356-6366&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701137s&quot;},&quot;abstract&quot;:&quot;Benzylamine and pyridinemethylamine derivatives were synthesized and characterized as potent and selective antagonists of the melanocortin-4 receptor (MC4R). These compounds were also profiled in rodents for their pharmacokinetic properties. Two compounds with diversified profiles in chemical structure, pharmacological activities, and pharmacokinetics, 10 and 12b, showed efficacy in an established murine cachexia model. For example, 12b had a Ki value of 3.4 nM at MC4R, was more than 200-fold selective over MC3R, and had a good pharmacokinetic profile in mice, including high brain penetration. Moreover, 12b was able to stimulate food intake in the tumor-bearing mice and reverse their lean body mass loss. Our results provided further evidence that a potent and selective MC4R antagonist with appropriate pharmacokinetic properties might potentially be useful for the treatment of cancer cachexia.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701137s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701137s" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701137s&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701137s" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701137s&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701137s" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701137s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701137s&amp;href=/doi/10.1021/jm701137s" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701137s" /></input><a href="/doi/pdf/10.1021/jm701137s" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (438 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701137s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701137s%26sid%3Dliteratum%253Aachs%26pmid%3D17994683%26genre%3Darticle%26aulast%3DTran%26date%3D2007%26atitle%3DDesign%252C%2BSynthesis%252C%2BIn%2BVitro%252C%2Band%2BIn%2BVivo%2BCharacterization%2Bof%2BPhenylpiperazines%2Band%2BPyridinylpiperazines%2Bas%2BPotent%2Band%2BSelective%2BAntagonists%2Bof%2Bthe%2BMelanocortin-4%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D50%26issue%3D25%26spage%3D6356%26epage%3D6366%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291411" title="Pharmacokinetics">Pharmacokinetics</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/50/25" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Benzylamine and pyridinemethylamine derivatives were synthesized and characterized as potent and selective antagonists of the melanocortin-4 receptor (MC4R). These compounds were also profiled in rodents for their pharmacokinetic properties. Two compounds with diversified profiles in chemical structure, pharmacological activities, and pharmacokinetics, <b>10</b> and <b>12b</b>, showed efficacy in an established murine cachexia model. For example, <b>12b</b> had a <i>K</i><sub>i</sub> value of 3.4 nM at MC4R, was more than 200-fold selective over MC3R, and had a good pharmacokinetic profile in mice, including high brain penetration. Moreover, <b>12b</b> was able to stimulate food intake in the tumor-bearing mice and reverse their lean body mass loss. Our results provided further evidence that a potent and selective MC4R antagonist with appropriate pharmacokinetic properties might potentially be useful for the treatment of cancer cachexia.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cachexia is a condition characterized by weight loss, wasting of muscle, loss of appetite, and general debility that accompanies many chronic diseases, affects various patient populations, including those with cancer, and is estimated to be responsible for over 20% of all cancer-related deaths.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Cancer cachexia significantly impairs quality of life and response to antineoplastic therapies and increases morbidity and mortality of cancer patients. Most current therapeutic strategies to counteract cancer cachexia have proven to be only partially effective.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In the past decade, research into the processes leading to cachexia have provided ideas for more effective therapeutic intervention that have been attempted pharmacologically with encouraging results in animal models and preliminary clinical trials. While recent studies have linked cancer cachexia to endocannabinoid,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> ghrelin,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and other biological systems associated with appetite stimulation and food intake, one key center that is likely involved in the propagation of symptoms of cachexia is the melanocortin system in the hypothalamus and brainstem.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">The melanocortin system consists of five cell surface receptors that belong to the class A G-protein-coupled receptor superfamily.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These receptors are activated by the family of melanocyte-stimulating hormone peptide agonists produced from the post-translational processing of pro-opiomelanocortin (POMC<a class="ref internalNav" href="#fnabb" aria-label="a">a</a>), including α-, β-, and γ-MSH and adrenocorticotropin hormone (ACTH).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In addition, these receptors are also regulated by the endogenous antagonists agouti-protein and agouti-related protein (AgRP).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The melanocortin-4 receptor (MC4R)<sup><i>a</i></sup> plays a very important role in feeding behavior and energy homeostasis in animals and humans.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> MC4 receptors are widely expressed in the brain, and MC4R mutations that impair receptor function have been associated with binge eating and obesity in humans.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> In addition, many studies have demonstrated that MC4R agonists suppress food intake and reduce body weight in animals.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">In contrast, recent studies have shown that MC4R antagonists promote food intake and increase weight gain in animals.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Moreover, evidence suggests that cachexia brought about by a variety of illnesses can be attenuated or reversed by blocking MC4R activation within the central nervous system.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> For example, Wisse and co-workers demonstrate that the peptide MC4R antagonist Ac-Nle(4)-c[Asp(5)-2′-Nal(7)-Lys(10)]-α-MSH(4–10)-NH<sub>2</sub> (SHU9119)<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> reverses body weight loss in mice after intracerebroventricular administration.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> This effect, however, is diminished in MC4R knock out mice,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> demonstrating MC4R involvement. Central infusion of AgRP(83–132) also prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">While potent peptide antagonists for the MC4 receptor have been known for years, small nonpeptide molecules that antagonize the receptor were only recently discovered.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> One advantage of nonpeptide molecules is the possibility of delineating pharmacological activity in animals without intracerebroventrical injection if the molecules achieve sufficient brain penetration after peripheral administration. For example, a 2-phenylimidazoline <b>1</b> (ML00253764, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is a functional MC4R antagonist (IC<sub>50</sub> = 103 nM) with poor selectivity versus MC3R, a receptor subtype that is also believed to have a role in feeding regulation<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and has demonstrated efficacy in a cachexia model via subcutaneous administration.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Additionally, we have shown that a β-alanine-(2,4-Cl)phenylalanine dipeptide derivative <b>2</b> is a potent functional MC4R antagonist with negligible affinity at MC3R.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Intraperitoneal administration of <b>2</b> effectively stimulates daytime (satiated) food intake and decreases basal metabolic rate in normal animals. Furthermore, this compound attenuates cachexia and preserves lean body mass in a murine cancer model.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> These data provide evidence for the potential utility of small molecule MC4R antagonists, particularly in the treatment of cancer cachexia.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of some small molecule MC4R antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Several MC4R antagonists from different chemical classes have been reported. For example, the structure–activity relationship of bispiperazine derivatives exemplified by <b>3</b> has been extensively studied.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> A series of acylguanidines exemplified by <b>4</b> are reported as highly potent MC4R antagonists with brain penetration in rodents.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Very recently, a series of benzimidazoles are described as potent and selective MC4R antagonists.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> We have previously reported the discovery of a series of piperazinebenzylamines such as <b>5</b> (<i>K</i><sub>i</sub> = 75 nM) as MC4R antagonists.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> By using <b>5</b> as a lead, we started a research effort to improve the MC4R antagonist properties associated with this compound in several categories including potency, metabolism, and pharmacokinetics. Here we report the design, synthesis, and in vitro and in vivo characterization of several compounds based on this initial lead. Among them, <i>N</i>-(1<i>S</i>-[2-{4-[(2<i>R</i>)-methyl-3-(4-chlorophenyl)propionyl]-1-piperazinyl}-5-chlorophenyl]-3-methylbutyl)-3-(dimethylamino)propionamide (<b>12b</b>) was identified as potent and selective at the MC4 receptor. It also exhibited suitable pharmacokinetic properties for further evaluation and demonstrated anticachectic activity in a murine cachexia model.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The target benzylamine compounds were synthesized from the protected piperazinebenzylamines <b>6</b>,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. A coupling reaction of the free amine derived from <b>6a</b> with 3-(2,4-dichlorophenyl)propionic acid afforded the amides <b>5</b> after deprotection with HCl in methanol, which was coupled with <i>N</i>-Boc-glycine to give <b>11</b> after a TFA treatment.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Similarly, <b>6a</b> was also coupled with 2-methyl-3-(2-methoxy-4-chlorophenyl)propionic acid to provide <b>7</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and compound <b>8</b> was obtained from <b>6b</b> and 2<i>R</i>-methyl-3-(4-chlorophenyl)propionic acid. Reaction of <b>8</b> with 3-(<i>N</i>,<i>N</i>-dimethylamino)propionic acid under coupling conditions gave the amide <b>12a</b>. Compound <b>12b</b> was prepared using the same procedure from <b>6c</b>. Compound <b>9</b> was synthesized from <b>6d</b> by the following sequence. A coupling reaction of the free amine of <b>6d</b> with <i>N</i>-Boc-<span class="smallcaps smallerCapital">d</span>-(2,4-Cl)Phe-OH provided an amide that was selectively Boc-deprotected with TFA and reacted with succinaldehydic acid under reductive conditions, followed by a cyclization promoted by EDC under coupling conditions to provide the desired product after deprotection with HCl in methanol.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Reductive alkylation of <b>9</b> with (2-oxoethyl)carbamic acid <i>tert</i>-butyl ester afforded the diamine <b>10</b> after Boc-deprotection.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Compound <b>13</b> was synthesized from <b>6b</b> by a sequence for <b>9</b>, followed by a coupling reaction with 3-(dimethylamino)propionic acid.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0006.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TFA/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 1 h; (b) 2,4-ClC<sub>6</sub>H<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>COOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (c) HCl/MeOH, r.t., 1 h; (d) 2-MeO,4-ClC<sub>6</sub>H<sub>3</sub>CH<sub>2</sub>CHMeCOOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (e) <i>R</i>-(4-ClC<sub>6</sub>H<sub>4</sub>)CH<sub>2</sub>CHMeCOOH/EDC/ HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (f) (i) <i>N</i>-Boc-<span class="smallcaps smallerCapital">d</span>-(2,4-Cl)Phe-OH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (ii) TFA/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 1 h; (iii) OCHCH<sub>2</sub>CH<sub>2</sub>COOH/NaBH(OAc)<sub>3</sub>/HOAc/ClCH<sub>2</sub>CH<sub>2</sub>Cl, r.t., 24 h; (iv) EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (g) <i>N</i>-Boc-GlyOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (h) Me<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>COOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF, r.t., 16 h; (i) <i>N</i>-Boc-NHCH<sub>2</sub>CHO/NaBH(OAc)<sub>3</sub>/CH<sub>2</sub>Cl<sub>2</sub>/r.t. 14 h.</p></p></figure><div class="NLM_p">The optically pure 2<i>R</i>-methyl-3-(4-chlorophenyl)propionic acid <b>16a</b> and 2<i>R</i>-methyl-3-(2,4-dichlorophenyl)propionic acid <b>16b</b> were synthesized according to Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Stereoselective alkylation of (<i>S</i>)-3-propionyl-4-benzyloxazolidine <b>14</b> with 4-chlorobenzyl or 2,4-dichlorobenzyl bromide, followed by hydrolyzis of the diastereomer <b>15</b> promoted by hydrogen peroxide under basic conditions afforded the desired acid <b>16a</b> or <b>16b</b> in good yield.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0007.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaHMDS/THF, −70°C, 1 h, then 2-Y-4-ClC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, −78 °C to r.t., 6 h; (b) LiOH/H<sub>2</sub>O<sub>2</sub>/THF/H<sub>2</sub>O, 0 °C to r.t., 1.5 h.</p></p></figure><div class="NLM_p">The synthesis of the pyridine derivatives <b>20</b>–<b>23</b> is outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. 2-Bromo-3-pyridylcarboxaldehyde <b>17a</b> was obtained by a formylation of 2-bromopyridine, which was achieved by quenching the carbanion, formed by LDA at −78 °C in THF, with DMF in 19% yield.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> 2-Chloro-6-methyl-3-pyridylcarboxaldehyde <b>17b</b> was obtained by the reduction of 2-chloro-3-cyano-6-methylpyridine with Dibal-H in toluene at −10 to 0 °C in 53% yield. These aldehydes were condensed with (<i>S</i>)-<i>tert</i>-butanesulfinamide to the corresponding pyridylmethylidene sulfinylamides <i>S</i>-<b>18a</b>−<b>b</b>. Reactions of <i>S</i>-<b>18</b> with isobutyllithium afforded the adducts <i>R</i>-<b>19a</b>,<b>b</b> using conditions similar to those for <b>6a</b>−<b>d</b>. Unexpectedly, the stereoselectivity of this reaction was reversed from the benzene analogs <b>6</b>, and the major stereoisomer had an <i>R</i>-configuration at the newly formed chiral center. The stereochemistry of <i>R</i>-<b>19b</b> was confirmed by X-ray crystal structure determination (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The reason for this reversed stereoselectivity was possibly caused by the participation of the pyridine nitrogen in the chelating process.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The corresponding <i>S</i>-<b>19a</b> was then synthesized from (<i>R</i>)-<i>tert</i>-butanesulfinamide using the same procedure. After a TFA treatment of <i>R</i>-<b>19a</b>, the resultant amine intermediate was coupled with 2,4-dichlorophenylpropionic acid to give <i>R</i>-<b>20a</b> after an HCl/MeOH treatment. Compound <i>R</i>-<b>20b</b> was obtained from <i>R</i>-<b>19a</b> and 2-methyl-3-(2,4-dichlorophenyl)propionic acid. Similarly, a coupling reaction of the free amine derived from <i>R</i>-<b>19b</b> with (2<i>R</i>)-methyl-3-(2,4-dichlorophenyl)propionic acid provided the amide <i>R</i>-<b>21</b>. Compound <i>R</i>-<b>20b</b> was further derivatized to <i>R</i>-<b>22</b> by coupling with glycine, while <i>R-</i><b>21</b> was converted to the <i>N</i>,<i>N</i>-dimethylpropionamide <i>R</i>-<b>23</b>. The <i>S</i>-isomers, <i>S</i>-<b>20a</b> and <i>S</i>-<b>22</b>, were also synthesized from <i>S</i>-<b>19a</b> for comparison.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0008.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF/DIEA/4-Boc-piperazine, 100°C, 8 h; (b) <i>S</i>-Me<sub>3</sub>CSONH<sub>2</sub>/Ti(OEt)<sub>4</sub>/THF, r.t., 8 h; (c) (i) Me<sub>3</sub>Al/THF, −40 °C, 20 min; (ii) <i>i</i>-BuLi/THF, −78 °C, 5–8 h; (d) (i) TFA/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 1 h; (ii) (2,4-Cl<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)CH<sub>2</sub>CH(R′)COOH/EDC/HOBt/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 8 h; (e) <i>N</i>-Boc-Gly-OH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 8 h; (ii) TFA/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 1 h; (f) Me<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>COOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 8 h.</p></p></figure><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <i>R</i>-<b>19b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Structure–Activity Relationship</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56705" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56705" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesized compounds were tested in a binding assay using membranes from HEK293 cells stably expressing the human melanocortin-4 receptor as previously described,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and the results are depicted in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Compounds <b>7</b>, <b>8</b>, <b>10</b>–<b>13</b> and <i>R</i>-<b>23</b> were also tested in a whole cell cAMP assay to study their functional antagonist activity. Selectivity profiles of these compounds at the other melanocortin receptor subtypes were determined in binding assays, and the results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinity of <b>5</b>, <b>7</b>–<b>13</b>, and <b>20</b>–<b>23</b> at <i>h</i>MC4R<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">compound</th><th class="rowsep1" align="center" char="."><i>K</i><sub>i</sub> (nM)</th><th class="rowsep1" align="center">compound</th><th class="rowsep1" align="center" char="."><i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>5</b></td><td align="char" valign="top" char=".">75</td><td align="left" valign="top"><b>13</b></td><td align="char" valign="top" char=".">0.6</td></tr><tr valign="top"><td align="left" valign="top"><b>7</b></td><td align="char" valign="top" char=".">14</td><td align="left" valign="top"><i>R</i>-<b>20a</b></td><td align="char" valign="top" char=".">260</td></tr><tr valign="top"><td align="left" valign="top"><b>8</b></td><td align="char" valign="top" char=".">25</td><td align="left" valign="top"><i>S</i>-<b>20a</b></td><td align="char" valign="top" char=".">890</td></tr><tr valign="top"><td align="left" valign="top"><b>9</b></td><td align="char" valign="top" char=".">9.7</td><td align="left" valign="top"><i>R</i>-<b>20b</b></td><td align="char" valign="top" char=".">36</td></tr><tr valign="top"><td align="left" valign="top"><b>10</b></td><td align="char" valign="top" char=".">0.9</td><td align="left" valign="top"><i>R</i>-<b>21</b></td><td align="char" valign="top" char=".">44</td></tr><tr valign="top"><td align="left" valign="top"><b>11</b></td><td align="char" valign="top" char=".">19</td><td align="left" valign="top"><i>R</i>-<b>22</b></td><td align="char" valign="top" char=".">6.0</td></tr><tr valign="top"><td align="left" valign="top"><b>12a</b></td><td align="char" valign="top" char=".">3.7</td><td align="left" valign="top">S-<b>22</b></td><td align="char" valign="top" char=".">39</td></tr><tr valign="top"><td align="left" valign="top"><b>12b</b></td><td align="char" valign="top" char=".">3.4</td><td align="left" valign="top"><i>R</i>-<b>23</b></td><td align="char" valign="top" char=".">2.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last"> Data are the average of two or more independent measurements.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinity (<i>K</i><sub>i</sub>, nM) at the Melanocortin Receptor Subtypes,<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a> Functional Activity at MC4R and Measured LogD Values of Some MC4R Antagonists</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th class="rowsep1" colspan="4" align="center">binding affinity (<i>K</i><sub>i</sub>, nM)</th><th align="center" char=".">MC4R function</th><th align="center" char="."> </th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">cmpd</th><th class="rowsep1" align="center">MC1<a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a></th><th class="rowsep1" align="center" char=".">MC3</th><th class="rowsep1" align="center" char=".">MC4</th><th class="rowsep1" align="center" char=".">MC5</th><th class="rowsep1" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#tbl2-fn3" aria-label="c">c</a> (nM)</th><th class="rowsep1" align="center" char=".">LogD<a class="ref internalNav" href="#tbl2-fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>7</b></td><td align="left" valign="top">(23%)</td><td align="char" valign="top" char=".">320</td><td align="char" valign="top" char=".">14</td><td align="char" valign="top" char=".">86</td><td align="char" valign="top" char=".">1700</td><td align="char" valign="top" char=".">4.5</td></tr><tr valign="top"><td align="left" valign="top"><b>8</b></td><td align="left" valign="top">3100</td><td align="char" valign="top" char=".">1300</td><td align="char" valign="top" char=".">25</td><td align="char" valign="top" char=".">1000</td><td align="char" valign="top" char=".">570</td><td align="char" valign="top" char=".">3.0</td></tr><tr valign="top"><td align="left" valign="top"><b>10</b></td><td align="left" valign="top">(38%)</td><td align="char" valign="top" char=".">750</td><td align="char" valign="top" char=".">0.9</td><td align="char" valign="top" char=".">850</td><td align="char" valign="top" char=".">21</td><td align="char" valign="top" char=".">1.8</td></tr><tr valign="top"><td align="left" valign="top"><b>11</b></td><td align="left" valign="top">(18%)</td><td align="char" valign="top" char=".">1200</td><td align="char" valign="top" char=".">19</td><td align="char" valign="top" char=".">500</td><td align="char" valign="top" char=".">1300</td><td align="char" valign="top" char=".">4.5</td></tr><tr valign="top"><td align="left" valign="top"><b>12a</b></td><td align="left" valign="top">(34%)</td><td align="char" valign="top" char=".">2800</td><td align="char" valign="top" char=".">3.7</td><td align="char" valign="top" char=".">710</td><td align="char" valign="top" char=".">160</td><td align="char" valign="top" char=".">2.4</td></tr><tr valign="top"><td align="left" valign="top"><b>12b</b></td><td align="left" valign="top">(20%)</td><td align="char" valign="top" char=".">710</td><td align="char" valign="top" char=".">3.4</td><td align="char" valign="top" char=".">600</td><td align="char" valign="top" char=".">930</td><td align="char" valign="top" char=".">3.9</td></tr><tr valign="top"><td align="left" valign="top"><b>13</b></td><td align="left" valign="top">8400</td><td align="char" valign="top" char=".">820</td><td align="char" valign="top" char=".">0.6</td><td align="char" valign="top" char=".">520</td><td align="char" valign="top" char=".">19</td><td align="char" valign="top" char=".">3.9</td></tr><tr valign="top"><td align="left" valign="top"><i>R</i>-<b>23</b></td><td align="left" valign="top">6400</td><td align="char" valign="top" char=".">3300</td><td align="char" valign="top" char=".">2.5</td><td align="char" valign="top" char=".">1200</td><td align="char" valign="top" char=".">49</td><td align="char" valign="top" char=".">3.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Data are the average of two or more independent measurements.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">The percentage inhibition at 10 µM concentration is indicated in parenthesis.</p></div><div class="footnote" id="tbl2-fn3"><sup>c</sup><p class="last">Dose-dependent inhibition of α-MSH-stimulated cAMP production via MC4R.</p></div><div class="footnote" id="tbl2-fn4"><sup>d</sup><p class="last">The logD value was measured using a shake-flake method.</p></div></div></div><div class="NLM_p">While the benzylamine <b>5</b> displayed a <i>K</i><sub>i</sub> of 75 nM, its glycine derivative <b>11</b> (<i>K</i><sub>i</sub> = 19 nM) exhibited increased potency. The 2-methyl-3-(2-methoxy-4-chlorophenyl)propionyl analog <b>7</b> (<i>K</i><sub>i</sub> = 14 nM) was over 5-fold better than <b>5</b> in binding affinity. Incorporating a <i>N</i>,<i>N</i>-dimethylpropionyl group at the benzyl nitrogen of <b>8</b> (<i>K</i><sub>i</sub> = 25 nM) improved the potency by about 7-fold (<b>12a</b>, <i>K</i><sub>i</sub> = 3.7 nM). Replacing the methyl group of <b>12a</b> with a chlorine gave an analog with the similar potency (<b>12b</b>, <i>K</i><sub>i</sub> = 3.4 nM). The pyrrolidinone <b>9</b> possessed a <i>K</i><sub>i</sub> value of 9.7 nM, which was increased by 10-fold when an aminoethyl group was attached (<b>10</b>, <i>K</i><sub>i</sub> = 0.9 nM). In comparison, the <i>N</i>,<i>N</i>-dimethylaminopropionamide <b>13</b> (<i>K</i><sub>i</sub> = 0.6 nM) also exhibited subnanomolar binding affinity.</div><div class="NLM_p">For the pyridine compounds <b>20a</b>, the <i>R</i>-configured compound <i>R</i>-<b>20a</b> (<i>K</i><sub>i</sub> = 260 nM) was more potent than its <i>S</i>-isomer (<i>S</i>-<b>20a</b>, <i>K</i><sub>i</sub> = 890 nM), the opposite of what was seen in the benzylamine series.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Incorporating a 2-methyl moiety at the 3-(2,4-dichlorophenyl)propionyl group of <i>R</i>-<b>20a</b> resulted in a more potent molecule (<i>R</i>-<b>20b</b>, <i>K</i><sub>i</sub> = 36 nM). Adding a glycine to <i>R</i>-<b>20b</b> improved its potency by 6-fold (<i>R</i>-<b>22</b>, <i>K</i><sub>i</sub> = 6 nM), parallel to the result of benzylamines <b>5</b> and <b>11</b>. Incorporating a methyl group at the 6-position of the pyridine <i>R</i>-<b>20b</b> had little effect on its binding affinity (<i>R</i>-<b>21</b>, <i>K</i><sub>i</sub> = 44 nM). An almost 20-fold increase in binding affinity from <i>R</i>-<b>21</b> was observed for the <i>N</i>,<i>N</i>-dimethylaminopropionamide derivative (<i>R</i>-<b>23</b>, <i>K</i><sub>i</sub> = 2.5 nM). The potencies of the pyridine derivatives <i>R</i>-<b>20</b>–<b>23</b> were quite similar to those of the phenyl analogs (<b>5</b> and <b>7</b>–<b>13</b>). In the solid state, the piperazine plane was orthogonal to the pyridine ring in 2-piperazinepyridine <i>R</i>-<b>19b</b> reflected by its X-ray crystal structure (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). This conformational feature is also observed for benzene analogs such as Boc-<b>6a</b>,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> although the overlay of these two X-ray structures indicates that the sulfinylamides point in different directions (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of pyridylpiperazine <i>R</i>-<b>19</b> and phenylpiperazine <b>6a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Most of these compounds (<b>7</b>, <b>8</b>, <b>10</b>–<b>13</b> and <i>R</i>-<b>23</b>) were very selective at MC4R over the other melanocortin receptor subtypes (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). For example, the pyridine compound <i>R</i>-<b>23</b> displayed at least 500-fold selectivity over the other receptor subtypes. The only exception was <b>7</b>, which only exhibited 6-fold selectivity at the MC5 receptor compared to MC4R. All of the compounds tested in the functional agonist assay showed no significant stimulation of cAMP accumulation via MC4R at up to 10 µM (data not shown). In the functional antagonist assay, all compounds displayed dose-dependent inhibition of α-MSH-stimulated cAMP accumulation with various potencies (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The functional IC<sub>50</sub> values were typically 20- to 30-fold higher than the binding affinity <i>K</i><sub>i</sub> values, possibly due to the different assay conditions. However, compounds <b>7</b>, <b>11</b>, and <b>12b</b> exhibited a much larger separation between their <i>K</i><sub>i</sub> and IC<sub>50</sub> values. It is worth noting that these compounds were highly lipophilic, with measured logD values of >3.9 (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Pharmacokinetics</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>7</b>, <b>8</b>, <b>10</b>, <b>11</b>, <b>12b</b>, and <i>R</i>-<b>22</b> were studied in mice for their pharmacokinetic properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). After an intravenous (i.v.) injection at a 5 mg/kg dose, the benzylamine <b>7</b> displayed a high plasma clearance (CL = 62.3 mL/min.kg). Despite its high volume of distribution (<i>V</i><sub>d</sub> = 10.3 L/kg), <b>7</b> had a short half-life (<i>t</i><sub>1/2</sub> = 1.9 h), indicative of fast elimination in this species. A concentration of 735 ng/g was detected in the brain at the 1 h time point post-dosing, indicating high brain penetration. A brain/plasma (b/p) ratio of 2.3 was calculated at this time point. The absorption of this compound was very fast after a 10 mg/kg oral gavage (p.o.), and a maximal concentration (<i>C</i><sub>max</sub> = 99 ng/mL) appeared at 0.25 h (<i>T</i><sub>max</sub>), resulting in an area under curve (AUC) of 249 ng/mL·h and a low oral bioavailability (<i>F</i>% = 8.6). In comparison, the benzylamine <b>8</b> had a moderate plasma clearance (CL = 33.3 mL/min·kg) and a high <i>V</i><sub>d</sub> value of 10.2 L/kg, resulting in a <i>t</i><sub>1/2</sub> of 3.5 h. The lipophilicity of <b>8</b> (LogD = 3.0) was significantly lower than that of <b>7</b> (LogD = 4.5), which might contribute to its lower plasma clearance. The brain penetration of <b>8</b> was high (b/p = 2.9 and 1.4 at 1 h and 4 h, respectively) and its oral bioavailability increased to 34% compared to <b>7</b>. The less lipophilic diamine <b>10</b> (logD = 1.8) had a low plasma clearance despite its high tissue distribution (<i>V</i><sub>d</sub> = 13 L/kg), resulting in a very long <i>t</i><sub>1/2</sub> of 10 h in mice. However, this compound had low brain penetration, with a b/p ratio of 0.14–0.23. In an in vitro Caco-2 assay, <b>10</b> exhibited a <i>P</i><sub>app</sub> of 20 nm/s from apical to basolateral direction, which was not significantly different from that of compound <b>8</b> (<i>P</i><sub>app</sub> = 18 nm/s). Its permeation from the basolateral to apical direction was about 3.4-fold higher than the apical to basolateral direction (ba/ab ratio = 3.4), suggesting a possible efflux mechanism involving P-glycoprotein.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> However, this value was also similar to that of <b>8</b> (ba/ab ratio = 4.4), indicating that the P-glycoprotein transporter might not be the only determinant for the difference between these two compounds in brain penetration. The plasma exposure of <b>10</b> after oral dosing was high (AUC = 1950 ng/mL.h), and the absolute bioavailability was about 20%.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Profiles of MC4R Antagonists in CD-1 Mice<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">cmpd</th><th class="rowsep1" align="center" char=".">CL (mL/min·kg)</th><th class="rowsep1" align="center" char="."><i>V</i><sub>d</sub> (L/kg)</th><th class="rowsep1" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="rowsep1" align="center" char="."><i>C</i><sub>b</sub> (ng/g) at 1, 4 h</th><th class="rowsep1" align="center" char=".">b/p ratio at 1, 4 h</th><th class="rowsep1" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="rowsep1" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="rowsep1" align="center" char=".">oral AUC (ng/mL.h)</th><th class="rowsep1" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>7</b></td><td align="char" valign="top" char=".">62.3</td><td align="char" valign="top" char=".">10.3</td><td align="char" valign="top" char=".">1.9</td><td align="char" valign="top" char=".">735, 122</td><td align="char" valign="top" char=".">2.3, 1.9</td><td align="char" valign="top" char=".">0.25</td><td align="char" valign="top" char=".">99</td><td align="char" valign="top" char=".">249</td><td align="char" valign="top" char=".">8.6</td></tr><tr valign="top"><td align="left" valign="top"><b>8</b></td><td align="char" valign="top" char=".">33.3</td><td align="char" valign="top" char=".">10.2</td><td align="char" valign="top" char=".">3.5</td><td align="char" valign="top" char=".">940, 330</td><td align="char" valign="top" char=".">2.9, 1.4</td><td align="char" valign="top" char=".">0.5</td><td align="char" valign="top" char=".">267</td><td align="char" valign="top" char=".">1762</td><td align="char" valign="top" char=".">34.4</td></tr><tr valign="top"><td align="left" valign="top"><b>10</b></td><td align="char" valign="top" char=".">15</td><td align="char" valign="top" char=".">13</td><td align="char" valign="top" char=".">10</td><td align="char" valign="top" char=".">63, 53</td><td align="char" valign="top" char=".">0.14, 0.23</td><td align="char" valign="top" char=".">2.0</td><td align="char" valign="top" char=".">552</td><td align="char" valign="top" char=".">1950</td><td align="char" valign="top" char=".">19.5</td></tr><tr valign="top"><td align="left" valign="top"><b>11</b></td><td align="char" valign="top" char=".">26.9</td><td align="char" valign="top" char=".">8.8</td><td align="char" valign="top" char=".">3.8</td><td align="char" valign="top" char=".">43, 33</td><td align="char" valign="top" char=".">0.08, 0.17</td><td align="char" valign="top" char=".">2.0</td><td align="char" valign="top" char=".">115</td><td align="char" valign="top" char=".">687</td><td align="char" valign="top" char=".">11.2</td></tr><tr valign="top"><td align="left" valign="top"><b>12b</b></td><td align="char" valign="top" char=".">36</td><td align="char" valign="top" char=".">11</td><td align="char" valign="top" char=".">3.5</td><td align="char" valign="top" char=".">800, 177</td><td align="char" valign="top" char=".">2.4, 2.2</td><td align="char" valign="top" char=".">0.5</td><td align="char" valign="top" char=".">132</td><td align="char" valign="top" char=".">1160</td><td align="char" valign="top" char=".">23.0</td></tr><tr valign="top"><td align="left" valign="top"><i>R</i>-<b>22</b></td><td align="char" valign="top" char=".">37.4</td><td align="char" valign="top" char=".">16.8</td><td align="char" valign="top" char=".">5.2</td><td align="char" valign="top" char=".">35, 14</td><td align="char" valign="top" char=".">0.07, 0.15</td><td align="char" valign="top" char=".">0.5</td><td align="char" valign="top" char=".">288</td><td align="char" valign="top" char=".">551</td><td align="char" valign="top" char=".">12.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Three animals were dosed intravenously at 5 mg/kg and orally at 10 mg/kg; brain concentrations were taken from the i.v. dosing.</p></div></div></div><div class="NLM_p">The aminoacetamide <b>11</b> had a moderate plasma clearance, but its brain penetration was low, similar to <b>10</b>. This phenomenon might be associated with the high polar surface area of these two compounds (PSA = 79 and 82 Å<sup>2</sup> for <b>11</b> and <b>10</b>, respectively). The <i>N</i>,<i>N</i>-dimethylpropionamide <b>12b</b> displayed a moderate clearance and a <i>t</i><sub>1/2</sub> of 3.5 h. Its brain penetration was much better (b/p ratio = 2.2–2.4, PSA = 56 Å<sup>2</sup>) than the diamine <b>10</b> and the aminoacetamide <b>11</b>. The oral absorption of <b>12b</b> was fast (<i>T</i><sub>max</sub> = 0.5 h) and the oral bioavailability was 23% in this species. The pyridine <i>R</i>-<b>22</b> was also profiled in this study, and its PK parameters were not significantly different from that of its close phenyl analog <b>11</b>, except for a higher <i>V</i><sub>d</sub> value, which resulted in a longer <i>t</i><sub>1/2</sub>.</div><div class="NLM_p">Because the <i>N</i>,<i>N</i>-dimethylpropionamide <b>12b</b> exhibited a desirable PK profile in mice (high brain penetration, good oral bioavailability, and moderate <i>t</i><sub>1/2</sub>), this compound and its close analogs <b>12a</b>, <b>13</b>, and <i>R</i>-<b>23</b> were also profiled in rats for their pharmacokinetic properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compounds <b>12a</b> and <b>12b</b> displayed very similar profiles in rats. The volume of distribution of <b>12b</b> (<i>V</i><sub>d</sub> = 2.5 L/kg) was much lower than that in mice, which resulted in a shorter <i>t</i><sub>1/2</sub> (2.2 h). Absorption was slow and the <i>C</i><sub>max</sub> appeared at 6 h after oral dosing. The whole brain concentration of <b>12b</b> in rats was much lower than that in mice, and the b/p ratio was observed to be 0.1 and 0.3, respectively, at the 1 and 4 h time points after an oral administration. Compound <b>13</b>, which had a similar lipophilic profile to <b>12b</b>, displayed a large <i>V</i><sub>d</sub> in this species. However, its <i>t</i><sub>1/2</sub> was not much longer than that of <b>12b</b> due to the high plasma clearance. The pyridine compound <i>R</i>-<b>23</b> had a very large <i>V</i><sub>d</sub> of 18.6 L/kg, which might be associated with its moderate basicity of the 2-aminopyridine structure (calculated p<i>K</i><sub>a</sub> = 9.3 for piperazinepyridine), although its measured lipophilicity at pH 7.4 (logD = 3.3) was only slightly lower than its close phenyl analog <b>12b</b> (logD = 3.9). The plasma clearance of <i>R</i>-<b>23</b> was high (CL = 64.9 mL/min.kg), which resulted in a moderate <i>t</i><sub>1/2</sub> of 3.3 h. Its plasma exposure and brain concentration after oral dosing was low. Overall, this pyridine compound did not show a better PK profile than its phenyl analogs such as <b>12b</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Profiles of <b>12a</b>,<b>b</b>, <b>13</b>, and <i>R</i>-<b>23</b> in Sprague–Dawley Rats<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">cmpd</th><th class="rowsep1" align="center" char=".">CL (mL/min·kg)</th><th class="rowsep1" align="center" char="."><i>V</i><sub>d</sub> (L/kg)</th><th class="rowsep1" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="rowsep1" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="rowsep1" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="rowsep1" align="center" char=".">oral AUC (ng/mL·h)</th><th class="rowsep1" align="center" char="."><i>F</i>(%)</th><th class="rowsep1" align="center"><i>C</i><sub>b</sub> (ng/g) at 1, 4 h</th><th class="rowsep1" align="center" char=".">b/p ratio at 1, 4 h</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>12a</b></td><td align="char" valign="top" char=".">15.0</td><td align="char" valign="top" char=".">4.1</td><td align="char" valign="top" char=".">3.1</td><td align="char" valign="top" char=".">5.3</td><td align="char" valign="top" char=".">196</td><td align="char" valign="top" char=".">2358</td><td align="char" valign="top" char=".">19</td><td align="left" valign="top">12, 36</td><td align="char" valign="top" char=".">0.2, 0.3</td></tr><tr valign="top"><td align="left" valign="top"><b>12b</b></td><td align="char" valign="top" char=".">13.0</td><td align="char" valign="top" char=".">2.5</td><td align="char" valign="top" char=".">2.2</td><td align="char" valign="top" char=".">6.0</td><td align="char" valign="top" char=".">163</td><td align="char" valign="top" char=".">1867</td><td align="char" valign="top" char=".">18</td><td align="left" valign="top">3, 27</td><td align="char" valign="top" char=".">0.1, 0.3</td></tr><tr valign="top"><td align="left" valign="top"><b>13</b></td><td align="char" valign="top" char=".">38.7</td><td align="char" valign="top" char=".">8.8</td><td align="char" valign="top" char=".">2.6</td><td align="char" valign="top" char=".">4.0</td><td align="char" valign="top" char=".">40</td><td align="char" valign="top" char=".">393</td><td align="char" valign="top" char=".">8.7</td><td align="left" valign="top">1.5, 15</td><td align="char" valign="top" char=".">0.2, 0.3</td></tr><tr valign="top"><td align="left" valign="top"><i>R</i>-<b>23</b><a class="ref internalNav" href="#tbl4-fn2" aria-label="b">b</a></td><td align="char" valign="top" char=".">64.9</td><td align="char" valign="top" char=".">18.6</td><td align="char" valign="top" char=".">3.3</td><td align="char" valign="top" char=".">2.0</td><td align="char" valign="top" char=".">60</td><td align="char" valign="top" char=".">517</td><td align="char" valign="top" char=".">19.6</td><td align="left" valign="top">15, 29</td><td align="char" valign="top" char=".">0.2, 0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Three animals were dosed intravenously at 5 mg/kg and orally at 10 mg/kg; brain concentrations were taken from p.o. dosing.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">i.v. dose at 2.5 mg/kg.</p></div></div></div><div class="NLM_p">The pharmacokinetic properties of <b>12b</b> were also profiled in monkeys and dogs (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The volume of distribution of <b>12b</b> was high in both dogs (<i>V</i><sub>d</sub> = 11.8 L/kg) and monkeys (<i>V</i><sub>d</sub> = 8.5 L/kg), which matched that in mice (<i>V</i><sub>d</sub> = 11 L/Kg), but not in rats (<i>V</i><sub>d</sub> = 2.5 L/kg). The low <i>V</i><sub>d</sub> value in rats may be associated with a species-specific phenomenon (e.g., high plasma protein binding). The half-life (4.7 and 4.1 h, respectively, for dogs and monkeys) was moderate and the oral bioavailability was good in dogs, but lower in monkeys.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Properties of <b>12b</b> in Dogs and Monkeys<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">species</th><th class="rowsep1" align="center" char=".">dog</th><th class="rowsep1" align="center" char=".">monkey</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">i.v. dose (mg/kg)</td><td align="char" valign="top" char=".">5</td><td align="char" valign="top" char=".">5</td></tr><tr valign="top"><td align="left" valign="top">CL (ml/min·kg)</td><td align="char" valign="top" char=".">29.4</td><td align="char" valign="top" char=".">24.3</td></tr><tr valign="top"><td align="left" valign="top"><i>V</i><sub>d</sub> (L/kg)</td><td align="char" valign="top" char=".">11.8</td><td align="char" valign="top" char=".">8.5</td></tr><tr valign="top"><td align="left" valign="top"><i>t</i><sub>1/2</sub> (h)</td><td align="char" valign="top" char=".">4.7</td><td align="char" valign="top" char=".">4.1</td></tr><tr valign="top"><td align="left" valign="top">AUC (ng/ml·h)</td><td align="char" valign="top" char=".">2509</td><td align="char" valign="top" char=".">3700</td></tr><tr valign="top"><td align="left" valign="top">p.o. dose (mg/kg)</td><td align="char" valign="top" char=".">10</td><td align="char" valign="top" char=".">10</td></tr><tr valign="top"><td align="left" valign="top"><i>C</i><sub>max</sub> (ng/mL)</td><td align="char" valign="top" char=".">142</td><td align="char" valign="top" char=".">108</td></tr><tr valign="top"><td align="left" valign="top"><i>T</i><sub>max</sub> (h)</td><td align="char" valign="top" char=".">1.0</td><td align="char" valign="top" char=".">2.7</td></tr><tr valign="top"><td align="left" valign="top">AUC (ng/mL·h)</td><td align="char" valign="top" char=".">1475</td><td align="char" valign="top" char=".">1070</td></tr><tr valign="top"><td align="left" valign="top"><i>F</i> (%)</td><td align="char" valign="top" char=".">29.4</td><td align="char" valign="top" char=".">13.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Data are the average of three animals.</p></div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">In Vivo Efficacy in Mouse Cachexia Model</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previously we have shown that when administered twice daily (3 mg/kg s.c.) for 4 days to C57BL6, mice bearing subcutaneous Lewis lung carcinoma tumors, <b>10</b>, stimulated food intake by 82% relative to vehicle-treated controls. The lean body mass of the tumor-bearing mice treated with <b>10</b> (−0.5%) significantly increased (9%) over that of tumor-vehicle treated animals (−9.5%), demonstrating a positive effect in this cachexia model.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">For the current in vivo study, C57BL/6J male mice were inoculated with Lewis lung carcinoma (LLC) tumor cells. Beginning 11 days after LLC inoculation, animals were treated over 4 days with <b>12b</b> twice daily (3 and 9 mg/kg, i.p.). LLC tumor bearing mice treated with a high dose of <b>12b</b> showed a significant increase in food intake relative to vehicle-treated tumor bearing controls (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). Body weight was also significantly increased in mice treated with <b>12b</b> in both dose groups. Analysis of body composition with dual-energy X-ray absorbatometry (DEXA) demonstrated that the greater increase of body weight in <b>12b</b>-treated mice was due to sparing of lean body mass (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Tumor bearing animals treated with vehicle demonstrated an ∼2% increase in lean body mass (LBM) over the course of the 14 day experiment, whereas tumor-bearing animals treated with <b>12b</b> increased their LBM by ∼7% for the 3 mg/kg group and ∼15% for the 9 mg/kg group, demonstrating a dose–response effect.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The effects of compound <b>12b</b> (i.p., 3 and 9 mg/kg twice per day) on food intake (4A, left) and lean body mass (4B, right) in tumor-bearing mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Pharmacokinetic and Pharmacodynamic Relationship</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The binding affinity (<i>K</i><sub>i</sub>) of <b>12b</b> at the mouse melanocortin-4 receptor was determined to be 18 nM, which was much lower than that of <b>10</b> (<i>K</i><sub>i</sub> = 0.71 nM at mouse MC4R). It also bound to the mouse melanocortin-3 receptor with a moderate affinity (<i>K</i><sub>i</sub> = 340 nM). We profiled the pharmacokinetics of <b>12b</b> in CD-1 mice via an intraperitoneal (i.p.) administration of a 10 mg/kg dose. Compound <b>12b</b> reached a maximal plasma concentration (<i>C</i><sub>max</sub>) of 1521 ng/mL (∼2.7 µM, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). At 8 h post-dosing, the plasma concentration was about 100 ng/mL (∼0.18 µM). Therefore, although the free fraction of the compound in the brain was unknown, the total brain concentration of <b>12b</b> at any time point during the in vivo efficacy study should have been 5-fold above its <i>K</i><sub>i</sub> value (18 nM) for a twice a day administration at a 3 mg/kg dose, considering its high brain/plasma ratio of ∼2 and assuming linear pharmacokinetics.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time–concentration curve of <b>12b</b> after an i.p. administration (10 mg/kg) to CD-1 mice (<i>n</i> = 3; <i>C</i><sub>max</sub> = 1521 ng/mL; <i>T</i><sub>max</sub> = 0.3 h; AUC = 3073 ng/mL·h).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because ghrelin agonists have demonstrated efficacy in cachexia models,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> we also measured these MC4 antagonists against the ghrelin receptor in vitro. Compound <b>10</b> was a moderately potent full agonist of the ghrelin receptor, with an EC<sub>50</sub> value of 79 nM (107% intrinsic activity). In comparison, <b>12b</b> was a much weaker partial agonist with an EC<sub>50</sub> of 720 nM and IA of 47% at the ghrelin receptor.</div><div class="NLM_p last">Both <b>10</b> and <b>12b</b> exhibited low binding affinity at the ghrelin receptor. Compound <b>10</b> had 100-fold selectivity for the mouse MC4R over the ghrelin receptor (<i>K</i><sub>i</sub> of 0.7 nM and 720 nM, respectively) and <b>12b</b> had a <i>K</i><sub>i</sub> value of 460 on the ghrelin receptor. The extent to which the ghrelin component of these compounds contributes to the efficacy in the mouse cachexia model is unclear, but unlikely to be significant, especially for compound <b>12b</b> due to its low intrinsic activity.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Metabolic Profile of 12b</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Compound <b>12b</b> was a fairly lipophilic molecule with a logD value of 3.9, measured by a shake-flask method. It did not show significant inhibitory activity at the major liver enzymes CYP1A2, CYP3A4, CYP2D6, CYP2C9, and CYP2C19 (IC<sub>50</sub> > 10 µM). In liver microsomes of various species, <b>12b</b> showed moderate metabolic stability and the scaled systemic clearances were 57, 35, 38.1, 17.1, and 18.5 mL/min·kg, respectively, in mouse, rat, monkey, dog, and human. After incubation with human liver microsomes, two major metabolites were observed. The metabolic profiles were similar in liver microsomes of CD-1 mice, Sprague–Dawley rats, rhesus monkeys, and beagle dogs. One of the major metabolites was identified as the <i>N</i>-demethylation product. The other was characterized as the hydroxylation of the piperazine ring based on MS-MS analyses.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03436" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03436" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, a series of α-isobutylbenzylamine derivatives <b>7</b>–<b>13</b> were synthesized and studied as potent and selective antagonists of the melanocortin-4 receptor. Pyridine alternatives <b>20</b>–<b>23</b> were also studied to compare to their benzene analogs. Although potent and selective MC4R antagonists such as <i>R</i>-<b>23</b> were identified, and these pyridine derivatives did not exhibit an advantage in pharmacokinetic properties over their phenyl analogs. Compounds <b>10</b> and <b>12b</b> were tested in a murine cachexia model and efficacy was demonstrated. Our results provide more evidence that a potent and selective MC4R antagonist has a potential utility in the treatment of cancer cachexia.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28053" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28053" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div id="sec9_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Methods</h4><div class="NLM_p last">NMR spectra were recorded on a Varian 300 MHz spectrometer with TMS as an internal standard. <sup>13</sup>C NMR spectra were recorded at 75 MHz. Chemical shifts are reported in parts per million (δ), and signals are expressed as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), or br (broad). High resolution mass spectra were measured at the Scripps Center for Mass Spectrometry using MALDI-FTMS. Purity measurements were performed on an HP Agilent 1100 HPLC-MS (detection at 220 and 254 nm).</div></div><div id="sec9_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (1<i>S</i>)-[2-{4-[3-(2,4-Dichlorophenyl)propionyl]-1-piperazinyl}-5-(trifluoromethyl)phenyl]-3-methylbutylamine Trifluoroacetate (<b>5</b>)</h4><div class="NLM_p last">Trifluoroacetic acid (0.2 mL) was added to a solution of 4-{2-[(1<i>S</i>)-((<i>S</i>)-<i>tert</i>-butanesulfinylamino)-3-methylbutyl]- 4-(trifluoromethyl)phenyl}-1-piperazinecarboxylic acid <i>tert</i>-butyl ester (<b>6a</b>, 50 mg, 0.096 mmol) in dichloromethane (0.8 mL), and the mixture was stirred at r.t. for 50 min. The reaction mixture was basified with saturated aqueous NaHCO<sub>3</sub> solution (5 mL) and extracted with EtOAc (30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to provide 4-{2-[(1<i>S</i>)-((<i>S</i>)-<i>tert</i>-butanesulfinylamino)-3-methylbutyl]-4-trifluoromethylphenyl}-1-piperazine as white foam, which was dissolved in DMF/dichloromethane (1:3, 1 mL). NaHCO<sub>3</sub> (16.2 mg, 0.192 mmol), 3-(2,4-dichlorophenyl)propionic acid (25.3 mg, 0.12 mmol), HOBt (15.5 mg, 0.12 mmol), and EDC (22.0 mg, 0.12 mmol) were sequentially added to this solution. The reaction mixture was stirred at r.t. overnight, diluted with EtOAc (20 mL), washed with 5% aqueous HCl (5 mL), saturated aqueous NaHCO<sub>3</sub> (5 mL), and brine (5 mL), and dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was concentrated in vacuo to provide a crude product that was dissolved in MeOH (2 mL) and treated with HCl (58 µL 4 N HCl in dioxane). The mixture was stirred at r.t. for 1 h and concentrated in vacuo. The residue was purified by flash column chromatography (5∼15% MeOH in dichloromethane) to provide the titled compound <b>5</b> as a yellowish foam (55.2 mg, 93%). HPLC purity: 100% (220 and 254 nm); <sup>1</sup>H NMR (CD<sub>3</sub>OD, TFA salt): 0.96 (d, <i>J</i> = 6.6 Hz, 3H), 1.04 (d, <i>J</i> = 6.6 Hz, 3H), 1.38–1.52 (m, 1H), 1.68–1.80 (m, 1H), 1.80–1.92 (m, 1H), 2.77 (t, <i>J</i> = 7.5 Hz, 2H), 2.82–3.12 (m, 5H), 3.21–3.27 (m, 2H), 3.50–3.80 (m, 3H), 5.00–5.08 (m, 1H), 7.22–7.38 (m, 3H), 7.46 (d, <i>J</i> = 1.8 Hz, 1H), 7.73 (dd, <i>J</i> = 1.8, 8.3 Hz, 1H), 7.83 (d, <i>J</i> = 1.8 Hz, 1H). MS: 516 (MH<sup>+</sup>).</div></div><div id="sec9_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(1<i>S</i>-[2-{4-[3-(4-Chlorophenyl)propionyl]-1-piperazinyl}-5-(trifluoromethyl)phenyl]-3-methylbutyl)-2-aminoacetamide (<b>11</b>)</h4><div class="NLM_p last">In a 4 dram vial, the crude (1<i>S</i>)-(2-{4-[3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-5-(trifluoromethyl)phenyl)-3-methylbutylamine (<b>5</b>, 0.70 g), <i>N</i>-Boc-glycine (0.19 g, 1.35 mmol), NaHCO<sub>3</sub> (208 mg, 2.48 mmol), and HOBt (0.183 g, 1.35 mmol) were combined and dissolved in dichloromethane (3 mL). The mixture was capped and stirred at r.t. for 15 min. EDC (0.258 g, 1.35 mmol) was added, and the mixture was stirred for 1 h. The mixture was diluted with dichloromethane (2 mL) and washed with saturated aqueous NaHCO<sub>3</sub> (2 × 1 mL) and brine (1 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated by a stream of nitrogen. The residue was dissolved in (1:1) TFA/CH<sub>2</sub>Cl<sub>2</sub>, and the solution was stirred at r.t. for 30 min. The mixture was concentrated in vacuo, and the residue was purified by column chromatography on silica using 1:1 hexane/ethyl acetate as the eluent to afford the titled compound as a light yellow solid (55 mg, 70% yield). HPLC purity: 98% (220 nm) and 97% (254 nm). <sup>1</sup>H NMR (CD<sub>3</sub>OD, TFA salt): 0.97 (d, <i>J</i> = 6.2 Hz, 3H), 0.97 (d, <i>J</i> = 6.2 Hz, 3H), 1.22–1.35 (m, 1H), 1.37–1.50 (m, 1H), 1.52–1.68 (m, 1H), 2.56–2.70 (m, 2H), 2.77 (t, <i>J</i> = 7.5 Hz, 2H), 3.07 (t, <i>J</i> = 7.5 Hz, 2H), 3.15–3.27 (m, 2H), 3.50–3.90 (m, 6H), 5.65–5.72 (m, 1H), 7.24–7.38 (m, 3H), 7.46 (d, <i>J</i> = 2.2 Hz, 1H), 7.53 (dd, <i>J</i> = 1.8, 8.3 Hz, 1H), 7.60 (d, <i>J</i> = 1.8 Hz, 1H). MS: 573 (MH<sup>+</sup>). HRMS (MH<sup>+</sup>) calcd for C<sub>27</sub>H<sub>34</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>, 573.2011; found, 573.2009.</div></div><div id="sec9_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (1<i>S</i>)-[2-{4-[2-Methyl-3-(2-methoxy-4-chlorophenyl)propionyl]-1-piperazinyl}-5-(trifluoromethyl)phenyl]-3-methylbutylamine Mesylate (<b>7</b>)</h4><div class="NLM_p last">This compound was prepared using a procedure similar to that for <b>5</b> from <b>6a</b> and 2-methyl-3-(2-methoxyl-4-chlorophenyl)propionic acid. White powder; HPLC purity: 100% (220 and 254 nm). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 0.85 (d, <i>J</i> = 6.6 Hz, 3H), 0.92 (d, <i>J</i> = 6.3 Hz, 3H), 0.99 and 1.00 (d, <i>J</i> = 6.6 Hz, 3H), 1.38 (m, 1H), 1.53 (m, 1H), 1.76 (m, 1H), 2.29 (s, 3H, MsOH), 2.30–3.20 (m, 3H), 3.30–3.70 (m, 8H), 3.80 and 3.83 (s, 3H), 4.79 (m, 1H), 6.92–7.12 (m, 3H), 7.35 (t, <i>J</i> = 8.7 Hz, 1H), 7.72 (d, <i>J</i> = 8.1 Hz, 1H), 7.93 (s, 1H), 8.20 (brs, 3H). MS: 526 (MH<sup>+</sup>). Anal. (C<sub>27</sub>H<sub>35</sub>ClF<sub>3</sub>N<sub>3</sub>O<sub>2</sub>·MeSO<sub>3</sub>H·H<sub>2</sub>O) C, H, N.</div></div><div id="sec9_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (1<i>S</i>)-(2-{4-[(2<i>R</i>)-Methyl-3-(4-chlorophenyl)propionyl]-1-piperazinyl}-5-methylphenyl)-3-methylbutylamine Mesylate (<b>8</b>)</h4><div class="NLM_p last">This compound was prepared using a procedure similar to that for <b>5</b> from <b>6b</b> and 2<i>R</i>-methyl-3-(4-chlorophenyl)propionic acid (<b>16a</b>). White powder; HPLC purity: 97.9% (220 nm) and 97.7% (254 nm). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, free base): 0.84 (d, <i>J</i> = 6.0 Hz, 3H), 0.89 (d, <i>J</i> = 6.0 Hz, 3H), 1.04 (d, <i>J</i> = 6.6 Hz, 3H), 1.43 (m, 1H), 1.58 (m, 1H), 2.26 (s, 3H), 2.45 (m, 1H), 2.62 (dd, <i>J</i> = 5.7, 12.6 Hz, 1H), 2.80 (m, 3H), 2.90–3.50 (m, 8H), 4.56 (t, <i>J</i> = 6.9 Hz, 1H), 6.40 (brs, 1H), 6.94 (brs, 1H), 7.07 (d, <i>J</i> = 8.1 Hz, 1H), 7.24 (d, <i>J</i> = 8.1 Hz, 2H), 7.30 (s, 1H), 7.36 (d, <i>J</i> = 8.1 Hz, 2H). MS: 442 (MH<sup>+</sup>). Anal. (C<sub>26</sub>H<sub>36</sub>ClN<sub>3</sub>O·1.3MeSO<sub>3</sub>H·2.5H<sub>2</sub>O) C, H, N, S.</div></div><div id="sec9_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (1<i>S</i>)-(2-{4-[(2<i>R</i>)-(2-Oxo-1-pyrrolidinyl)-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-3-fluorophenyl)-3-methylbutylamine (<b>9</b>)</h4><div class="NLM_p">TFA (4.5 mL) was added to a solution of 4-{2-[(1<i>S</i>)-((<i>S</i>)-<i>tert</i>-butanesulfinylamino)-3-methylbutyl]- 6-fluorophenyl}-1-piperazinecarboxylic acid <i>tert</i>-butyl ester (<b>6d</b>, 1.02 g, 2.17 mmol) in dichloromethane (18 mL), and the mixture was stirred at r.t. for 45 min. The reaction mixture was basified with saturated aqueous NaHCO<sub>3</sub> solution (100 mL) and extracted with EtOAc (2 × 100 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to provide 4-{6-fluoro-2-[(1<i>S</i>)-((<i>S</i>)-<i>tert</i>-butylsulfinylamino)-3-methylbutyl]phenyl}-1-piperazine as white foam, which was dissolved in DMF/CH<sub>2</sub>Cl<sub>2</sub> (1:3, 12 mL). NaHCO<sub>3</sub> (0.365 g, 4.34 mmol), <i>N</i>-Boc-<span class="smallcaps smallerCapital">d</span>-(2,4-Cl)Phe-OH (0.871 g, 2.61 mmol), HOBt (0.352 g, 2.61 mmol), and EDC (0.50 g, 2.61 mmol) were sequentially added to this solution. The reaction mixture was stirred at r.t. overnight. The mixture was diluted with EtOAc (60 mL), washed with 5% aqueous HCl (15 mL), saturated aqueous NaHCO<sub>3</sub> (15 mL) and brine (15 mL), and was dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was concentrated in vacuo, and the residue was purified by flash column chromatography (30∼60% EtOAc in hexanes) to provide <i>N</i>-((1<i>S</i>)-[2-{4-[(2<i>R</i>)-(<i>tert</i>-butoxycarbonylamino)-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-3-fluorophenyl]-3-methylbutyl)-(<i>S</i>)-<i>tert</i>-butanesulfinamide as a white solid (1.295 g, 87%).</div><div class="NLM_p">TFA (1 mL) was added to a solution of the above compound (338 mg, 0.494 mmol) in dichloromethane (4 mL), and the mixture was stirred at r.t. for 1 h. The reaction mixture was basified with saturated aqueous NaHCO<sub>3</sub> solution (30 mL) and extracted with EtOAc (2 × 30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to provide <i>N</i>-((1<i>S</i>)-{2-[4-[(2<i>R</i>)-amino-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-3-fluorophenyl]-3-methylbutyl)-(<i>S</i>)-<i>tert</i>-butanesulfinamide as a white foam, which was dissolved in 1,2-dichloroethane (5 mL). This solution was treated with acetic acid (118 µL, 1.98 mmol) and succinic semialdehyde (374 µL 15 wt% solution in water, 0.592 mmol) and stirred for 30 min NaBH(OAc)<sub>3</sub> (220 mg, 0.987 mmol) was added, and the mixture was stirred at r.t. for 24 h. LC-MS showed the reductive amination was completed and the ratio of lactam product (M.W. = 653) to carboxylic acid product (M.W. = 671) was 1:1. The reaction was quenched with brine (10 mL), and the products were extracted with EtOAc (40 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was dissolved in DMF/CH<sub>2</sub>Cl<sub>2</sub> (1:3, 10 mL), and NaHCO<sub>3</sub> (0.083 g, 0.988 mmol), HOBt (0.080 g, 0.592 mmol), and EDC (0.113 g, 0.592 mmol) were sequentially added. The reaction mixture was stirred at r.t. overnight, diluted with EtOAc (60 mL), washed with 5% aqueous HCl (10 mL), saturated aqueous NaHCO<sub>3</sub> solution (10 mL), and brine (10 mL), and dried over Na<sub>2</sub>SO<sub>4</sub>. After filtration, the solution was concentrated in vacuo, and the residue was purified by flash column chromatography (40∼70% EtOAc in hexanes) to provide <i>N</i>-((1<i>S</i>)-{2-[4-[(2<i>R</i>)-(2-oxo-1-pyrrolidinyl)-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-3-fluorophenyl]-3-methylbutyl)-(<i>S</i>)-<i>tert</i>-butanesulfinamide as a white solid (0.239 g, 74%).</div><div class="NLM_p last">To a solution of the above compound (239 mg, 0.366 mmol) in MeOH (4 mL) was added 2 equiv HCl (183 µL, 4 N HCl in dioxane), and the mixture was stirred at r.t. for 30 min. The mixture was concentrated in vacuo to give the crude product. A small sample was purified using HPLC-MS. Light yellow foam; HPLC purity: 100% (220 nm). <sup>1</sup>H NMR (CD<sub>3</sub>OD, free base): 0.91 (d, <i>J</i> = 6.2 Hz, 3H), 0.95 (d, <i>J</i> = 6.2 Hz, 3H), 1.22–1.36 (m, 1H), 1.45–1.63 (m, 2H), 2.00–2.15 (m, 2H), 2.22–2.37 (m, 2H), 2.72–2.99 (m, 5H), 3.12–3.30 (m, 5H), 3.40–3.53 (m, 1H), 3.60–3.77 (m, 1H), 3.90–4.00 (m, 1H), 4.42–4.63 (m, 2H), 5.41–5.55 (m, 1H), 6.90–7.00 (m, 1H), 7.18–7.24 (m, 2H), 7.24–7.35 (m, 2H), 7.45 (dd, <i>J</i> = 1.8, 10.1 Hz, 1H). MS: 549 (MH<sup>+</sup>). HRMS (MH<sup>+</sup>) calcd for C<sub>28</sub>H<sub>36</sub>Cl<sub>2</sub>FN<sub>4</sub>O<sub>2</sub>, 549.2244; found, 549.2266.</div></div><div id="sec9_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(1-Aminoethyl)-<i>N</i>-[(1<i>S</i>)-(2-{4-[(2<i>R</i>)-(2-oxo-1-pyrrolidinyl)-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-3-fluorophenyl)-3-methylbutyl]amine Mesylate (<b>10</b>)</h4><div class="NLM_p last">A solution of (1<i>S</i>)-(2-{4-[(2<i>R</i>)-(2-oxo-1-pyrrolidinyl)-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-3-fluorophenyl)-3-methylbutylamine (<b>9</b>, 34.0 mg, 0.0615 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was treated with glacial acetic acid (7.4 µL) and <i>tert</i>-butyl-<i>N</i>-(2-oxoethyl)carbamate (14.7 mg, 0.0923 mmol).The mixture was stirred at r.t. for 30 min, and then NaBH(OAc)<sub>3</sub> (26.1 mg, 0.123 mmol) was added. The resulting suspension was stirred at room temperature for 14 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (10 mL), transferred to a separatory funnel, and washed with saturated NaHCO<sub>3</sub> aqueous solution (2 × 5 mL). The organic layers were dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel, eluting with ethyl acetate. The product was obtained as white foam, which was treated with 2 mL of TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:1) for 1 h. The excess of TFA and solvent were removed in vacuo, and the crude product was purified by flash column chromatography (5∼10% MeOH /CH<sub>2</sub>Cl<sub>2</sub>) to provide the titled product as a white solid (20 mg, 54%). The free base was converted to the mesylate salt by treatment with 1 equiv of methanesulfonic acid as a white solid; HPLC purity: 99% (220 nm) and 97.8% (254 nm). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 0.86 (d, <i>J</i> = 6.6 Hz, 3H), 0.92 (d, <i>J</i> = 6.6 Hz, 3H), 1.95 (m, 2H), 2.13 (m, 2H), 2.34 (s, 3H, MeSO<sub>3</sub>H), 2.60–3.45 (m, 16H), 3.60 (m, 2H), 4.38 (m, 1H), 4.43 (m, 1H), 5.25 (m, 1H), 5.31 (t, <i>J</i> = 7.8 Hz, 1H), 7.30 (brs, 3H), 7.39 (m, 5H), 7.57 (m, 1H). MS: 592 (MH<sup>+</sup>). Anal. (C<sub>30</sub>H<sub>40</sub>Cl<sub>2</sub>FN<sub>5</sub>O<sub>2</sub>·MeSO<sub>3</sub>H·3H<sub>2</sub>O) C, H, N.</div></div><div id="sec9_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-(1<i>S</i>-[2-{4-[(2<i>R</i>)-Methyl-3-(4-chlorophenyl)propionyl]-1-piperazinyl}-5-chlorophenyl]-3-methylbutyl)-3-(dimethylamino)propionamide Hydrochloride <b>(12b)</b></h4><div class="NLM_p">4-{2-[(1<i>S</i>)-((<i>S</i>)-<i>tert</i>-Butanesulfinylamino)-3-methylbutyl]-4-chlorophenyl}-1-piperazinecarboxylic acid <i>tert</i>-butyl ester (<b>6c</b>, 21.39 g, 44.1 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (440 mL) with magnetic stirring. Trifluoroacetic acid (88 mL) was added slowly, and the resulting solution was stirred at r.t. for 1 h. The reaction mixture was slowly poured into 0.5 M K<sub>2</sub>CO<sub>3</sub> (500 mL). After all the bubbling had ceased, the mixture was placed in a separatory funnel and the organic layer was separated. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and the combined organics were washed with water and brine, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give 4-{2-[(1<i>S</i>)-((<i>S</i>)-<i>tert</i>-butylsulfinylamino)-3-methylbutyl]-4-chlorophenyl}-1-piperazine as a pale yellow foam (18 g), which was used in the next step without further purification.</div><div class="NLM_p">(2<i>R</i>)-methyl-3-(4-chlorophenyl)propionic acid (<b>16a</b>, 10.1 g, 50.9 mmol), diisopropylethylamine (17.6 mL, 101 mmol), and HOBt (10.27 g, 76.1 mmol) were sequentially added to a stirring solution of the above compound (16.98 g, 44.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (220 mL) under N<sub>2</sub>. The resulting mixture was stirred at r.t. for 0.5 h. Then EDC (14.58 g, 76.1 mmol) was added portionwise, and the resulting solution was stirred at r.t. overnight. The reaction mixture was placed in a separatory funnel and washed with 0.1 N HCl (200 mL), water, saturated aqueous NaHCO<sub>3</sub>, and brine. The organics were dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel, eluting with a 3:1 v/v mixture of hexanes and ethyl acetate, which was gradually increased to a 1:2 ratio, to give <i>N</i>-((1<i>S</i>)-{2-[4-[(2<i>R</i>)-methyl-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-5-chlorophenyl]-3-methylbutyl)-(<i>S</i>)-<i>tert</i>-butanesulfinamide (13.80 g, 55% over 2 steps). <i><i>R</i><sub>f</sub></i> = 0.36 (1:1 v/v hexanes/EtOAc). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 0.87 (d, <i>J</i> = 6.6 Hz, 3H), 0.92 (d, <i>J</i> = 6.6 Hz, 3H), 1.19 (d, <i>J</i> = 5.7 Hz, 3H), 1.20 (s, 9H), 1.54–1.39 (m, 2H), 1.75–1.70 (m, 1H), 2.71–2.63 (m, 2H), 2.89–2.82 (m, 1H), 3.01–2.95 (m, 2H), 4.00–3.00 (br, 6H), 4.85 (br, 1H), 6.95 (br, 1H), 7.38–7.13 (m, 7H). MS: 566 (MH<sup>+</sup>).</div><div class="NLM_p">The above compound (13.78 g, 24.3 mmol) was dissolved in MeOH (243 mL), and HCl (2 M in ether, 15.81 mL, 31.61 mmol) was added. The reaction mixture was stirred at r.t. for 45 min. Nitrogen gas was then bubbled through the reaction mixture to evaporate residual HCl, and the remaining solvent was removed in vacuo. The residue was dissolved in dichloromethane (250 mL) and washed with saturated NaHCO<sub>3</sub> (3 × 250 mL) and brine (250 mL). The organic layer was separated, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo to give <i>N</i>-((1<i>S</i>)-(2-{4-[(2<i>R</i>)-methyl-3-(4-chlorophenyl)propionyl]-1-piperazinyl}-5-chlorophenyl)-3-methylbutylamine as an off-white foam in quantitative yield. This compound (11.3 g, 24.32 mmol) was dissolved in dichloromethane (122 mL) along with 3-dimethylaminopropionic acid hydrochloride (3.74 g, 24.32 mmol) and triethylamine (3.42 mL, 24.32 mmol). The reaction mixture was stirred at r.t. for 5 min and then HOBt (3.28 g, 24.3 mmol) was added. After another 5 min, EDC (4.66 g, 24.32 mmol) was added to the reaction mixture, and stirring was continued at r.t. for an additional 8 h. The reaction mixture was washed with saturated NaHCO<sub>3</sub> (3 × 250 mL) and brine (250 mL). The organic layer was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica using 5% methanol/dichloromethane as the eluent (<i>R<sub>f</sub></i> = 0.3) to give the desired product as a free base (10.35 g, 18.42 mmol, 76% yield). HPLC purity: 98.4% (220 nm) and 97.6% (254 nm). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 0.93 (d, <i>J</i> = 6.3 Hz, 3H), 0.94 (d, <i>J</i> = 6.3 Hz, 3H), 1.18 (d, <i>J</i> = 5.7 Hz, 3H), 1.22–1.60 (m, 3H), 2.20–2.70 (m, 10H) 2.35 (s, 6H), 2.70–3.62 (m, 5H), 5.44 (m, 1H), 6.89 (d, <i>J</i> = 8.7 Hz, 1H), 7.08 (d, <i>J</i> = 2.4 Hz, 1H), 7.16 (m, 3H), 7.27 (d, <i>J</i> = 8.4 Hz, 2H), 8.94 (d, <i>J</i> = 8.4 Hz, 1H). MS: 561 (MH<sup>+</sup>).</div><div class="NLM_p last"><i>N</i>-((1<i>S</i>)-[2-{4-[(2<i>R</i>)-Methyl-3-(4-chlorophenyl)propionyl]-1-piperazinyl}-5-chlorophenyl]-3-methylbutyl)-3-(dimethylamino)propionamide (10.02 g, 17.84 mmol) was dissolved in dichloromethane (90 mL). With constant stirring, HCl (2 M in ether, 13.38 mL, 26.76 mmol) was added in one portion. The reaction mixture was stirred at r.t. for 5 min and then nitrogen gas was bubbled through the reaction mixture for 10 min to evaporate excess HCl. The remaining solvent was removed in vacuo. Ether (200 mL) was then added to the solid residue, and the mixture was evaporated to dryness (repeated three times). The residual solid powder was then filtered off and washed with additional ether (3 × 200 mL). The solid was dried in a vacuum oven at 40 °C for 4 h and then at r.t. for 2 days. The product was recovered as a hydrochloride salt in 98% yield (10.49 g, 17.55 mmol) as an off-whiter powder. [α]<sup>25</sup><sub>D</sub> = −22.65 (1.04, MeOH). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 0.86 (d, <i>J</i> = 5.1 Hz, 6H), 1.02 (d, <i>J</i> = 6.6 Hz, 3H), 1.22 (m, 1H), 1.48 (m, 2H), 2.28 (m, 1H), 2.60 (m, 2H), 2.70 (s, 3H), 2.71 (s, 3H), 2.79 (m, 2H), 3.02 (m, 2H), 3.20 (m, 2H), 3.40 (m, 2H), 4.15 (brs, 4H), 5.33 (m, 1H), 6.97 (d, <i>J</i> = 8.1 Hz, 1H), 7.22 (m, 3H), 7.34 (m, 3H), 8.68 (d, <i>J</i> = 8.1 Hz, 1H), 10.2 (brs, 1H). MS: 561.3 (MH<sup>+</sup>). Anal. (C<sub>30</sub>H<sub>42</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>·HCl·2/3H<sub>2</sub>O) C, H, N.</div></div><div id="sec9_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-(1<i>S</i>-[2-{4-[(2<i>R</i>)-Methyl-3-(4-chlorophenyl)propionyl]-1-piperazinyl}-5-methylphenyl]-3-methylbutyl)-3-(dimethylamino)propanamide Mesylate (<b>12a</b>)</h4><div class="NLM_p last">This compound was synthesized using a procedure similar to that for <b>12b</b> from <b>6b</b>. HPLC purity: 100% (220 nm) and 95.1% (254 nm). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 0.86 (d, <i>J</i> = 6.6 Hz, 6H), 1.04 (d, <i>J</i> = 6.6 Hz, 3H), 1.22 (m, 1H), 1.46 (m, 2H), 2.22 (s, 3H), 2.30 (s, 3H, MeSO<sub>3</sub>H), 2.40 (m, 1H), 2.56 (m, 4H), 2.60 (s, 6H), 2.80 (m, 1H), 2.80–3.36 (m, 10H), 5.37 (m, 1H), 6.85 (brs, 1H), 6.98 (dd, <i>J</i> = 1.8, 8.4 Hz, 1H), 7.08 (d, <i>J</i> = 1.8 Hz, 1H), 7.24 (d, <i>J</i> = 8.1 Hz, 2H), 7.35 (s, <i>J</i> = 8.4 Hz, 2H), 8.44 (d, <i>J</i> = 8.1 Hz, 1H). MS: 541 (MH<sup>+</sup>). Anal. (C<sub>31</sub>H<sub>45</sub>ClN<sub>4</sub>O<sub>2</sub>·MeSO<sub>3</sub>H·1/2H<sub>2</sub>O) C, H, N, S.</div></div><div id="sec9_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-[(1<i>S</i>)-1-[2-[4-[(2<i>R</i>)-3-(2,4-Dichlorophenyl)-2-(2-oxo-1-pyrrolidinyl)propionyl]-1-piperazinyl]-5-methylphenyl]-3-methylbutyl]-3-(dimethylamino)propanamide Mesylate (<b>13</b>)</h4><div class="NLM_p last">This compound was synthesized from <b>6b</b> using a procedure similar to that for <b>9</b>, followed by a procedure similar to that for <b>12b</b>. White solid; HPLC purity: 98.7% (220 nm) and 96.6% (254 nm). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 0.88 (d, <i>J</i> = 6.6 Hz, 6H), 1.04 (d, <i>J</i> = 6.6 Hz, 3H), 1.27 (m, 1H), 1.46 (m, 2H), 1.91 (m, 1H), 2.09 (m, 1H), 2.23 (s, 3H), 2.28 (s, 3H, MeSO<sub>3</sub>H), 2.35–2.60 (m, 9H), 2.63 (s, 6H), 2.80 (m, 1H), 2.88–3.50 (m, 6H), 5.37 (m, 1H), 6.86 (brs, 1H), 6.98 (dd, <i>J</i> = 1.8, 8.4 Hz, 1H), 7.08 (d, <i>J</i> = 1.8 Hz, 1H), 7.24 (d, <i>J</i> = 8.1 Hz, 2H), 7.35 (d, <i>J</i> = 8.4 Hz, 2H), 8.44 (d, <i>J</i> = 8.1 Hz, 1H). MS: 644 (MH<sup>+</sup>). Anal. (C<sub>34</sub>H<sub>47</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>3</sub>·MeSO<sub>3</sub>H) C, H, N, S.</div></div><div id="sec9_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4<i>S</i>-Benzyl-3-[3-(4-chlorophenyl)-2<i>R</i>-methylpropionyl]oxazolidin-2-one (<b>15a</b>)</h4><div class="NLM_p last">(<i>S</i>)-4-benzyl-3-propionyloxazolidin-2-one (<b>14</b>, 46.7g, 200 mmol) was dissolved in THF (870 mL) under an inert atmosphere (N<sub>2</sub>). This was then cooled to −70 °C (dry ice/acetone) and treated with sodium hexamethyldisilazide (110 mL of a 2.0 M solution in THF, 220 mmol) in a dropwise fashion (addition lasted for ∼45 min). The resulting mixture was stirred at −70 °C for 1 h. A solution of 4-chlorobenzyl bromide (53.4 g, 260 mmol) in THF (160 mL) was then added dropwise over 30 min. The resulting mixture was stirred at −70 °C for 6 h and then allowed to warm to r.t. overnight. The reaction was carefully quenched with water (100 mL), and the solvent was removed in vacuo. The resulting slurry was suspended in water (200 mL) and filtered. The solid was rinsed with EtOAc and air-dried to give the desired product (36.67 g, 102.6 mmol, 51%). A second crop of product was obtained from the filtrates after the organic layer was separated, washed with brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The resulting brown solid was suspended in MeOH and filtered to give 17.22 g (48.2 mmol, 24%) of the desired product. Total yield, 53.89 g (75%). Only one diastereomer was observed by <sup>1</sup>H NMR, and stereochemistry was confirmed by single crystal X-ray analysis. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 1.18 (d, <i>J</i> = 6.3 Hz, 3H), 2.66–2.56 (m, 2H), 3.16–3.07 (m, 2H), 4.22–4.02 (m, 3H), 4.71–4.63 (m, 1H), 7.08–7.05 (m, 2H), 7.32–7.21 (m, 7H).</div></div><div id="sec9_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2<i>R</i>-Methyl-3-(4-chlorophenyl)propionic Acid (<b>16a</b>)</h4><div class="NLM_p last">4<i>S</i>-Benzyl-3-[3-(4-chlorophenyl)-2<i>R</i> -methylpropionyl]oxazolidin-2-one (<b>15a</b>, 53.89 g, 150.7 mmol) was dissolved in a 4:1 v/v THF/H<sub>2</sub>O mixture (750 mL) and cooled to 0 °C (ice/water bath). Hydrogen peroxide 50% (60 mL) was added slowly, followed by a solution of lithium hydroxide monohydrate (11.08 g, 263.7 mmol) in H<sub>2</sub>O (380 mL). The resulting mixture was stirred at 0 °C for 1.5 h. Na<sub>2</sub>SO<sub>3</sub>·7H<sub>2</sub>O (155.70 g, 618.0 mmol) dissolved in H<sub>2</sub>O (250 mL) was added at 0 °C, and the resulting mixture was allowed to slowly reach r.t. The volatiles were removed in vacuo, and the aqueous residue was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 300 mL). The aqueous layer was separated, made acidic with 2.0 N HCl, and then extracted with EtOAc (2 × 250 mL). The organics were washed with brine, dried over MgSO<sub>4</sub>, and concentrated in vacuo to give the titled compound as an oil that solidified upon standing (29.80 g, 150.1 mmol, 99%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 1.18 (d, <i>J</i> = 6.3 Hz, 3H), 2.80–2.62 (m, 2H), 3.02 (dd, <i>J</i> = 6.0, 12.6 Hz, 1H), 7.12 (d, <i>J</i> = 8.7 Hz, 2H), 7.26 (d, <i>J</i> = 8.7 Hz, 2H). [α]<sup>25</sup><sub>D</sub> = −27.930 (<i>c</i> 8.685 mg/cc, MeOH).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec9_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-{3-[(1<i>R</i>)-((<i>S</i>)-<i>tert</i>-Butanesulfinylamino)-3-methylbutyl]-2-pyridinyl}-1-piperazinecarboxylic Acid <i>tert</i>-Butyl Ester (<i>R</i>-<b>19a</b>)</h4><div class="NLM_p">Lithium diisopropylamide (131 mL, 262 mmol, 2 M in THF) was added to a stirring solution of 2-bromopyridine (25 mL, 262 mmol) in THF (208 mL) at –78 °C under nitrogen. The reaction mixture was stirred at −78 °C for 2 h and then a solution of DMF (20.3 mL, 262 mmol) in THF (104 mL) was added. After the addition, the reaction mixture was allowed to warm to r.t. and was neutralized by adding to a saturated solution of ammonium chloride. The crude product was extracted with ethyl acetate (3 × 200 mL), the organic layers were combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered, and solvent was removed in vacuo. The residue was purified by column chromatography on silica using 15% ethyl acetate/hexanes as the eluent (<i>R<sub>f</sub></i> = 0.3). The product 2-bromo-3-formylpyridine <b>17a</b> was obtained as yellow oil (9.4 g, 50.5 mmol, 19% yield).</div><div class="NLM_p">2-Bromo-3-formylpyridine (<b>17a</b>, 9.4 g, 50.5 mmol) was dissolved in DMF (100 mL) along with diisopropylethylamine (8.8 mL, 50.5 mmol) and 1-Boc-piperazine (9.4 g, 50.5 mmol) in a reaction flask. The reaction mixture was heated at 100 °C for 8 h, then cooled to r.t., and quenched with saturated NaHCO<sub>3</sub> (150 mL). The product was extracted with ethyl acetate (3 × 100 mL), the organic layers were combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the solvent was removed in vacuo. The residue was purified by column chromatography on silica using 25% ethyl acetate/hexanes as the eluent (<i>R<sub>f</sub></i> = 0.3). The product 2-(4-Boc-1-piperazinyl)-3-formylpyridine was obtained as a yellow solid (9.8 g, 33.5 mmol, 67% yield).</div><div class="NLM_p">2-(4-Boc-1-piperazinyl)-3-formylpyridine (3 g, 10.3 mmol) was dissolved in THF (51 mL) along with (<i>S</i>)-<i>tert</i>-butanesulfinamide (1.4 g, 11.3 mmol) and titanium(IV) ethoxide (8.6 mL, 41.2 mmol). The reaction mixture was allowed to stir at r.t. for 8 h and then brine (20 mL) was added. The reaction mixture was filtered, and the solid was washed with ethyl acetate (3 × 75 mL). The organic layer was collected, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give the titled compound as a yellow solid in quantitative yield without further purification (4.1 g, 10.3 mmol).</div><div class="NLM_p last">The above intermediate (4.1 g, 10.3 mmol) in THF (30 mL) was cooled to –40 °C, and Me<sub>3</sub>Al (15.45 mL, 30.9 mmol) was added. The reaction mixture was allowed to stir at −40 °C under nitrogen atmosphere for 20 min and was then cooled to −78 °C. To the reaction mixture, isobutyl lithium (12.9 mL, 20.6 mmol, 1.6 M in heptane) was added slowly. After the addition was complete, the reaction was warmed to r.t. and carefully quenched with water. The mixture was then concentrated in vacuo and diluted with dichloromethane (150 mL). The organic layer was then washed with saturated NaHCO<sub>3</sub> solution (2 × 100 mL) and brine (100 mL), dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica using 75% ethyl acetate/hexanes as the eluent (<i>R<sub>f</sub></i> = 0.3). The titled product was obtained as a yellow solid (2.8 g, 6.15 mmol, 60%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 0.89 (d, <i>J</i> = 6.3 Hz, 3H), 0.94 (d, <i>J</i> = 6.0 Hz, 3H), 1.21 (s, 9H), 1.47 (s, 9H), 1.24–1.30 (m, 2H), 1.5–1.58 (m, 1H), 2.80–3.40 (m, 4H), 3.40–3.70 (m, 4H), 4.69 (dd, <i>J</i> = 6.9 Hz, 1H), 7.06 (dd, <i>J</i> = 4.8 Hz, 1H), 7.61 (dd, <i>J</i> = 1.8 Hz, 1H), 8.29 (dd, <i>J</i> = 1.8 Hz, 1H).</div></div><div id="sec9_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4-{3-[(1<i>R</i>)-((<i>S</i>)-<i>tert</i>-Butanesulfinylamino)-3-methylbutyl]-6-methyl-2-pyridinyl}-1-piperazinecarboxylic Acid <i>tert</i>-Butyl Ester (<i>R</i>-<b>19b</b>)</h4><div class="NLM_p last">This compound was synthesized from 2-bromo-6-methylpyridine and <i>S</i>-<i>tert</i>-butanesulfinamide using a procedure similar to that for <b>19a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 0.87 (d. <i>J</i> = 6.0 Hz, 3H), 0.94 (d. <i>J</i> = 6.0 Hz, 3H), 1.12 (s. 9H), 1.46 (s. 9H), 1.48–1.58 (m, 2H), 1.70–1.78 (m, 1H), 2.43 (s, 3H), 2.8–3.05 (m, 4H), 3.40–3.78 (m, 4H), 4.64 (dd, <i>J</i> = 6.9 Hz, 1H), 6.89 (d, <i>J</i> = 7.8 Hz, 1H), 7.46 (d, <i>J</i> = 7.8 Hz, 1H). A small sample was crystallized in ether/hexanes to give single crystals for X-ray determination.</div></div><div id="sec9_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-{3-[(1<i>R</i>)-Amino-3-methylbutyl]-2-pyridinyl}-4-[3-(2,4-dichlorophenyl)-propionyl]piperazine Trifluoroacetate (<i>R</i>-<b>20a</b>)</h4><div class="NLM_p last">4-{3-[(1<i>R</i>)-((<i>S</i>)-<i>tert</i>-Butanesulfinylamino)-3-methylbutyl]-2-pyridinyl}-1-piperazinecarboxylic acid <i>tert</i>-butyl ester (<i>R</i>-<b>19a</b>, 452.6 mg, 1 mmol) was allowed to stir at r.t. for 1.5 h in a 20% TFA/CH<sub>2</sub>Cl<sub>2</sub> mixture (20 mL). The reaction was quenched with saturated NaHCO<sub>3</sub> solution (5 mL). The organic layer was washed with saturated NaHCO<sub>3</sub> solution (2 × 10 mL) and brine(10 mL), dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The deprotected intermediate was recovered in quantitative yield. A small portion of this piperazine intermediate (35.2 mg, 0.1 mmol) was dissolved in dichloromethane (0.5 mL) along with HOBt (13.5 mg, 0.1 mmol), NaHCO<sub>3</sub> (8.4 mg, 0.1 mmol), and 3-(2,4-dichlorophenyl)propanic acid (21.9 mg, 0.1 mmol). The reaction mixture was allowed to stir at r.t. for 10 min and then EDC (19.2 mg, 0.1 mmol) was added. The reaction was then stirred for an additional 8 h followed by quenching with saturated NaHCO<sub>3</sub> solution. The organic layer was separated, washed with brine (2 mL), dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The resulting residue was dissolved in MeOH (2 mL), and 0.2 M HCl/ether (1 mL) was added. The reaction was stirred at r.t. for 1 h and then solvent was removed under a stream of nitrogen. The crude product was purified by prep HPLC to yield the desired product as the TFA salt (15 mg, 0.026 mmol, 26% yield). Light yellow foam; HPLC purity: 98% (220 nm) and 95% (254 nm). <sup>1</sup>H NMR (CD<sub>3</sub>OD): 0.95 (d, <i>J</i> = 6.6 Hz, 3H), 1.03 (d, <i>J</i> = 6.6 Hz, 3H), 1.37–1.53 (m, 1H), 1.69–1.82 (m, 1H), 1.82–1.93 (m, 1H), 2.76 (t, <i>J</i> = 7.7 Hz, 2H), 2.85–2.96 (m, 4H), 3.00–3.13 (m, 4H), 3.55–3.64 (m, 1H), 3.64–3.84 (m, 3H), 4.83 (t, <i>J</i> = 7.5 Hz, 1H), 7.24–7.38 (m, 3H), 7.44 (d, <i>J</i> = 4.1 Hz, 1H), 7.90 (dd, <i>J</i> = 1.8, 7.7 Hz, 1H), 8.39 (dd, <i>J</i> = 1.8, 4.8 Hz, 1H). MS: 449 (MH<sup>+</sup>). HRMS (MH<sup>+</sup>) calcd for C<sub>23</sub>H<sub>31</sub>Cl<sub>2</sub>N<sub>4</sub>O, 449.1875; found, 449.1892.</div></div><div id="sec9_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-{3-[(1<i>S</i>)-Amino-3-methylbutyl]-2-pyridinyl}-4-[3-(2,4-dichlorophenyl)-propionyl]piperazine Trifluoroacetate (<i>S</i>-<b>20a</b>)</h4><div class="NLM_p last">This compound was synthesized using the same method for <i>R</i>-<b>20a</b> from <i>S</i>-<i>tert</i>-butanesulfinamide. Light yellow foam, HPLC purity: 92% (220 nm) and 96% (254 nm). <sup>1</sup>H NMR (CD<sub>3</sub>OD): 0.95 (d, <i>J</i> = 6.6 Hz, 3H), 1.03 (d, <i>J</i> = 6.6 Hz, 3H), 1.37–1.53 (m, 1H), 1.69–1.82 (m, 1H), 1.82–1.93 (m, 1H), 2.76 (t, <i>J</i> = 7.7 Hz, 2H), 2.85–2.96 (m, 4H), 3.00–3.13 (m, 4H), 3.55–3.64 (m, 1H), 3.64–3.84 (m, 3H), 4.83 (t, <i>J</i> = 7.5 Hz, 1H), 4.83 (t, <i>J</i> = 7.5 Hz, 1H), 7.24–7.38 (m, 3H), 7.44 (d, <i>J</i> = 4.1 Hz, 1H), 7.90 (dd, <i>J</i> = 1.8, 7.7 Hz, 1H), 8.39 (dd, <i>J</i> = 1.8, 4.8 Hz, 1H). MS: 449 (MH<sup>+</sup>).</div></div><div id="sec9_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-{3-[(1<i>R</i>)-1-Amino-3-methylbutyl]-2-pyridinyl}-4-[2-methyl-3-(2,4-dichlorophenyl)propionyl]piperazine Trifluoroacetate (<i>R</i>-<b>20b</b>)</h4><div class="NLM_p last">This compound was synthesized from <i>R</i>-<b>19a</b> and 2-methyl-3-(2,4-dichlorophenyl)propionic acid using a procedure similar to that for <i>R</i>-<b>20a</b>. Light yellow foam; HPLC purity: 97% (220 and 254 nm). <sup>1</sup>H NMR (CD<sub>3</sub>OD): 0.94 (d, <i>J</i> = 6.6 Hz, 3H), 1.01 (d, <i>J</i> = 6.6 Hz, 3H), 1.19 and 1.20 (d, <i>J</i> = 6.6 Hz, 3H), 1.34–1.50 (m, 1H), 1.67–1.91 (m, 2H), 2.40–2.54 (m, 1H), 2.60–2.76 (m, 1H), 2.80–3.08 (m, 5H), 3.32–3.46 (m, 2H), 3.52–3.88 (m, 4H), 4.81 (t, <i>J</i> = 7.5 Hz, 1H), 7.24–7.30 (m, 3H), 7.42–7.47 (m, 1H), 7.83–7.89 (m, 1H), 8.39 (dd, <i>J</i> = 1.8, 4.8 Hz, 1H). MS: 463 (MH<sup>+</sup>).</div></div><div id="sec9_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-{3-[(1<i>R</i>)-1-Amino-3-methylbutyl]-6-methyl-2-pyridinyl}-4-[2<i>R</i>-methyl-3-(2,4-dichlorophenyl)propionyl]piperazine Trifluoroacetate (<i>R</i>-<b>21</b>)</h4><div class="NLM_p last">This compound was synthesized from <i>R</i>-<b>19b</b> and 2<i>R</i>-methyl-3-(2,4-dichlorophenyl)propionic acid using a procedure similar to that for <i>R</i>-<b>20a</b>. Light yellow foam; HPLC purity: 100% (220 and 254 nm). <sup>1</sup>H NMR (CD<sub>3</sub>OD): 0.92 (d, <i>J</i> = 6.6 Hz, 3H), 1.00 (d, <i>J</i> = 6.6 Hz, 3H), 1.21 (d, <i>J</i> = 6.6 Hz, 3H), 1.32–1.47 (m, 1H), 1.65–1.88 (m, 2H), 2.39–2.50 (m, 1H), 2.47 (s, 3H), 2.78–3.04 (m, 6H), 3.32–3.45 (m, 2H), 3.54–3.80 (m, 4H), 4.75 (t, <i>J</i> = 7.5 Hz, 1H), 7.12 (d, <i>J</i> = 7.9 Hz, 1H), 7.24–7.28 (m, 2H), 7.43 (d, <i>J</i> = 1.3 Hz, 1H), 7.71 (d, <i>J</i> = 7.9 Hz, 1H). MS: 477 (MH<sup>+</sup>). HRMS (MH<sup>+</sup>) calcd for C<sub>25</sub>H<sub>34</sub>Cl<sub>2</sub>N<sub>4</sub>O, 477.2188; found, 477.2165.</div></div><div id="sec9_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-((1<i>R</i>)-[2-{4-[2<i>R</i>-Methyl-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-3-pyridinyl]-3-methylbutyl)-2-aminoacetamide Mesylate Trifluoroacetate (<i>R</i>-<b>22</b>)</h4><div class="NLM_p last">This compound was synthesized from <i>R</i>-<b>20b</b> using a procedure similar to that for <b>11</b>. White solid; HPLC purity: 99% (220 nm) and 98% (254 nm). <sup>1</sup>H NMR (CD<sub>3</sub>OD): 0.94 (d, <i>J</i> = 6.1 Hz, 3H), 0.96 (d, <i>J</i> = 6.1 Hz, 3H), 1.18 and 1.20 (d, <i>J</i> = 6.6 Hz, 3H), 1.34–1.50 (m, 1H), 1.50–1.66 (m, 2H), 2.42–2.54 (m, 1H), 2.60–2.70 (m, 1H), 2.74–3.14 (m, 5H), 3.20–3.42 (m, 2H), 3.52–3.86 (m, 7H), 5.36–5.45 (m, 1H), 7.12–7.19 (m, 1H), 7.23–7.26 (m, 2H), 7.42 and 7.46 (d, <i>J</i> = 1.8 Hz, 1H), 7.72–7.78 (m, 1H), 8.17–8.22 (m, 1H). MS: 520 (MH+).</div></div><div id="sec9_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-((1<i>S</i>)-[2-{4-[2<i>R</i>-Methyl-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-3-pyridinyl]-3-methylbutyl)-2-aminoacetamide Trifluoroacetate (<i>S</i>-<b>22)</b></h4><div class="NLM_p last">This compound was synthesized from <i>S</i><b>-20</b> using a procedure similar to that for <b>11</b>. Light yellow foam; HPLC purity: 100% (220 and 254 nm). <sup>1</sup>H NMR (CD<sub>3</sub>OD): 0.94 (d, <i>J</i> = 6.1 Hz, 3H), 0.96 (d, <i>J</i> = 6.1 Hz, 3H), 1.18 and 1.20 (d, <i>J</i> = 6.6 Hz, 3H), 1.34–1.50 (m, 1H), 1.50–1.66 (m, 2H), 2.42–2.54 (m, 1H), 2.60–2.70 (m, 1H), 2.74–3.14 (m, 5H), 3.20–3.42 (m, 2H), 3.52–3.86 (m, 7H), 5.36–5.45 (m, 1H), 7.12–7.19 (m, 1H), 7.23–7.26 (m, 2H), 7.42 and 7.46 (d, <i>J</i> = 1.8 Hz, 1H), 7.72–7.78 (m, 1H), 8.17–8.22 (m, 1H). MS: 520 (MH<sup>+</sup>). HRMS (MH<sup>+</sup>) calcd for C<sub>26</sub>H<sub>36</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>2</sub>, 520.2246; found, 520.2236.</div></div><div id="sec9_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-((1<i>R</i>)-[2-{4-[2<i>R</i>-Methyl-3-(2,4-dichlorophenyl)propionyl]-1-piperazinyl}-6-methyl-3-pyridinyl]-3-methylbutyl)-3-(dimethylamino)propionamide (<i>R</i>-<b>23</b>)</h4><div class="NLM_p last">This compound was synthesized from <i>R</i>-<b>21</b> using a procedure similar to that for <b>12b</b>. White solid; HPLC purity: 96.1% (220 nm) and 96.5 (254 nm). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 0.91 (d, <i>J</i> = 6.5 Hz, 3H), 0.93 (d, <i>J</i> = 6.5 Hz, 3H), 1.17 (d, <i>J</i> = 7.0 Hz, 3H), 1.40 (m, 1H), 1.47 (m, 2H), 2.37 (s, 6H), 2.42 (s, 3H), 2.43 (m, 2H), 2.52 (m, 1H), 2.67 (m, 2H), 2.83 (m, 2H), 3.03 (dd, <i>J</i> = 8.0, 13.0 Hz, 1H), 3.18 (dd, <i>J</i> = 7.0, 14.5 Hz, 1H), 3.22 (m, 1H), 3.35 (m, 1H), 3.42 (m, 1H), 3.58 (m, 2H), 3.88 (m, 1H), 5.28 (m, 1H), 6.83 (d, <i>J</i> = 7.5 Hz, 1H), 7.17 (dd, <i>J</i> = 2.0, 8.5 Hz, 1H), 7.19 (d, <i>J</i> = 8.5 Hz, 1H), 7.33 (m, 2H), 8.60 (brs, 1H). MS: 576 (MH<sup>+</sup>). Anal. (C<sub>30</sub>H<sub>43</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>·H<sub>2</sub>O) C, H, N.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/jm701137s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedure for the preparation of compound <b>6c</b>, analytic data of key compounds, and description of pharmacokinetic studies and protocol for the murine cachexia model. This material is available free of charge via the Internet at <a href="http://http:/pubs.acs.org" class="extLink">http:/pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701137s/suppl_file/jm701137s-file003.pdf">jm701137s-file003.pdf (113.44 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701137s" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chen Chen</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a5c6c6cdc0cbe5cbc0d0d7cac6d7cccbc08bc6cac8"><span class="__cf_email__" data-cfemail="aac9c9c2cfc4eac4cfdfd8c5c9d8c3c4cf84c9c5c7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joe A. Tran</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wanlong Jiang</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio C. Tucci</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beth A. Fleck</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jenny Wen</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Sai</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ajay Madan</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ta Kung Chen</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stacy Markison</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan C. Foster</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sam R. Hoare</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Marks</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Harman</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caroline W. Chen</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa Arellano</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dragan Marinkovic</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haig Bozigian</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Saunders</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Pharmacology, Department of Neuroscience and Department of Preclinical Development, Neurocrine Biosciences, Inc., 12790 El Camino Real, San Diego, California 92130</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="ref1_1"><span><span class="NLM_contrib-group">Gordon, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goggin, P. M.</span><span> </span><span class="NLM_article-title">Cancer cachexia</span> <span class="citation_source-journal">QJM</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/ref1_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1093%2Fqjmed%2Fhci127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/ref1_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16214835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/ref1_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A280%3ADC%252BD2MrlvVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2005&pages=779-788&author=J.+N.+Gordonauthor=S.+R.+Greenauthor=P.+M.+Goggin&title=Cancer+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref1_1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer cachexia</span></div><div class="casAuthors">Gordon J N; Green S R; Goggin P M</div><div class="citationInfo"><span class="NLM_cas:title">QJM : monthly journal of the Association of Physicians</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">779-88</span>
        ISSN:<span class="NLM_cas:issn">1460-2725</span>.
    </div><div class="casAbstract">Cancer cachexia is a severe debilitating disorder for which there are currently few therapeutic options.  It is driven by the release of pro-inflammatory cytokines and cachectic factors by both host and tumour.  Over the past few years, basic science advances have begun to reveal the breadth and complexity of the immunological mechanisms involved, and in the process have uncovered some novel potential therapeutic targets.  The effectiveness of thalidomide and eicosapentaenoic acid at attenuating weight loss in clinical trials also provides a further rationale for modulating the immune response.  We are now entering an exciting period in cachexia research, and it is likely that the next few years will see effective new biological therapies reach clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwm63OvtxyCFVwdslNBF-tfW6udTcc2eaxstlEBTHKMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrlvVKrsA%253D%253D&md5=8ce1ca3e6fd7d9b49c3ccc5b182a36c3</span></div><a href="/servlet/linkout?suffix=ref1_1&amp;dbid=16384&amp;doi=10.1093%2Fqjmed%2Fhci127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fqjmed%252Fhci127%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DJ.%2BN.%26aulast%3DGreen%26aufirst%3DS.%2BR.%26aulast%3DGoggin%26aufirst%3DP.%2BM.%26atitle%3DCancer%2520cachexia%26jtitle%3DQJM%26date%3D2005%26volume%3D98%26spage%3D779%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="ref2_1"><span><span class="NLM_contrib-group">Bossola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doglietto, G. B.</span><span> </span><span class="NLM_article-title">Cancer cachexia: it’s time for more clinical trials</span> <span class="citation_source-journal">Ann. Surg. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/ref2_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1245%2Fs10434-006-9179-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/ref2_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=17094025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/ref2_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fks1Sntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=276-285&author=M.+Bossolaauthor=F.+Pacelliauthor=A.+Tortorelliauthor=G.+B.+Doglietto&title=Cancer+cachexia%3A+it%E2%80%99s+time+for+more+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref2_1R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer cachexia: it's time for more clinical trials</span></div><div class="casAuthors">Bossola Maurizio; Pacelli Fabio; Tortorelli Antonio; Doglietto Giovan Battista</div><div class="citationInfo"><span class="NLM_cas:title">Annals of surgical oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">276-85</span>
        ISSN:<span class="NLM_cas:issn">1068-9265</span>.
    </div><div class="casAbstract">Cancer cachexia (CC) is a multifactorial paraneoplastic syndrome characterized by anorexia, body weight loss, loss of adipose tissue and skeletal muscle, accounting for at least 20% of deaths in neoplastic patients.  CC significantly impairs quality of life and response to anti-neoplastic therapies, increasing morbidity and mortality of cancer patients.  Muscle wasting is the most important phenotypic feature of CC and the principal cause of function impairment, fatigue and respiratory complications, mainly related to a hyperactivation of muscle proteolytic pathways.  Most current therapeutic strategies to counteract CC have proven to be only partially effective.  In the last decade, the correction of anorexia, the inhibition of catabolic processes and the stimulation of anabolic pathways in muscle have been attempted pharmacologically with encouraging results in animal models and through preliminary clinical trials.  However, data in the clinical setting are still scanty and non definitive.  It is time to start prospective, randomized, controlled trials to evaluate which drugs are effective in counteracting the loss of lean of muscle mass and in improving nutritional status and quality of life in patients affected by cancer-related cachexia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBL9dWmtA7wOkdrW1FkXG-fW6udTcc2eaxstlEBTHKMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fks1Sntg%253D%253D&md5=7c83ff58caabb3520a5ff0375e044202</span></div><a href="/servlet/linkout?suffix=ref2_1&amp;dbid=16384&amp;doi=10.1245%2Fs10434-006-9179-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1245%252Fs10434-006-9179-5%26sid%3Dliteratum%253Aachs%26aulast%3DBossola%26aufirst%3DM.%26aulast%3DPacelli%26aufirst%3DF.%26aulast%3DTortorelli%26aufirst%3DA.%26aulast%3DDoglietto%26aufirst%3DG.%2BB.%26atitle%3DCancer%2520cachexia%253A%2520it%25E2%2580%2599s%2520time%2520for%2520more%2520clinical%2520trials%26jtitle%3DAnn.%2520Surg.%2520Oncol.%26date%3D2007%26volume%3D14%26spage%3D276%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="ref3_1"><span><span class="NLM_contrib-group">Osei-Hyiaman, D.</span><span> </span><span class="NLM_article-title">Endocannabinoid system in cancer cachexia</span> <span class="citation_source-journal">Curr. Opin. Clin. Nutr. Metab. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/ref3_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1097%2FMCO.0b013e3281900ecc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/ref3_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=17563462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/ref3_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotl2lsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=443-448&author=D.+Osei-Hyiaman&title=Endocannabinoid+system+in+cancer+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref3_1R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid system in cancer cachexia</span></div><div class="casAuthors">Osei-Hyiaman, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-448</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review More than 60% of advanced cancer patients suffer from anorexia and cachexia.  This review focuses on the possible mechanisms by which the endocannabinoid system antagonizes cachexia-anorexia processes in cancer patients and how it can be tapped for therapeutic applications.  Recent findings Cannabinoids stimulate appetite and food intake.  Hepatocytes express functional cannabinoid type 1 receptors, activation of which increases the expression of lipogenic genes (e.g those encoding sterol regulatory element binding protein 1c, acetyl-CoA carboxylase-1, and fatty acid synthase in the liver and hypothalamus) and increase de-novo fatty acid synthesis, which contributes to development of diet-induced obesity.  Both ghrelin and cannabinoids stimulate AMP-activated protein kinase in the hypothalamus, whereas they inhibit it in the liver and adipose tissues.  Both anandamide and synthetic cannabinoid type 1 receptor agonists such as HU210 and the plant-derived cannabinoid tetrahydrocannabinol also significantly inhibit tumor necrosis factor-α.  Summary Cannabinoid type 1 receptor activation stimulates appetite and promotes lipogenesis and energy storage.  Further study of cancer-cachexia pathophysiol. and the role of endocannabinoids will help us to develop cannabinoids without psychotropic properties, which will help cancer patients suffering from cachexia and improve outcomes of clin. antitumor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofZbq0SfSI5LVg90H21EOLACvtfcHk0lh6l6V3ydn0lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotl2lsbo%253D&md5=b42f61b6dcf092c461f31ac4d675b60f</span></div><a href="/servlet/linkout?suffix=ref3_1&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e3281900ecc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e3281900ecc%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Hyiaman%26aufirst%3DD.%26atitle%3DEndocannabinoid%2520system%2520in%2520cancer%2520cachexia%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2007%26volume%3D10%26spage%3D443%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="ref4_1"><span><span class="NLM_contrib-group">Akamizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kangawa, K.</span><span> </span><span class="NLM_article-title">Emerging results of anticatabolic therapy with ghrelin</span> <span class="citation_source-journal">Curr. Opin. Clin. Nutr. Metab. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/ref4_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1097%2FMCO.0b013e3280fa8208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/ref4_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=17414495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/ref4_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtFemu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=278-283&author=T.+Akamizuauthor=K.+Kangawa&title=Emerging+results+of+anticatabolic+therapy+with+ghrelin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref4_1R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging results of anticatabolic therapy with ghrelin</span></div><div class="casAuthors">Akamizu, Takashi; Kangawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">278-283</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review summarizes recent developments in research into anticatabolic therapies with ghrelin.  Potential conditions in which ghrelin treatment may be useful include cachexia, anorexia and ageing.  We highlight a no. of intriguing basic topics related to the anticatabolic effects of ghrelin.  Recent finding: Repeated administration of ghrelin to patients with congestive heart failure or chronic obstructive pulmonary disease improved appetite, body compn., muscle wasting and functional capacity in open-label pilot studies.  An acute, randomized, placebo-controlled, crossover clin. trial of cancer patients with anorexia revealed marked increases in energy intake following treatment.  The effects of ghrelin treatment in patients with anorexia nervosa are controversial.  Basic research studies have extended our understanding of the upstream regulation of neuropeptide Y/agouti-related protein signalling and the central control of adipocyte metab.  In addn., alterations in fat-free mass may play a role in ghrelin regulation.  Summary: A no. of studies are currently evaluating the anticatabolic effects of ghrelin in the treatment of various diseases, including cachexia, anorexia and age-related disorders.  These studies will hopefully lead to the development of novel clin. applications for ghrelin treatment.  These studies have also facilitated a better understanding of the mol. basis of the anticatabolic effects of ghrelin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnaNFQmg05OrVg90H21EOLACvtfcHk0lh6l6V3ydn0lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtFemu7Y%253D&md5=0e2dff9dac044a0ef5e41f7c5c50c852</span></div><a href="/servlet/linkout?suffix=ref4_1&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e3280fa8208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e3280fa8208%26sid%3Dliteratum%253Aachs%26aulast%3DAkamizu%26aufirst%3DT.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DEmerging%2520results%2520of%2520anticatabolic%2520therapy%2520with%2520ghrelin%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2007%26volume%3D10%26spage%3D278%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="ref5_1"><span><span class="NLM_contrib-group">Deboer, M. D.</span><span> </span><span class="NLM_article-title">Melanocortin interventions in cachexia: how soon from bench to bedside</span> <span class="citation_source-journal">Curr. Opin. Clin. Nutr. Metab. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/ref5_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1097%2FMCO.0b013e328108f441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/ref5_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=17563464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/ref5_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotl2lsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=457-462&author=M.+D.+Deboer&title=Melanocortin+interventions+in+cachexia%3A+how+soon+from+bench+to+bedside"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref5_1R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Melanocortin interventions in cachexia: how soon from bench to bedside?</span></div><div class="casAuthors">DeBoer, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-462</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review Cachexia is a condition of anorexia and wasting that accompanies many diseases including cancer, heart failure, and renal failure.  One key center that is probably involved in the propagation of symptoms of cachexia is the melanocortin system in the hypothalamus and brainstem.  This review focuses on cachexia treatment interventions that act via melanocortin antagonism, by direct or indirect means.  Recent findings Recent reports include a description of the physiol. of the melanocortin system and its responsiveness to inflammatory cytokines.  Regarding treatment potential, multiple reports describe the effectiveness of small mol. antagonists of the melanocortin-4 receptor in animal models of cachexia.  These melanocortin antagonists, given by peripheral injection, improve food intake and lean body mass retention in the setting of cancer and renal failure.  Addnl. reports provide evidence of melanocortin antagonism following treatment of cachexia using ghrelin and eicosanoic acid.  Summary Cachexia is a serious condition that accompanies various disease states and currently does not have effective treatments.  The melanocortin system may play a direct role in producing symptoms of cachexia, making antagonism of this system a logical objective for ameliorating these symptoms.  Thus far, however, no data on human application have been published.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMys3_l7XJJ7Vg90H21EOLACvtfcHk0lh6l6V3ydn0lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotl2lsbY%253D&md5=40acd523630c355b2a099b7b305aeba8</span></div><a href="/servlet/linkout?suffix=ref5_1&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e328108f441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e328108f441%26sid%3Dliteratum%253Aachs%26aulast%3DDeboer%26aufirst%3DM.%2BD.%26atitle%3DMelanocortin%2520interventions%2520in%2520cachexia%253A%2520how%2520soon%2520from%2520bench%2520to%2520bedside%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2007%26volume%3D10%26spage%3D457%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="ref6_1"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span> </span><span class="NLM_article-title">Structural mimicry in G-protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1-19&author=J.+A.+Ballesterosauthor=L.+Shiauthor=J.+A.+Javitch&title=Structural+mimicry+in+G-protein-coupled+receptors%3A+Implications+of+the+high-resolution+structure+of+rhodopsin+for+structure-function+analysis+of+rhodopsin-like+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref6_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26atitle%3DStructural%2520mimicry%2520in%2520G-protein-coupled%2520receptors%253A%2520Implications%2520of%2520the%2520high-resolution%2520structure%2520of%2520rhodopsin%2520for%2520structure-function%2520analysis%2520of%2520rhodopsin-like%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="ref7_1"><span><span class="NLM_contrib-group">Goodfellow, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">The melanocortin system and its role in obesity and cachexia</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">883</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/ref7_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.2174%2F1568026033452212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/ref7_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=12678837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/ref7_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFClsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=855-883&author=V.+S.+Goodfellowauthor=J.+Saunders&title=The+melanocortin+system+and+its+role+in+obesity+and+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref7_1R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The melanocortin system and its role in obesity and cachexia</span></div><div class="casAuthors">Goodfellow, Val S.; Saunders, John</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">855-883</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Melanocortin receptors (MC-R) activated by one of several peptides derived from the proopiomelanocortin (POMC) precursor have become leading contenders for a pivotal role in controlling food intake.  Evidence has emerged over the last decade to implicate primarily the MC4-R and, to a lesser extent, MC3-R as the key sub-types involved and both are strategically located in those regions within the hypothalamus known to be assocd. with feeding.  The receptors are within class A of the GPCR superfamily and the key electrostatic interaction with the pos. charged peptide (Arg8) has been mapped to one or more Asp or Glu residues located on helixes II and III of the seven helical bundle characteristic of this class of receptor.  Sites for secondary interactions from which sub-type selectivity may be derived have also been located in the extracellular and helical domains.  Unique amongst GPCRs is the presence of endogenous antagonist peptides, Agouti and Agouti-related peptide (AGRP), which confer an extra level of control on the system.  Recently, several reports of potent and selective non-peptide ligands have been published and these are seen as prototypic mols. from which drugs may emerge to treat obesity (agonists) and cachexia (antagonists).  The role played by the melanocortin system is the subject of this review and advances in our understanding of the structure of the endogenous ligand(s), non-peptide, small mol. ligands and the receptors at which they interact will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQwzaktjSlVLVg90H21EOLACvtfcHk0lhC6dEHWPBmwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFClsr8%253D&md5=49aba14cf21093bab1e60d68aaac1aff</span></div><a href="/servlet/linkout?suffix=ref7_1&amp;dbid=16384&amp;doi=10.2174%2F1568026033452212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452212%26sid%3Dliteratum%253Aachs%26aulast%3DGoodfellow%26aufirst%3DV.%2BS.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DThe%2520melanocortin%2520system%2520and%2520its%2520role%2520in%2520obesity%2520and%2520cachexia%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D855%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="ref8_1"><span><span class="NLM_contrib-group">Wilczynski, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskell-Luevano, C.</span><span> </span><span class="NLM_article-title">Current trends in the structure−activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/ref8_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1002%2Fmed.20037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/ref8_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16044415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/ref8_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGiurfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=545-556&author=A.+M.+Wilczynskiauthor=C.+G.+Josephauthor=C.+Haskell-Luevano&title=Current+trends+in+the+structure%E2%88%92activity+relationship+studies+of+the+endogenous+agouti-related+protein+%28AGRP%29+melanocortin+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref8_1R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Current trends in the structure-activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist</span></div><div class="casAuthors">Wilczynski, Andrzej M.; Joseph, Christine G.; Haskell-Luevano, Carrie</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Agouti-related protein (AGRP) is an endogenous antagonist of the melanocortin-3 and -4 (MC3R and MC4) G-protein coupled receptors.  The 87 - 132 amino acid C-terminal domain of hAGRP possesses five disulfide bridges and a well-defined three-dimensional structure that displays full biol. activity as compared to the full-length protein.  Based on the NMR structure of the C-terminal AGRP(87 - 132), a novel mini-protein, referred to as "Mini-AGRP" was designed that exhibited receptor binding affinity and antagonism similar to that of the parent hAGRP(87 - 132) protein.  It was demonstrated that this new-engineered protein autonomously folds to the inhibitor cystine knot (ICK) motif.  As this AGRP is a novel mammalian protein involved in energy homeostasis and possibly other physiol. functions remaining to be identified, structure-function studies are starting to emerge toward the understanding of how this unique protein putatively interacts with the melanocortin receptors with the objective of designing potential therapeutic agents for in vivo physiol. studies.  This article summarizes the progress to date of AGRP-based structure-activity relationships and putative ligand-receptor interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0QnlstAeNrVg90H21EOLACvtfcHk0lhC6dEHWPBmwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGiurfO&md5=5e8fd6aa056c12e764dc42476d3e8361</span></div><a href="/servlet/linkout?suffix=ref8_1&amp;dbid=16384&amp;doi=10.1002%2Fmed.20037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20037%26sid%3Dliteratum%253Aachs%26aulast%3DWilczynski%26aufirst%3DA.%2BM.%26aulast%3DJoseph%26aufirst%3DC.%2BG.%26aulast%3DHaskell-Luevano%26aufirst%3DC.%26atitle%3DCurrent%2520trends%2520in%2520the%2520structure%25E2%2588%2592activity%2520relationship%2520studies%2520of%2520the%2520endogenous%2520agouti-related%2520protein%2520%2528AGRP%2529%2520melanocortin%2520receptor%2520antagonist%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D545%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="ref9_1"><span><span class="NLM_contrib-group">Cone, R. D.</span><span> </span><span class="NLM_article-title">The central melanocortin system and energy homeostasis</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/ref9_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1016%2FS1043-2760%2899%2900153-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/ref9_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=10407394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/ref9_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=211-216&author=R.+D.+Cone&title=The+central+melanocortin+system+and+energy+homeostasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref9_1R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The central melanocortin system and energy homeostasis</span></div><div class="casAuthors">Cone, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 53 refs.  Obesity is a significant health problem owing to increased risk for diabetes and cardiovascular disease, and several lines of evidence suggest that alterations in the central melanocortin system might account for some of the genetic contribution to obesity in humans.  First, the phenotypic aspects and dominant inheritance of the melanocortin obesity syndromes in the mouse are more like human obesity than other murine obesity syndromes.  Second, studies recently published present two rare cases of familial obesity resulting from null alleles of the proopiomelanocortin (POMC) gene, providing the first evidence that the melanocortin pathway in humans subserves the same function in regulation of energy homeostasis as it does in the rodent.  Addnl. studies suggest that heterozygous mutations in the melanocortin 4 receptor might be a common reason for genetic predisposition to obesity in children.  Research on the central melanocortin system in rodents suggests that this system might be a fundamental component of the adipostat, the mechanism by which energy stores are held relatively const., and this hypothesis will be the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZOl70E49pTLVg90H21EOLACvtfcHk0lhC6dEHWPBmwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKkt7w%253D&md5=0f180e7a29e3b0664630e4f255f28da7</span></div><a href="/servlet/linkout?suffix=ref9_1&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2899%2900153-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252899%252900153-8%26sid%3Dliteratum%253Aachs%26aulast%3DCone%26aufirst%3DR.%2BD.%26atitle%3DThe%2520central%2520melanocortin%2520system%2520and%2520energy%2520homeostasis%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D1999%26volume%3D10%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="ref10_1"><span><span class="NLM_contrib-group">Tao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segaloff, D. L.</span><span> </span><span class="NLM_article-title">Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">5632</span><span class="NLM_x">–</span> <span class="NLM_lpage">5638</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/ref10_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1210%2Fjc.2005-0519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/ref10_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16030156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/ref10_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWjt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2005&pages=5632-5638&author=Y.+X.+Taoauthor=D.+L.+Segaloff&title=Functional+analyses+of+melanocortin-4+receptor+mutations+identified+from+patients+with+binge+eating+disorder+and+nonobese+or+obese+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref10_1R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects</span></div><div class="casAuthors">Tao, Ya-Xiong; Segaloff, Deborah L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5632-5638</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Whether mutations in the melanocortin-4 receptor (MC4R) are the cause of binge eating disorder was controversial.  In addn., the penetrance of mutations in the MC4R in causing obesity was debated.  Objective: We investigated whether MC4R variants identified from obese patients with binge eating disorder (T11A, F51L, T112M, and M200V) and variants identified in nonobese (I102T, F202L, and N240S) or obese (I102S, A154D, and S295P) subjects cause loss-of-function and what are the defects.  Design: Variant or wild-type MC4Rs were expressed in HEK293 cells and examd. for their pharmacol. characteristics.  Setting: The study setting was in vitro bench-top lab. expts.  Main Outcome Measures: Ligand binding, signaling, and cell surface expression of the variant MC4Rs were compared with wild-type MC4R.  Results: Our data clearly show a loss-of-function phenotype in vitro for I102T and N240S variants identified in nonobese individuals.  Furthermore, not all MC4R variants identified in obese subjects exhibit a loss-of-function phenotype in vitro.  Finally, the MC4R variants T11A, F51L, T112M, and M200V identified from patients with binge eating disorder displayed normal function with regards to the parameters measured in our study.  Conclusions: Patients harboring loss-of-function MC4R mutations do not always exhibit obesity.  Novel MC4R variant identified from an obese patient cannot be assumed to be the cause of obesity without demonstrating a loss-of-function phenotype in vitro for the variant MC4R.  Whether MC4R mutations are involved in the pathogenesis of binge eating disorder needs addnl. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohWlYPNtUm2rVg90H21EOLACvtfcHk0lhC6dEHWPBmwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWjt73J&md5=e088d4991bfd6f238f09505cc2f5d0f4</span></div><a href="/servlet/linkout?suffix=ref10_1&amp;dbid=16384&amp;doi=10.1210%2Fjc.2005-0519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2005-0519%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DY.%2BX.%26aulast%3DSegaloff%26aufirst%3DD.%2BL.%26atitle%3DFunctional%2520analyses%2520of%2520melanocortin-4%2520receptor%2520mutations%2520identified%2520from%2520patients%2520with%2520binge%2520eating%2520disorder%2520and%2520nonobese%2520or%2520obese%2520subjects%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2005%26volume%3D90%26spage%3D5632%26epage%3D5638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="ref11_1"><span><span class="NLM_contrib-group">MacKenzie, R. G.</span><span> </span><span class="NLM_article-title">Obesity-associated mutations in the human melanocortin-4 receptor gene</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=395-403&author=R.+G.+MacKenzie&title=Obesity-associated+mutations+in+the+human+melanocortin-4+receptor+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref11_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DR.%2BG.%26atitle%3DObesity-associated%2520mutations%2520in%2520the%2520human%2520melanocortin-4%2520receptor%2520gene%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D395%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="ref12_1"><span><span class="NLM_contrib-group">Boyce, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duhl, D. M.</span><span> </span><span class="NLM_article-title">Melanocortin-4 receptor agonists for the treatment of obesity</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1063</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1063-1071&author=R.+S.+Boyceauthor=D.+M.+Duhl&title=Melanocortin-4+receptor+agonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref12_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DR.%2BS.%26aulast%3DDuhl%26aufirst%3DD.%2BM.%26atitle%3DMelanocortin-4%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D1063%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="ref13_1"><span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joppa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, B. A.</span><span> </span><span class="NLM_article-title">Body weight regulation by selective MC4 receptor agonists and antagonists</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">994</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=994&publication_year=2003&pages=103-110&author=A.+C.+Fosterauthor=M.+Joppaauthor=S.+Markisonauthor=K.+R.+Gogasauthor=B.+A.+Fleck&title=Body+weight+regulation+by+selective+MC4+receptor+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref13_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DJoppa%26aufirst%3DM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DGogas%26aufirst%3DK.%2BR.%26aulast%3DFleck%26aufirst%3DB.%2BA.%26atitle%3DBody%2520weight%2520regulation%2520by%2520selective%2520MC4%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D994%26spage%3D103%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="ref14_1"><span><span class="NLM_contrib-group">DeBoer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, D. L.</span><span> </span><span class="NLM_article-title">Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease</span> <span class="citation_source-journal">Nat. Clin. Pract. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/ref14_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1038%2Fncpendmet0221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/ref14_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16932335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/ref14_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xosl2ht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=459-466&author=M.+D.+DeBoerauthor=D.+L.+Marks&title=Therapy+insight%3A+Use+of+melanocortin+antagonists+in+the+treatment+of+cachexia+in+chronic+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref14_1R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease</span></div><div class="casAuthors">DeBoer, Mark D.; Marks, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">NCPEDB</span>;
        ISSN:<span class="NLM_cas:issn">1745-8366</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cachexia is a process that accompanies many chronic diseases, and consists of a combination of wasting of lean body mass, increased energy expenditure, and a paradoxical loss of appetite.  Cachexia both worsens quality of life and neg. affects treatment of the underlying disease.  Conditions as diverse as cancer, renal failure, and heart failure show a remarkable similarity in their assocd. cachexia, exhibiting changes in metab. and endocrinol., including marked increases in levels of cytokines that accompany these diseases.  So far, it has been difficult to treat disease-assocd. cachexia successfully.  One treatment that has shown promise in animal trials, however, involves antagonism of the central melanocortin system, an anorexigenic pathway in the hypothalamus and brainstem.  Humans who have genetic mutations involving pro-opiomelanocortin or the melanocortin 4 receptor in this pathway exhibit increased appetite and increased lean body mass.  Recent research has shown that in rodent models of cancer and renal failure, administration of melanocortin 4 receptor antagonists results in an attenuation of symptoms of cachexia, including maintenance of appetite, lean body mass, and basal energy expenditure.  Although this research needs to be substantiated in humans, it provides a promising direction for treating the wasting that is assocd. with a variety of disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfRZFaKLBcrbVg90H21EOLACvtfcHk0lgS1GeypbSTpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xosl2ht78%253D&md5=646f63ecd6116216781fcd9939a71df8</span></div><a href="/servlet/linkout?suffix=ref14_1&amp;dbid=16384&amp;doi=10.1038%2Fncpendmet0221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpendmet0221%26sid%3Dliteratum%253Aachs%26aulast%3DDeBoer%26aufirst%3DM.%2BD.%26aulast%3DMarks%26aufirst%3DD.%2BL.%26atitle%3DTherapy%2520insight%253A%2520Use%2520of%2520melanocortin%2520antagonists%2520in%2520the%2520treatment%2520of%2520cachexia%2520in%2520chronic%2520disease%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Endocrinol.%2520Metab.%26date%3D2006%26volume%3D2%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="ref15_1"><span><span class="NLM_contrib-group">Li, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. D.</span><span> </span><span class="NLM_article-title">Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5182</span><span class="NLM_x">–</span> <span class="NLM_lpage">5188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/ref15_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1523%2FJNEUROSCI.16-16-05182.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/ref15_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=8756446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/ref15_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADyaK28XkvFaht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=5182-5188&author=S.+J.+Liauthor=K.+Vargaauthor=P.+Archerauthor=V.+J.+Hrubyauthor=S.+D.+Sharma&title=Melanocortin+antagonists+define+two+distinct+pathways+of+cardiovascular+control+by+alpha-+and+gamma-melanocyte-stimulating+hormones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref15_1R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Melanocortin antagonists define two distinct pathways of cardiovascular control by α- and γ-melanocyte-stimulating hormones</span></div><div class="casAuthors">Li, Si-Jai; Varga, Karoly; Archer, Phillip; Hruby, Victor J.; Sharama, Shubh D.; Kesterson, Robert A.; Cong, Roger D.; Kunos, George</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5182-5188</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Melanocortin peptides and at least two subtypes of melanocortin receptors (MC3-R and MC4-R) are present in brain regions involved in cardiovascular regulation.  In urethane-anesthetized rats, unilateral microinjection of α-MSH into the medullary dorsal-vagal complex (DVC) causes dose-dependent (125-250 pmol) hypotension and bradycardia, whereas γ-MSH is less effective.  The effects of α-MSH are inhibited by microinjection to the same site of the novel MC4-R/MC3-R antagonist SHU9119 (2-100 pmol) but not naloxone (270 pmol), whereas the similar effects of intra-DVC injection of β-endorphin (1 pmol) are inhibited by naloxone and not by SHU9119.  Hypotensive and bradycardic responses to elec. stimulation of the arcuate nucleus also are inhibited by ipsilateral intra-DVC microinjection of SHU9119.  γ-MSH and ACTH(4-10), but not α-MSH, elicit dose-dependent (0.1-12.5 nmol) pressor tachycardic effects, which are much more pronounced after intracarotid than after i.v. administration.  The effects of γ-MSH (1.25 nmol) are not inhibited by the intracarotid injection of SHU9119 (1.25-12.5 nmol) or the novel MC3-R antagonist SHU9005 (1.25-12.5 nmol).  We conclude that the hypotension and bradycardia elicited by the release of α-MSH from arcuate neurons is mediated by neural melanocortin receptors (MC4-R/MC3-R) located in the DVC, whereas the similar effects of β-endorphin, a peptide derived from the same precursor, are mediated by opiate receptors at the same site.  In contrast, neither MC3-R nor MC4-R is involved in the centrally mediated pressor and tachycardic actions of γ-MSH, which, likely, are mediated by an as yet unidentified receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm9gwh_Mtut7Vg90H21EOLACvtfcHk0lgS1GeypbSTpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFaht7g%253D&md5=64873dfb90c5d6777a36cb4c55bb730f</span></div><a href="/servlet/linkout?suffix=ref15_1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.16-16-05182.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.16-16-05182.1996%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%2BJ.%26aulast%3DVarga%26aufirst%3DK.%26aulast%3DArcher%26aufirst%3DP.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DSharma%26aufirst%3DS.%2BD.%26atitle%3DMelanocortin%2520antagonists%2520define%2520two%2520distinct%2520pathways%2520of%2520cardiovascular%2520control%2520by%2520alpha-%2520and%2520gamma-melanocyte-stimulating%2520hormones%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D5182%26epage%3D5188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="ref16_1"><span><span class="NLM_contrib-group">Wisse, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frayo, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, D. E.</span><span> </span><span class="NLM_article-title">Reversal of cancer anorexia by blockade of central melanocortin receptors in rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">3292</span><span class="NLM_x">–</span> <span class="NLM_lpage">3301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2001&pages=3292-3301&author=B.+E.+Wisseauthor=R.+S.+Frayoauthor=M.+W.+Schwartzauthor=D.+E.+Cummings&title=Reversal+of+cancer+anorexia+by+blockade+of+central+melanocortin+receptors+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref16_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWisse%26aufirst%3DB.%2BE.%26aulast%3DFrayo%26aufirst%3DR.%2BS.%26aulast%3DSchwartz%26aufirst%3DM.%2BW.%26aulast%3DCummings%26aufirst%3DD.%2BE.%26atitle%3DReversal%2520of%2520cancer%2520anorexia%2520by%2520blockade%2520of%2520central%2520melanocortin%2520receptors%2520in%2520rats%26jtitle%3DEndocrinology%26date%3D2001%26volume%3D142%26spage%3D3292%26epage%3D3301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="ref17_1"><span><span class="NLM_contrib-group">Marks, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookhart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cone, R. D.</span><span> </span><span class="NLM_article-title">Differential role of melanocortin receptor subtypes in cachexia</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">1513</span><span class="NLM_x">–</span> <span class="NLM_lpage">1523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/ref17_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1210%2Fen.2002-221099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/ref17_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=12639936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/ref17_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVegtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=1513-1523&author=D.+L.+Marksauthor=A.+A.+Butlerauthor=R.+Turnerauthor=G.+Brookhartauthor=R.+D.+Cone&title=Differential+role+of+melanocortin+receptor+subtypes+in+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref17_1R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential role of melanocortin receptor subtypes in cachexia</span></div><div class="casAuthors">Marks, Daniel L.; Butler, Andrew A.; Turner, Renn; Brookhart, Gregor; Cone, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1513-1523</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Animals and humans respond to starvation with a complex neuroendocrine response that ultimately leads to an increase in appetite, a sparing of lean body mass (LBM) and burning of fat, and an overall decrease in basal metabolic rate.  In contrast, cachexia is a pathol. state of malnutrition assocd. with many infections and chronic diseases, wherein appetite is diminished concomitant with an increase in metabolic rate, and a relative wasting of LBM.  In previous studies, we demonstrated that anorexia and wt. loss in mouse cachexia models induced by lipopolysaccharide (LPS) administration and by tumor growth are ameliorated by central melanocortin-4 (MC4) receptor (MC4-R) blockade.  In contrast to the results seen with MC4 blockade, melanocortin-3 (MC3) receptor knockout (MC3-RKO) mice show illness-induced anorexia and wt. loss with LPS administration and with cytokine administration, and they have similar decreases in mobility.  Both MC3-RKOs and MC4-RKOs have an intact corticosterone response and fever with LPS injection.  In tumor models, we show that MC4-RKO mice resist the loss of LBM brought about by tumor growth, whereas MC3-RKO animals show enhanced tissue wasting.  These data underscore the importance of central melanocortin signaling in wt. homeostasis and demonstrate differential effects of MC3-R and MC4-R blockade on the development of cachexia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwfaUe64Rgt7Vg90H21EOLACvtfcHk0lgS1GeypbSTpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVegtrs%253D&md5=5ae36664febda3d0f09baccebcb46abc</span></div><a href="/servlet/linkout?suffix=ref17_1&amp;dbid=16384&amp;doi=10.1210%2Fen.2002-221099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2002-221099%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DD.%2BL.%26aulast%3DButler%26aufirst%3DA.%2BA.%26aulast%3DTurner%26aufirst%3DR.%26aulast%3DBrookhart%26aufirst%3DG.%26aulast%3DCone%26aufirst%3DR.%2BD.%26atitle%3DDifferential%2520role%2520of%2520melanocortin%2520receptor%2520subtypes%2520in%2520cachexia%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D1513%26epage%3D1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="ref18_1"><span><span class="NLM_contrib-group">Joppa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span> </span><span class="NLM_article-title">Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83–132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=636-642&author=M.+A.+Joppaauthor=K.+R.+Gogasauthor=A.+C.+Fosterauthor=S.+Markison&title=Central+infusion+of+the+melanocortin+receptor+antagonist+agouti-related+peptide+%28AgRP%2883%E2%80%93132%29%29+prevents+cachexia-related+symptoms+induced+by+radiation+and+colon-26+tumors+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref18_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJoppa%26aufirst%3DM.%2BA.%26aulast%3DGogas%26aufirst%3DK.%2BR.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DMarkison%26aufirst%3DS.%26atitle%3DCentral%2520infusion%2520of%2520the%2520melanocortin%2520receptor%2520antagonist%2520agouti-related%2520peptide%2520%2528AgRP%252883%25E2%2580%2593132%2529%2529%2520prevents%2520cachexia-related%2520symptoms%2520induced%2520by%2520radiation%2520and%2520colon-26%2520tumors%2520in%2520mice%26jtitle%3DPeptides%26date%3D2007%26volume%3D28%26spage%3D636%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="ref19_1"><span><span class="NLM_contrib-group">Foster, A. C.; Chen, C. Melanocortin-4 receptor antagonists as potential therapeutics in the treatment of cachexia</span>.  <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span><div class="note"><p class="first last"><i>7</i>, 1131–1136</p></div> .</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Foster%2C+A.+C.%3B+Chen%2C+C.+Melanocortin-4+receptor+antagonists+as+potential+therapeutics+in+the+treatment+of+cachexia.+Curr.+Top.+Med.+Chem.+2007%2C+7%2C+1131%E2%80%931136+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref19_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DA.%2BC.%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="ref20_1"><span><span class="NLM_contrib-group">Marks, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cone, R. D.</span><span> </span><span class="NLM_article-title">The role of the melanocortin-3 receptor in cachexia</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">994</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=994&publication_year=2003&pages=258-266&author=D.+L.+Marksauthor=R.+D.+Cone&title=The+role+of+the+melanocortin-3+receptor+in+cachexia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref20_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DD.%2BL.%26aulast%3DCone%26aufirst%3DR.%2BD.%26atitle%3DThe%2520role%2520of%2520the%2520melanocortin-3%2520receptor%2520in%2520cachexia%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D994%26spage%3D258%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="ref21_1"><span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caracoti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, C. A.</span><span> </span><span class="NLM_article-title">Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1<i>H</i>-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1602</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034244g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1602-1604&author=T.+J.+Vosauthor=A.+Caracotiauthor=J.+L.+Cheauthor=M.+Daiauthor=C.+A.+Farrer&title=Identification+of+2-%5B2-%5B2-%285-bromo-2-+methoxyphenyl%29-ethyl%5D-3-fluorophenyl%5D-4%2C5-dihydro-1H-imidazole+%28ML00253764%29%2C+a+small+molecule+melanocortin+4+receptor+antagonist+that+effectively+reduces+tumor-induced+weight+loss+in+a+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref21_1&amp;dbid=16384&amp;doi=10.1021%2Fjm034244g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034244g%26sid%3Dliteratum%253Aachs%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DCaracoti%26aufirst%3DA.%26aulast%3DChe%26aufirst%3DJ.%2BL.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DFarrer%26aufirst%3DC.%2BA.%26atitle%3DIdentification%2520of%25202-%255B2-%255B2-%25285-bromo-2-%2520methoxyphenyl%2529-ethyl%255D-3-fluorophenyl%255D-4%252C5-dihydro-1H-imidazole%2520%2528ML00253764%2529%252C%2520a%2520small%2520molecule%2520melanocortin%25204%2520receptor%2520antagonist%2520that%2520effectively%2520reduces%2520tumor-induced%2520weight%2520loss%2520in%2520a%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1602%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="ref22_1"><span><span class="NLM_contrib-group">Nicholson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaerer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyermann, P.</span><span> </span><span class="NLM_article-title">Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/ref22_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1124%2Fjpet.105.097725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/ref22_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16436498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/ref22_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=771-777&author=J.+R.+Nicholsonauthor=G.+Kohlerauthor=F.+Schaererauthor=C.+Sennauthor=P.+Weyermann&title=Peripheral+administration+of+a+melanocortin+4-receptor+inverse+agonist+prevents+loss+of+lean+body+mass+in+tumor-bearing+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref22_1R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice</span></div><div class="casAuthors">Nicholson, Janet R.; Kohler, Gotz; Schaerer, Florian; Senn, Claudia; Weyermann, Philipp; Hofbauer, Karl G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">771-777</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cachexia affects many different chronically ill patient populations, including those with cancer.  It results in loss of body wt., particularly of lean body mass (LBM), and is estd. to be responsible for over 20% of all cancer-related deaths.  Currently, available drugs are ineffective, and new therapies are urgently needed.  Melanocortin 4-receptor (MC4-R) blockade has been shown recently to be effective in preventing cancer cachexia in rodent models.  In the present study, we have tested a MC4-R blocker, ML00253764 [2-{2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1H-imidazolium hydrochloride], in vitro and in vivo.  In membranes of human embryonic kidney 293 cells expressing human MC4-R, ML00253764 displaced [Nle4, D-Phe7]-α-MSH binding with an IC50 of 0.32 μM.  At concns. above 1 μM, ML00253764 decreased cAMP accumulation (maximal redn. of -20%) indicative of inverse agonist activity.  ML00253764 was administered twice daily (15 mg/kg s.c.) for 13 days to C57BL6 mice bearing s.c. Lewis lung carcinoma tumors.  Food intake and body wt. were measured, and body compn. was assessed using magnetic resonance relaxometry.  ML00253764 stimulated light-phase food intake relative to vehicle-treated controls (p < 0.05), although no effect was obsd. on 24-h food intake.  During the 21 days of the expt., the LBM of tumor vehicle-treated mice decreased (p < 0.05).  In contrast, the tumor-bearing mice treated with ML00253764 maintained their LBM.  These data support the view that MC4-R blockade may be a suitable approach for the treatment of cancer cachexia and that MC4-R inverse agonists may have potential as drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR75n3KXNhM7Vg90H21EOLACvtfcHk0lhjx9u3zBwPJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamu7o%253D&md5=b2a4319a2dac210cdfee31238030476e</span></div><a href="/servlet/linkout?suffix=ref22_1&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097725%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DJ.%2BR.%26aulast%3DKohler%26aufirst%3DG.%26aulast%3DSchaerer%26aufirst%3DF.%26aulast%3DSenn%26aufirst%3DC.%26aulast%3DWeyermann%26aufirst%3DP.%26atitle%3DPeripheral%2520administration%2520of%2520a%2520melanocortin%25204-receptor%2520inverse%2520agonist%2520prevents%2520loss%2520of%2520lean%2520body%2520mass%2520in%2520tumor-bearing%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D771%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="ref23_1"><span><span class="NLM_contrib-group">Tucci, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joppa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J. A.</span><span> </span><span class="NLM_article-title">Potent and orally active nonpeptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4389-4395&author=F.+C.+Tucciauthor=N.+S.+Whiteauthor=S.+Markisonauthor=M.+Joppaauthor=J.+A.+Tran&title=Potent+and+orally+active+nonpeptide+antagonists+of+the+human+melanocortin-4+receptor+based+on+a+series+of+trans-2-disubstituted+cyclohexylpiperazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref23_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTucci%26aufirst%3DF.%2BC.%26aulast%3DWhite%26aufirst%3DN.%2BS.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoppa%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DJ.%2BA.%26atitle%3DPotent%2520and%2520orally%2520active%2520nonpeptide%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor%2520based%2520on%2520a%2520series%2520of%2520trans-2-disubstituted%2520cyclohexylpiperazines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4389%26epage%3D4395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="ref24_1"><span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookhart, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesse, A.</span><span> </span><span class="NLM_article-title">The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">2766</span><span class="NLM_x">–</span> <span class="NLM_lpage">2773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=2766-2773&author=S.+Markisonauthor=A.+C.+Fosterauthor=C.+Chenauthor=G.+B.+Brookhartauthor=A.+Hesse&title=The+regulation+of+feeding+and+metabolic+rate+and+the+prevention+of+murine+cancer+cachexia+with+a+small-molecule+melanocortin-4+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref24_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DBrookhart%26aufirst%3DG.%2BB.%26aulast%3DHesse%26aufirst%3DA.%26atitle%3DThe%2520regulation%2520of%2520feeding%2520and%2520metabolic%2520rate%2520and%2520the%2520prevention%2520of%2520murine%2520cancer%2520cachexia%2520with%2520a%2520small-molecule%2520melanocortin-4%2520receptor%2520antagonist%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26spage%3D2766%26epage%3D2773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="ref25_1"><span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, D. L.</span><span> </span><span class="NLM_article-title">MC4 receptor antagonists: A potential treatment for cachexia</span> <span class="citation_source-journal">IDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=15800806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFOrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=314-319&author=A.+C.+Fosterauthor=C.+Chenauthor=S.+Markisonauthor=D.+L.+Marks&title=MC4+receptor+antagonists%3A+A+potential+treatment+for+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref25_1R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">MC4 receptor antagonists: a potential treatment for cachexia</span></div><div class="casAuthors">Foster, Alan C.; Chen, Chen; Markison, Stacy; Marks, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">IDrugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">314-319</span>CODEN:
                <span class="NLM_cas:coden">IDRUFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-7056</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Cachexia (involuntary wt. loss) is a devastating syndrome assocd. with many chronic diseases including cancer, and heart, lung, kidney and liver failure.  There are currently no effective treatments capable of reversing the loss of lean body mass that is believed to be a major contributor to morbidity and mortality in these chronic diseases.  Recent findings strongly indicate that blockade of central melanocortin signaling through the MC4 receptor subtype attenuates cachexia.  This review summarizes the evidence supporting the role of MC4 receptors in cachexia, and highlights the progress achieved in the development of small-mol. MC4 antagonists, which have recently proved to be effective in animal models of cachexia.  MC4 antagonists are an attractive therapeutic approach for cachexia that may ameliorate the loss of lean body mass in cachectic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFP6R2JMJEXbVg90H21EOLACvtfcHk0lg5WyMmxX-03A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFOrtL8%253D&md5=2402516fd0a9ad4573baae4191882edb</span></div><a href="/servlet/linkout?suffix=ref25_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMarks%26aufirst%3DD.%2BL.%26atitle%3DMC4%2520receptor%2520antagonists%253A%2520A%2520potential%2520treatment%2520for%2520cachexia%26jtitle%3DIDrugs%26date%3D2005%26volume%3D8%26spage%3D314%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="ref26_1"><span><span class="NLM_contrib-group">Nozawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakinuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1989</span><span class="NLM_x">–</span> <span class="NLM_lpage">2005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1989-2005&author=D.+Nozawaauthor=T.+Okuboauthor=T.+Ishiiauthor=H.+Kakinumaauthor=S.+Chaki&title=Structure%E2%88%92activity+relationships+of+novel+piperazines+as+antagonists+for+the+melanocortin-4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref26_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNozawa%26aufirst%3DD.%26aulast%3DOkubo%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DKakinuma%26aufirst%3DH.%26aulast%3DChaki%26aufirst%3DS.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520novel%2520piperazines%2520as%2520antagonists%2520for%2520the%2520melanocortin-4%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D1989%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="ref27_1"><span><span class="NLM_contrib-group">Nozawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span> </span><span class="NLM_article-title">Novel piperazines: Potent melanocortin-4 receptor antagonists with anxiolytic-like activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2375-2385&author=D.+Nozawaauthor=T.+Okuboauthor=T.+Ishiiauthor=K.+Takamoriauthor=S.+Chaki&title=Novel+piperazines%3A+Potent+melanocortin-4+receptor+antagonists+with+anxiolytic-like+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref27_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNozawa%26aufirst%3DD.%26aulast%3DOkubo%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DTakamori%26aufirst%3DK.%26aulast%3DChaki%26aufirst%3DS.%26atitle%3DNovel%2520piperazines%253A%2520Potent%2520melanocortin-4%2520receptor%2520antagonists%2520with%2520anxiolytic-like%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D2375%26epage%3D2385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="ref28_1"><span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danca, M. D.</span><span> </span><span class="NLM_article-title">Identification and structure−activity relationships of a new series of melanocortin-4 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2302</span><span class="NLM_x">–</span> <span class="NLM_lpage">2305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2302-2305&author=T.+J.+Vosauthor=S.+Balaniauthor=C.+Blackburnauthor=R.+W.+Chauauthor=M.+D.+Danca&title=Identification+and+structure%E2%88%92activity+relationships+of+a+new+series+of+melanocortin-4+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref28_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DBalani%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DChau%26aufirst%3DR.%2BW.%26aulast%3DDanca%26aufirst%3DM.%2BD.%26atitle%3DIdentification%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520a%2520new%2520series%2520of%2520melanocortin-4%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2302%26epage%3D2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="ref29_1"><span><span class="NLM_contrib-group">Poitout, L.; Brault, V.; Sackur, C.; Bernetiere, S.; Camara, J.; et al.</span><span> </span><span class="NLM_article-title">Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=L.+Poitout&author=V.+Brault&author=C.+Sackur&author=S.+Bernetiere&author=J.+Camara+et+al.&title=Identification+of+a+novel+series+of+benzimidazoles+as+potent+and+selective+antagonists+of+the+human+melanocortin-4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref29_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoitout%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520benzimidazoles%2520as%2520potent%2520and%2520selective%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="ref30_1"><span><span class="NLM_contrib-group">Chen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucci, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arellano, M.</span><span> </span><span class="NLM_article-title">Propionylpiperazines as human melanocortin-4 receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4800</span><span class="NLM_x">–</span> <span class="NLM_lpage">4803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4800-4803&author=C.+W.+Chenauthor=J.+A.+Tranauthor=W.+Jiangauthor=F.+C.+Tucciauthor=M.+Arellano&title=Propionylpiperazines+as+human+melanocortin-4+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref30_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%2BW.%26aulast%3DTran%26aufirst%3DJ.%2BA.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DTucci%26aufirst%3DF.%2BC.%26aulast%3DArellano%26aufirst%3DM.%26atitle%3DPropionylpiperazines%2520as%2520human%2520melanocortin-4%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4800%26epage%3D4803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="ref31_1"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. W.</span><span> </span><span class="NLM_article-title">Practical asymmetric synthesis of alpha-branched 2-piperazinylbenzylamines by 1,2-additions of organometallic reagents to <i>N</i>-<i>tert</i>-butanesulfinyl imines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8924</span><span class="NLM_x">–</span> <span class="NLM_lpage">8931</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo051514p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=8924-8931&author=W.+Jiangauthor=C.+Chenauthor=D.+Marinkovicauthor=J.+A.+Tranauthor=C.+W.+Chen&title=Practical+asymmetric+synthesis+of+alpha-branched+2-piperazinylbenzylamines+by+1%2C2-additions+of+organometallic+reagents+to+N-tert-butanesulfinyl+imines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref31_1&amp;dbid=16384&amp;doi=10.1021%2Fjo051514p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo051514p%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DMarinkovic%26aufirst%3DD.%26aulast%3DTran%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DC.%2BW.%26atitle%3DPractical%2520asymmetric%2520synthesis%2520of%2520alpha-branched%25202-piperazinylbenzylamines%2520by%25201%252C2-additions%2520of%2520organometallic%2520reagents%2520to%2520N-tert-butanesulfinyl%2520imines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D8924%26epage%3D8931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="ref32_1"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucci, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arellano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J. A.</span><span> </span><span class="NLM_article-title">Arylpropionylpiperazines as antagonists of the human melanocortin-4 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4674</span><span class="NLM_x">–</span> <span class="NLM_lpage">4678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4674-4678&author=W.+Jiangauthor=F.+C.+Tucciauthor=C.+W.+Chenauthor=M.+Arellanoauthor=J.+A.+Tran&title=Arylpropionylpiperazines+as+antagonists+of+the+human+melanocortin-4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref32_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DTucci%26aufirst%3DF.%2BC.%26aulast%3DChen%26aufirst%3DC.%2BW.%26aulast%3DArellano%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DJ.%2BA.%26atitle%3DArylpropionylpiperazines%2520as%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4674%26epage%3D4678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="ref33_1"><span><span class="NLM_contrib-group">Tran, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucci, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. W.</span><span> </span><span class="NLM_article-title">Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5166</span><span class="NLM_x">–</span> <span class="NLM_lpage">5176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5166-5176&author=J.+A.+Tranauthor=F.+C.+Tucciauthor=W.+Jiangauthor=D.+Marinkovicauthor=C.+W.+Chen&title=Pyrrolidinones+as+orally+bioavailable+antagonists+of+the+human+melanocortin-4+receptor+with+anti-cachectic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref33_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DJ.%2BA.%26aulast%3DTucci%26aufirst%3DF.%2BC.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DMarinkovic%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%2BW.%26atitle%3DPyrrolidinones%2520as%2520orally%2520bioavailable%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor%2520with%2520anti-cachectic%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5166%26epage%3D5176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="ref34_1"><span><span class="NLM_contrib-group">Kotake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takiguchi, Y.</span><span> </span><span class="NLM_article-title">Design and synthesis of a new polymer-supported Evans-type oxazolidinone: An efficient chiral auxiliary in the solid-phase asymmetric alkylation reactions</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3819</span><span class="NLM_x">–</span> <span class="NLM_lpage">3844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=3819-3844&author=T.+Kotakeauthor=Y.+Hayashiauthor=S.+Rajeshauthor=Y.+Mukaiauthor=Y.+Takiguchi&title=Design+and+synthesis+of+a+new+polymer-supported+Evans-type+oxazolidinone%3A+An+efficient+chiral+auxiliary+in+the+solid-phase+asymmetric+alkylation+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref34_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotake%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DRajesh%26aufirst%3DS.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DTakiguchi%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520new%2520polymer-supported%2520Evans-type%2520oxazolidinone%253A%2520An%2520efficient%2520chiral%2520auxiliary%2520in%2520the%2520solid-phase%2520asymmetric%2520alkylation%2520reactions%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D3819%26epage%3D3844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="ref35_1"><span><span class="NLM_contrib-group">Numata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, T.</span><span> </span><span class="NLM_article-title">General synthetic method for naphthyridines and their N-oxides containing isoquinolinic nitrogen</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1999&pages=311&author=A.+Numataauthor=Y.+Kondoauthor=T.+Sakamoto&title=General+synthetic+method+for+naphthyridines+and+their+N-oxides+containing+isoquinolinic+nitrogen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref35_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNumata%26aufirst%3DA.%26aulast%3DKondo%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DT.%26atitle%3DGeneral%2520synthetic%2520method%2520for%2520naphthyridines%2520and%2520their%2520N-oxides%2520containing%2520isoquinolinic%2520nitrogen%26jtitle%3DSynthesis%26date%3D1999%26volume%3D306%26spage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="ref36_1"><span><span class="NLM_contrib-group">Nickolls, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cismowski, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conlon, P. J.</span><span> </span><span class="NLM_article-title">Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/ref36_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1124%2Fjpet.102.044974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/ref36_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=12604699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/ref36_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1eis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=1217-1227&author=S.+A.+Nickollsauthor=M.+I.+Cismowskiauthor=X.+Wangauthor=M.+Wolffauthor=P.+J.+Conlon&title=Molecular+determinants+of+melanocortin+4+receptor+ligand+binding+and+MC4%2FMC3+receptor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref36_1R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity</span></div><div class="casAuthors">Nickolls, Sarah A.; Cismowski, Mary I.; Wang, Xiaochuan; Wolff, Meira; Conlon, Paul J.; Maki, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1217-1227</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The mol. basis of ligand recognition by the melanocortin 4 receptor (MC4R) has not been fully defined.  In this study, we investigated the mol. determinants of MC4R ligand binding, employing a large array of ligands, using three approaches.  First; mol. modeling of the receptor was used to identify Phe284, in transmembrane (TM) 7, as a potential site of ligand interaction.  Mutation of Phe284 to alanine reduced binding affinity and potency of peptides contg. L-Phe by up to 71-fold but did not appreciably affect binding of linear peptides contg. D-Phe, consistent with a hydrophobic interaction between the Phe7 of α-MSH and Phe284.  Second, we examd. the effect of a naturally occurring mutation in TM3 (I137T) that is linked to obesity.  This mutation decreased affinity and potency of cyclic, rigid peptides but not more flexible peptides, consistent with an indirect effect of the mutation on the tertiary structure of the receptor.  Third, we examd. the residues that support ligand selectivity for the MC4R over the MC3R.  Mutation of lle125 (TM3) of the MC4R to the equiv. residue of the MC3R (phenylalanine) selectively decreased affinity and potency of MC4R-selective ligands.  This effect was mirrored by the reciprocal MC3R mutation F157I.  The magnitude of this effect indicates that this locus is not of major importance.  However, it is considered that an isoleucine/phenylalanine mutation may affect the orientation of Asp122, which has been identified as a major determinant of ligand binding affinity.  Thus, this study provides further characterization of the MC4R binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-46mcgWzdLLVg90H21EOLACvtfcHk0lgBTeh5oHZtTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1eis7c%253D&md5=d41f83b8dbc4db2ccee2349cd2f2d7e2</span></div><a href="/servlet/linkout?suffix=ref36_1&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.044974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.044974%26sid%3Dliteratum%253Aachs%26aulast%3DNickolls%26aufirst%3DS.%2BA.%26aulast%3DCismowski%26aufirst%3DM.%2BI.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DConlon%26aufirst%3DP.%2BJ.%26atitle%3DMolecular%2520determinants%2520of%2520melanocortin%25204%2520receptor%2520ligand%2520binding%2520and%2520MC4%252FMC3%2520receptor%2520selectivity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D1217%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="ref37_1"><span><span class="NLM_contrib-group">Loscher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potschka, H.</span><span> </span><span class="NLM_article-title">Blood−brain barrier active efflux transporters: ATP-binding cassette gene family</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=86-98&author=W.+Loscherauthor=H.+Potschka&title=Blood%E2%88%92brain+barrier+active+efflux+transporters%3A+ATP-binding+cassette+gene+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref37_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoscher%26aufirst%3DW.%26aulast%3DPotschka%26aufirst%3DH.%26atitle%3DBlood%25E2%2588%2592brain%2520barrier%2520active%2520efflux%2520transporters%253A%2520ATP-binding%2520cassette%2520gene%2520family%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D86%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="ref38_1"><span><span class="NLM_contrib-group">Jiang, J.; Tucci, F. C.; Tran, J. A.; Fleck, B. A.; Wen, J.</span> et al. <span> </span><span class="NLM_article-title">Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5610</span><span class="NLM_x">–</span> <span class="NLM_lpage">5613</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5610-5613&author=J.+Jiang&author=F.+C.+Tucci&author=J.+A.+Tran&author=B.+A.+Fleck&author=J.+Wen&title=Pyrrolidinones+as+potent+functional+antagonists+of+the+human+melanocortin-4+receptor."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref38_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26atitle%3DPyrrolidinones%2520as%2520potent%2520functional%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5610%26epage%3D5613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="ref39_1"><span><span class="NLM_contrib-group">Konturek, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konturek, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzozowski, T.</span><span> </span><span class="NLM_article-title">Brain−gut axis and its role in the control of food intake</span> <span class="citation_source-journal">J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/ref39_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=15082874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/ref39_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Orurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=137-154&author=S.+J.+Konturekauthor=J.+W.+Konturekauthor=T.+Pawlikauthor=T.+Brzozowski&title=Brain%E2%88%92gut+axis+and+its+role+in+the+control+of+food+intake"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref39_1R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-gut axis and its role in the control of food intake</span></div><div class="casAuthors">Konturek, S. J.; Konturek, J. W.; Pawlik, T.; Brzozowki, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1, Pt. 2</span>),
    <span class="NLM_cas:pages">137-154</span>CODEN:
                <span class="NLM_cas:coden">JPHPEI</span>;
        ISSN:<span class="NLM_cas:issn">0867-5910</span>.
    
            (<span class="NLM_cas:orgname">Polish Physiological Society</span>)
        </div><div class="casAbstract">A review.  Gastrointestinal tract (GIT) and nervous system, both central (CNS) and enteric (ENS), are involved in 2-way extrinsic communication by parasympathetic and sympathetic nerves, each comprising efferents fibers such as cholinergic and noradrenergic, resp., and afferent sensory fibers required for gut-brain signaling.  Afferent nerves are equipped with numerous sensors at their terminals in the gut related to visceral mechano- chemo- and noci-receptors, whose excitations may trigger a variety of visceral reflexes regulating GIT functions, including the appetitive behavior.  Food intake depends upon various influences from the CNS as well as from the body energy stores (adipocytes) that express and release the product of Ob gene, leptin, in proportion to fat stored and acting in long-term regulation of food intake.  Leptin acts through receptors (Ob-R) present in afferent visceral nerves and hypothalamic arcuate nucleus (ARC), whose neurons are capable of expressing and releasing neuropeptide Y (NPY) and agouti related protein (AgRP) that activate the ingestive behavior through paraventricular nucleus (PVN) ("feeding center").  In addn., to this long-term regulation, a short-term regulation, on meal-to-meal basis, is secured by several gut hormones, such as cholecystokinin (CCK), peptides YY (PYY) and oxyntomodulin (OXM), released from the endocrine intestinal cells and acting via G-protein coupled receptors (GPCR) either on afferent nerves or directly on ARC neurons, which in turn inhibit expression and release of food-intake stimulating NPY and AgRP, thereby inducing satiety through inhibition of PVN.  In contrast, during fasting, the GIT, esp. oxyntic mucosa, expresses and releases appetite stimulating (orexigenic) factors such as ghrelin and orexins (OX) -A and OX-B, and cannabinoid CB1 agonist.  Ghrelin activates growth-hormone secretagogue receptor (GHS-R) in hypothalamic ARC and stimulates growth hormone (GH) release and in vagal afferents to promote the expression and release of hypothalamic NPY and AgRP stimulating PVN and driving ingestive behavior.  The balance and interaction between anorexigenic (CCK, PYY, OXM) and orexigenic (ghrelin and OX) factors originating from GIT appears to play an important role in short-term regulation of food intake and growth hormone (GH) release.  An impairment of this balance may result in disorders of feeding behavior and wt. gain (obesity) or wt. loss (cachexia).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLXDDB_IWw7Vg90H21EOLACvtfcHk0lh_lVsAsRn1pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Orurc%253D&md5=0ef9dff0a2329bcfaa0598c24e587376</span></div><a href="/servlet/linkout?suffix=ref39_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKonturek%26aufirst%3DS.%2BJ.%26aulast%3DKonturek%26aufirst%3DJ.%2BW.%26aulast%3DPawlik%26aufirst%3DT.%26aulast%3DBrzozowski%26aufirst%3DT.%26atitle%3DBrain%25E2%2588%2592gut%2520axis%2520and%2520its%2520role%2520in%2520the%2520control%2520of%2520food%2520intake%26jtitle%3DJ.%2520Physiol.%2520Pharmacol.%26date%3D2004%26volume%3D55%26spage%3D137%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="ref40_1"><span><span class="NLM_contrib-group">Ferorelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiodice, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amoroso, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettoni, G.</span><span> </span><span class="NLM_article-title">Isosteres of chiral clofibric acid analogs: synthesis, resolution, absolute configuration and HPLC detection of the optical purity</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=367-374&author=S.+Ferorelliauthor=F.+Loiodiceauthor=V.+Tortorellaauthor=R.+Amorosoauthor=G.+Bettoni&title=Isosteres+of+chiral+clofibric+acid+analogs%3A+synthesis%2C+resolution%2C+absolute+configuration+and+HPLC+detection+of+the+optical+purity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref40_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerorelli%26aufirst%3DS.%26aulast%3DLoiodice%26aufirst%3DF.%26aulast%3DTortorella%26aufirst%3DV.%26aulast%3DAmoroso%26aufirst%3DR.%26aulast%3DBettoni%26aufirst%3DG.%26atitle%3DIsosteres%2520of%2520chiral%2520clofibric%2520acid%2520analogs%253A%2520synthesis%252C%2520resolution%252C%2520absolute%2520configuration%2520and%2520HPLC%2520detection%2520of%2520the%2520optical%2520purity%26jtitle%3DFarmaco%26date%3D1999%26volume%3D52%26spage%3D367%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['ref1_1'],'ref2':['ref2_1'],'ref3':['ref3_1'],'ref4':['ref4_1'],'ref5':['ref5_1'],'ref6':['ref6_1'],'ref7':['ref7_1'],'ref8':['ref8_1'],'ref9':['ref9_1'],'ref10':['ref10_1'],'ref11':['ref11_1'],'ref12':['ref12_1'],'ref13':['ref13_1'],'ref14':['ref14_1'],'ref15':['ref15_1'],'ref16':['ref16_1'],'ref17':['ref17_1'],'ref18':['ref18_1'],'ref19':['ref19_1'],'ref20':['ref20_1'],'ref21':['ref21_1'],'ref22':['ref22_1'],'ref23':['ref23_1'],'ref24':['ref24_1'],'ref25':['ref25_1'],'ref26':['ref26_1'],'ref27':['ref27_1'],'ref28':['ref28_1'],'ref29':['ref29_1'],'ref30':['ref30_1'],'ref31':['ref31_1'],'ref32':['ref32_1'],'ref33':['ref33_1'],'ref34':['ref34_1'],'ref35':['ref35_1'],'ref36':['ref36_1'],'ref37':['ref37_1'],'ref38':['ref38_1'],'ref39':['ref39_1'],'ref40':['ref40_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">MaryAnn T.  Robak</span>, <span class="hlFld-ContribAuthor ">Melissa A.  Herbage</span> and <span class="hlFld-ContribAuthor ">Jonathan A.  Ellman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Applications of tert-Butanesulfinamide. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2010,</strong> <em>110 </em>
                                    (6)
                                     , 3600-3740. <a href="https://doi.org/10.1021/cr900382t" title="DOI URL">https://doi.org/10.1021/cr900382t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr900382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr900382t%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DSynthesis%252Band%252BApplications%252Bof%252Btert-Butanesulfinamide%26aulast%3DRobak%26aufirst%3DMaryAnn%2BT.%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D18%252011%25202009%26date%3D26042010%26date%3D09062010%26volume%3D110%26issue%3D6%26spage%3D3600%26epage%3D3740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua‐Jie  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiu‐Mei  Zhong</span>, <span class="hlFld-ContribAuthor ">Zi‐Ye  Liu</span>, <span class="hlFld-ContribAuthor ">Rui‐Long  Geng</span>, <span class="hlFld-ContribAuthor ">Yang‐Yang  Li</span>, <span class="hlFld-ContribAuthor ">Yun‐Dong  Wu</span>, <span class="hlFld-ContribAuthor ">Xinhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Liu‐Zhu  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Palladium Catalyst Assembled from Chiral Phosphoric Acid and Thioamide for Enantioselective β‐C(sp
              3
              )−H Arylation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (31)
                                     , 12874-12878. <a href="https://doi.org/10.1002/ange.202004485" title="DOI URL">https://doi.org/10.1002/ange.202004485</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202004485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202004485%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DHybrid%252BPalladium%252BCatalyst%252BAssembled%252Bfrom%252BChiral%252BPhosphoric%252BAcid%252Band%252BThioamide%252Bfor%252BEnantioselective%252B%2525CE%2525B2%2525E2%252580%252590C%252528sp%252B3%252B%252529%2525E2%252588%252592H%252BArylation%26aulast%3DJiang%26aufirst%3DHua%25E2%2580%2590Jie%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D31%26spage%3D12874%26epage%3D12878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua‐Jie  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiu‐Mei  Zhong</span>, <span class="hlFld-ContribAuthor ">Zi‐Ye  Liu</span>, <span class="hlFld-ContribAuthor ">Rui‐Long  Geng</span>, <span class="hlFld-ContribAuthor ">Yang‐Yang  Li</span>, <span class="hlFld-ContribAuthor ">Yun‐Dong  Wu</span>, <span class="hlFld-ContribAuthor ">Xinhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Liu‐Zhu  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Palladium Catalyst Assembled from Chiral Phosphoric Acid and Thioamide for Enantioselective β‐C(sp
              3
              )−H Arylation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (31)
                                     , 12774-12778. <a href="https://doi.org/10.1002/anie.202004485" title="DOI URL">https://doi.org/10.1002/anie.202004485</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202004485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202004485%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DHybrid%252BPalladium%252BCatalyst%252BAssembled%252Bfrom%252BChiral%252BPhosphoric%252BAcid%252Band%252BThioamide%252Bfor%252BEnantioselective%252B%2525CE%2525B2%2525E2%252580%252590C%252528sp%252B3%252B%252529%2525E2%252588%252592H%252BArylation%26aulast%3DJiang%26aufirst%3DHua%25E2%2580%2590Jie%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D31%26spage%3D12774%26epage%3D12778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa A.  Herbage</span>, <span class="hlFld-ContribAuthor ">Jolaine  Savoie</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Sieber</span>, <span class="hlFld-ContribAuthor ">Jean-Nicolas  Desrosiers</span>, <span class="hlFld-ContribAuthor ">Yongda  Zhang</span>, <span class="hlFld-ContribAuthor ">Maurice A.  Marsini</span>, <span class="hlFld-ContribAuthor ">Keith R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Daniel  Rivalti</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Addition of Non-Stabilized Carbon-Based Nucleophilic Reagents to Chiral
              N
              -Sulfinyl Imines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-422. <a href="https://doi.org/10.1002/0471264180.or099.01" title="DOI URL">https://doi.org/10.1002/0471264180.or099.01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264180.or099.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264180.or099.01%26sid%3Dliteratum%253Aachs%26atitle%3DAddition%252Bof%252BNon-Stabilized%252BCarbon-Based%252BNucleophilic%252BReagents%252Bto%252BChiral%252BN%252B-Sulfinyl%252BImines%26aulast%3DHerbage%26aufirst%3DMelissa%2BA.%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D422%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DOrganic%252BReactions%26date%3D2004%26date%3D2004%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruce  Blough</span>, <span class="hlFld-ContribAuthor ">Ojas  Namjoshi</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Neuropeptide S and Melanocortin 4 Receptor Ligands as Potential Treatments for Substance Use Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 61-87. <a href="https://doi.org/10.1007/164_2019_313" title="DOI URL">https://doi.org/10.1007/164_2019_313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2019_313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2019_313%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%252BMolecule%252BNeuropeptide%252BS%252Band%252BMelanocortin%252B4%252BReceptor%252BLigands%252Bas%252BPotential%252BTreatments%252Bfor%252BSubstance%252BUse%252BDisorders%26aulast%3DBlough%26aufirst%3DBruce%26date%3D2019%26date%3D2019%26spage%3D61%26epage%3D87%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSubstance%252BUse%252BDisorders%26aulast%3DNader%26aufirst%3DMichael%2BA.%26date%3D2020%26volume%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Singhal</span>, <span class="hlFld-ContribAuthor ">Jennifer W.  Hill</span>. </span><span class="cited-content_cbyCitation_article-title">Obesity and Stress: The Melanocortin Connection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 271-319. <a href="https://doi.org/10.1007/978-3-319-89506-2_11" title="DOI URL">https://doi.org/10.1007/978-3-319-89506-2_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-89506-2_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-89506-2_11%26sid%3Dliteratum%253Aachs%26atitle%3DObesity%252Band%252BStress%25253A%252BThe%252BMelanocortin%252BConnection%26aulast%3DSinghal%26aufirst%3DSara%26date%3D2018%26date%3D2018%26spage%3D271%26epage%3D319%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTextbook%252Bof%252BEnergy%252BBalance%25252C%252BNeuropeptide%252BHormones%25252C%252Band%252BNeuroendocrine%252BFunction%26aulast%3DNillni%26aufirst%3DEduardo%2BA.%26date%3D2018%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masahiro  Ohsawa</span>, <span class="hlFld-ContribAuthor ">Tomoyasu  Murakami</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Kume</span>. </span><span class="cited-content_cbyCitation_article-title">Possible Involvement of Insulin Resistance in the Progression of Cancer Cachexia in Mice. </span><span class="cited-content_cbyCitation_journal-name">YAKUGAKU ZASSHI</span><span> <strong>2016,</strong> <em>136 </em>
                                    (5)
                                     , 687-692. <a href="https://doi.org/10.1248/yakushi.15-00262-1" title="DOI URL">https://doi.org/10.1248/yakushi.15-00262-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/yakushi.15-00262-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fyakushi.15-00262-1%26sid%3Dliteratum%253Aachs%26jtitle%3DYAKUGAKU%2520ZASSHI%26atitle%3DPossible%252BInvolvement%252Bof%252BInsulin%252BResistance%252Bin%252Bthe%252BProgression%252Bof%252BCancer%252BCachexia%252Bin%252BMice%26aulast%3DOhsawa%26aufirst%3DMasahiro%26date%3D2016%26volume%3D136%26issue%3D5%26spage%3D687%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chukwuemeka Charles  Ezeoke</span>, <span class="hlFld-ContribAuthor ">John E.  Morley</span>. </span><span class="cited-content_cbyCitation_article-title">Pathophysiology of anorexia in the cancer cachexia syndrome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cachexia, Sarcopenia and Muscle</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 287-302. <a href="https://doi.org/10.1002/jcsm.12059" title="DOI URL">https://doi.org/10.1002/jcsm.12059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcsm.12059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcsm.12059%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cachexia%252C%2520Sarcopenia%2520and%2520Muscle%26atitle%3DPathophysiology%252Bof%252Banorexia%252Bin%252Bthe%252Bcancer%252Bcachexia%252Bsyndrome%26aulast%3DEzeoke%26aufirst%3DChukwuemeka%2BCharles%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D4%26spage%3D287%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esther CY  Lee</span>, <span class="hlFld-ContribAuthor ">Philip A  Carpino</span>. </span><span class="cited-content_cbyCitation_article-title">Melanocortin-4 receptor modulators for the treatment of obesity: a patent analysis (2008–2014). </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2015,</strong> <em>4 </em>
                                    (2)
                                     , 95-107. <a href="https://doi.org/10.4155/ppa.15.1" title="DOI URL">https://doi.org/10.4155/ppa.15.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.15.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.15.1%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DMelanocortin-4%252Breceptor%252Bmodulators%252Bfor%252Bthe%252Btreatment%252Bof%252Bobesity%25253A%252Ba%252Bpatent%252Banalysis%252B%2525282008%2525E2%252580%2525932014%252529%26aulast%3DLee%26aufirst%3DEsther%2BCY%26date%3D2015%26volume%3D4%26issue%3D2%26spage%3D95%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy  Steinman</span>, <span class="hlFld-ContribAuthor ">Mark Daniel  DeBoer</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of Cachexia. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 197-242. <a href="https://doi.org/10.1016/B978-0-12-410473-0.00008-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-410473-0.00008-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-410473-0.00008-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-410473-0.00008-8%26sid%3Dliteratum%253Aachs%26atitle%3DTreatment%252Bof%252BCachexia%26aulast%3DSteinman%26aufirst%3DJeremy%26date%3D2013%26spage%3D197%26epage%3D242%26pub%3DElsevier%26atitle%3DAnorexia%26date%3D2013%26volume%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roxana  Tucaliuc</span>, <span class="hlFld-ContribAuthor ">Valeriu V.  Cotea</span>, <span class="hlFld-ContribAuthor ">Costel  Moldoveanu</span>, <span class="hlFld-ContribAuthor ">Gheorghita  Zbancioc</span>, <span class="hlFld-ContribAuthor ">Calin  Deleanu</span>, <span class="hlFld-ContribAuthor ">Peter G.  Jones</span>, <span class="hlFld-ContribAuthor ">Ionel I.  Mangalagiu</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient and selective route to hybrid trifluoromethyl-substituted γ-lactones or fused nitrogen derivatives via cascade reactions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2011,</strong> <em>52 </em>
                                    (48)
                                     , 6439-6442. <a href="https://doi.org/10.1016/j.tetlet.2011.09.093" title="DOI URL">https://doi.org/10.1016/j.tetlet.2011.09.093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2011.09.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2011.09.093%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Band%252Bselective%252Broute%252Bto%252Bhybrid%252Btrifluoromethyl-substituted%252B%2525CE%2525B3-lactones%252Bor%252Bfused%252Bnitrogen%252Bderivatives%252Bvia%252Bcascade%252Breactions%26aulast%3DTucaliuc%26aufirst%3DRoxana%26date%3D2011%26volume%3D52%26issue%3D48%26spage%3D6439%26epage%3D6442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark Daniel  DeBoer</span>. </span><span class="cited-content_cbyCitation_article-title">Update on melanocortin interventions for cachexia: Progress toward clinical application. </span><span class="cited-content_cbyCitation_journal-name">Nutrition</span><span> <strong>2010,</strong> <em>26 </em>
                                    (2)
                                     , 146-151. <a href="https://doi.org/10.1016/j.nut.2009.07.003" title="DOI URL">https://doi.org/10.1016/j.nut.2009.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nut.2009.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nut.2009.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrition%26atitle%3DUpdate%252Bon%252Bmelanocortin%252Binterventions%252Bfor%252Bcachexia%25253A%252BProgress%252Btoward%252Bclinical%252Bapplication%26aulast%3DDeBoer%26aufirst%3DMark%2BDaniel%26date%3D2010%26volume%3D26%26issue%3D2%26spage%3D146%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark D  DeBoer</span>. </span><span class="cited-content_cbyCitation_article-title">Animal models of anorexia and cachexia. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2009,</strong> <em>4 </em>
                                    (11)
                                     , 1145-1155. <a href="https://doi.org/10.1517/17460440903300842" title="DOI URL">https://doi.org/10.1517/17460440903300842</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460440903300842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460440903300842%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAnimal%252Bmodels%252Bof%252Banorexia%252Band%252Bcachexia%26aulast%3DDeBoer%26aufirst%3DMark%2BD%26date%3D2009%26date%3D2009%26volume%3D4%26issue%3D11%26spage%3D1145%26epage%3D1155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurizio  Bossola</span>, <span class="hlFld-ContribAuthor ">Fabio  Pacelli</span>, <span class="hlFld-ContribAuthor ">Giovan Battista  Doglietto</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer cachexia: drugs in the patent literature. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2008,</strong> <em>18 </em>
                                    (7)
                                     , 739-757. <a href="https://doi.org/10.1517/13543776.18.7.739" title="DOI URL">https://doi.org/10.1517/13543776.18.7.739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.18.7.739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.18.7.739%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DCancer%252Bcachexia%25253A%252Bdrugs%252Bin%252Bthe%252Bpatent%252Bliterature%26aulast%3DBossola%26aufirst%3DMaurizio%26date%3D2008%26date%3D2008%26volume%3D18%26issue%3D7%26spage%3D739%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Fabio C.  Tucci</span>, <span class="hlFld-ContribAuthor ">Wanlong  Jiang</span>, <span class="hlFld-ContribAuthor ">Joe A.  Tran</span>, <span class="hlFld-ContribAuthor ">Beth A.  Fleck</span>, <span class="hlFld-ContribAuthor ">Sam R.  Hoare</span>, <span class="hlFld-ContribAuthor ">Jenny  Wen</span>, <span class="hlFld-ContribAuthor ">Takung  Chen</span>, <span class="hlFld-ContribAuthor ">Michael  Johns</span>, <span class="hlFld-ContribAuthor ">Stacy  Markison</span>, <span class="hlFld-ContribAuthor ">Alan C.  Foster</span>, <span class="hlFld-ContribAuthor ">Dragan  Marinkovic</span>, <span class="hlFld-ContribAuthor ">Caroline W.  Chen</span>, <span class="hlFld-ContribAuthor ">Melissa  Arellano</span>, <span class="hlFld-ContribAuthor ">John  Harman</span>, <span class="hlFld-ContribAuthor ">John  Saunders</span>, <span class="hlFld-ContribAuthor ">Haig  Bozigian</span>, <span class="hlFld-ContribAuthor ">Daniel  Marks</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological and pharmacokinetic characterization of 2-piperazine-α-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2008,</strong> <em>16 </em>
                                    (10)
                                     , 5606-5618. <a href="https://doi.org/10.1016/j.bmc.2008.03.072" title="DOI URL">https://doi.org/10.1016/j.bmc.2008.03.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2008.03.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2008.03.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPharmacological%252Band%252Bpharmacokinetic%252Bcharacterization%252Bof%252B2-piperazine-%2525CE%2525B1-isopropyl%252Bbenzylamine%252Bderivatives%252Bas%252Bmelanocortin-4%252Breceptor%252Bantagonists%26aulast%3DChen%26aufirst%3DChen%26date%3D2008%26volume%3D16%26issue%3D10%26spage%3D5606%26epage%3D5618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of some small molecule MC4R antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0006.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TFA/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 1 h; (b) 2,4-ClC<sub>6</sub>H<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>COOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (c) HCl/MeOH, r.t., 1 h; (d) 2-MeO,4-ClC<sub>6</sub>H<sub>3</sub>CH<sub>2</sub>CHMeCOOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (e) <i>R</i>-(4-ClC<sub>6</sub>H<sub>4</sub>)CH<sub>2</sub>CHMeCOOH/EDC/ HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (f) (i) <i>N</i>-Boc-<span class="smallcaps smallerCapital">d</span>-(2,4-Cl)Phe-OH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (ii) TFA/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 1 h; (iii) OCHCH<sub>2</sub>CH<sub>2</sub>COOH/NaBH(OAc)<sub>3</sub>/HOAc/ClCH<sub>2</sub>CH<sub>2</sub>Cl, r.t., 24 h; (iv) EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (g) <i>N</i>-Boc-GlyOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h; (h) Me<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>COOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF, r.t., 16 h; (i) <i>N</i>-Boc-NHCH<sub>2</sub>CHO/NaBH(OAc)<sub>3</sub>/CH<sub>2</sub>Cl<sub>2</sub>/r.t. 14 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0007.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaHMDS/THF, −70°C, 1 h, then 2-Y-4-ClC<sub>6</sub>H<sub>4</sub>CH<sub>2</sub>Br, −78 °C to r.t., 6 h; (b) LiOH/H<sub>2</sub>O<sub>2</sub>/THF/H<sub>2</sub>O, 0 °C to r.t., 1.5 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0008.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF/DIEA/4-Boc-piperazine, 100°C, 8 h; (b) <i>S</i>-Me<sub>3</sub>CSONH<sub>2</sub>/Ti(OEt)<sub>4</sub>/THF, r.t., 8 h; (c) (i) Me<sub>3</sub>Al/THF, −40 °C, 20 min; (ii) <i>i</i>-BuLi/THF, −78 °C, 5–8 h; (d) (i) TFA/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 1 h; (ii) (2,4-Cl<sub>2</sub>C<sub>6</sub>H<sub>3</sub>)CH<sub>2</sub>CH(R′)COOH/EDC/HOBt/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 8 h; (e) <i>N</i>-Boc-Gly-OH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 8 h; (ii) TFA/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 1 h; (f) Me<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>COOH/EDC/HOBt/NaHCO<sub>3</sub>/DMF/CH<sub>2</sub>Cl<sub>2</sub>, r.t., 8 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <i>R</i>-<b>19b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overlay of pyridylpiperazine <i>R</i>-<b>19</b> and phenylpiperazine <b>6a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. The effects of compound <b>12b</b> (i.p., 3 and 9 mg/kg twice per day) on food intake (4A, left) and lean body mass (4B, right) in tumor-bearing mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/medium/jm-2007-01137s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time–concentration curve of <b>12b</b> after an i.p. administration (10 mg/kg) to CD-1 mice (<i>n</i> = 3; <i>C</i><sub>max</sub> = 1521 ng/mL; <i>T</i><sub>max</sub> = 0.3 h; AUC = 3073 ng/mL·h).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-25/jm701137s/production/images/large/jm-2007-01137s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701137s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-ref1_1"><span><span class="NLM_contrib-group">Gordon, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goggin, P. M.</span><span> </span><span class="NLM_article-title">Cancer cachexia</span> <span class="citation_source-journal">QJM</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/ref1_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1093%2Fqjmed%2Fhci127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/ref1_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16214835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/ref1_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A280%3ADC%252BD2MrlvVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2005&pages=779-788&author=J.+N.+Gordonauthor=S.+R.+Greenauthor=P.+M.+Goggin&title=Cancer+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref1_1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer cachexia</span></div><div class="casAuthors">Gordon J N; Green S R; Goggin P M</div><div class="citationInfo"><span class="NLM_cas:title">QJM : monthly journal of the Association of Physicians</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">779-88</span>
        ISSN:<span class="NLM_cas:issn">1460-2725</span>.
    </div><div class="casAbstract">Cancer cachexia is a severe debilitating disorder for which there are currently few therapeutic options.  It is driven by the release of pro-inflammatory cytokines and cachectic factors by both host and tumour.  Over the past few years, basic science advances have begun to reveal the breadth and complexity of the immunological mechanisms involved, and in the process have uncovered some novel potential therapeutic targets.  The effectiveness of thalidomide and eicosapentaenoic acid at attenuating weight loss in clinical trials also provides a further rationale for modulating the immune response.  We are now entering an exciting period in cachexia research, and it is likely that the next few years will see effective new biological therapies reach clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwm63OvtxyCFVwdslNBF-tfW6udTcc2eb57pD0JrHQJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrlvVKrsA%253D%253D&md5=8ce1ca3e6fd7d9b49c3ccc5b182a36c3</span></div><a href="/servlet/linkout?suffix=ref1_1&amp;dbid=16384&amp;doi=10.1093%2Fqjmed%2Fhci127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fqjmed%252Fhci127%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DJ.%2BN.%26aulast%3DGreen%26aufirst%3DS.%2BR.%26aulast%3DGoggin%26aufirst%3DP.%2BM.%26atitle%3DCancer%2520cachexia%26jtitle%3DQJM%26date%3D2005%26volume%3D98%26spage%3D779%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-ref2_1"><span><span class="NLM_contrib-group">Bossola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doglietto, G. B.</span><span> </span><span class="NLM_article-title">Cancer cachexia: it’s time for more clinical trials</span> <span class="citation_source-journal">Ann. Surg. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">276</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/ref2_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1245%2Fs10434-006-9179-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/ref2_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=17094025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/ref2_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fks1Sntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=276-285&author=M.+Bossolaauthor=F.+Pacelliauthor=A.+Tortorelliauthor=G.+B.+Doglietto&title=Cancer+cachexia%3A+it%E2%80%99s+time+for+more+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref2_1R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer cachexia: it's time for more clinical trials</span></div><div class="casAuthors">Bossola Maurizio; Pacelli Fabio; Tortorelli Antonio; Doglietto Giovan Battista</div><div class="citationInfo"><span class="NLM_cas:title">Annals of surgical oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">276-85</span>
        ISSN:<span class="NLM_cas:issn">1068-9265</span>.
    </div><div class="casAbstract">Cancer cachexia (CC) is a multifactorial paraneoplastic syndrome characterized by anorexia, body weight loss, loss of adipose tissue and skeletal muscle, accounting for at least 20% of deaths in neoplastic patients.  CC significantly impairs quality of life and response to anti-neoplastic therapies, increasing morbidity and mortality of cancer patients.  Muscle wasting is the most important phenotypic feature of CC and the principal cause of function impairment, fatigue and respiratory complications, mainly related to a hyperactivation of muscle proteolytic pathways.  Most current therapeutic strategies to counteract CC have proven to be only partially effective.  In the last decade, the correction of anorexia, the inhibition of catabolic processes and the stimulation of anabolic pathways in muscle have been attempted pharmacologically with encouraging results in animal models and through preliminary clinical trials.  However, data in the clinical setting are still scanty and non definitive.  It is time to start prospective, randomized, controlled trials to evaluate which drugs are effective in counteracting the loss of lean of muscle mass and in improving nutritional status and quality of life in patients affected by cancer-related cachexia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSBL9dWmtA7wOkdrW1FkXG-fW6udTcc2eb57pD0JrHQJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fks1Sntg%253D%253D&md5=7c83ff58caabb3520a5ff0375e044202</span></div><a href="/servlet/linkout?suffix=ref2_1&amp;dbid=16384&amp;doi=10.1245%2Fs10434-006-9179-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1245%252Fs10434-006-9179-5%26sid%3Dliteratum%253Aachs%26aulast%3DBossola%26aufirst%3DM.%26aulast%3DPacelli%26aufirst%3DF.%26aulast%3DTortorelli%26aufirst%3DA.%26aulast%3DDoglietto%26aufirst%3DG.%2BB.%26atitle%3DCancer%2520cachexia%253A%2520it%25E2%2580%2599s%2520time%2520for%2520more%2520clinical%2520trials%26jtitle%3DAnn.%2520Surg.%2520Oncol.%26date%3D2007%26volume%3D14%26spage%3D276%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-ref3_1"><span><span class="NLM_contrib-group">Osei-Hyiaman, D.</span><span> </span><span class="NLM_article-title">Endocannabinoid system in cancer cachexia</span> <span class="citation_source-journal">Curr. Opin. Clin. Nutr. Metab. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">448</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/ref3_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1097%2FMCO.0b013e3281900ecc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/ref3_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=17563462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/ref3_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotl2lsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=443-448&author=D.+Osei-Hyiaman&title=Endocannabinoid+system+in+cancer+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref3_1R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid system in cancer cachexia</span></div><div class="casAuthors">Osei-Hyiaman, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">443-448</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review More than 60% of advanced cancer patients suffer from anorexia and cachexia.  This review focuses on the possible mechanisms by which the endocannabinoid system antagonizes cachexia-anorexia processes in cancer patients and how it can be tapped for therapeutic applications.  Recent findings Cannabinoids stimulate appetite and food intake.  Hepatocytes express functional cannabinoid type 1 receptors, activation of which increases the expression of lipogenic genes (e.g those encoding sterol regulatory element binding protein 1c, acetyl-CoA carboxylase-1, and fatty acid synthase in the liver and hypothalamus) and increase de-novo fatty acid synthesis, which contributes to development of diet-induced obesity.  Both ghrelin and cannabinoids stimulate AMP-activated protein kinase in the hypothalamus, whereas they inhibit it in the liver and adipose tissues.  Both anandamide and synthetic cannabinoid type 1 receptor agonists such as HU210 and the plant-derived cannabinoid tetrahydrocannabinol also significantly inhibit tumor necrosis factor-α.  Summary Cannabinoid type 1 receptor activation stimulates appetite and promotes lipogenesis and energy storage.  Further study of cancer-cachexia pathophysiol. and the role of endocannabinoids will help us to develop cannabinoids without psychotropic properties, which will help cancer patients suffering from cachexia and improve outcomes of clin. antitumor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofZbq0SfSI5LVg90H21EOLACvtfcHk0ljWQA6g1p15YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotl2lsbo%253D&md5=b42f61b6dcf092c461f31ac4d675b60f</span></div><a href="/servlet/linkout?suffix=ref3_1&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e3281900ecc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e3281900ecc%26sid%3Dliteratum%253Aachs%26aulast%3DOsei-Hyiaman%26aufirst%3DD.%26atitle%3DEndocannabinoid%2520system%2520in%2520cancer%2520cachexia%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2007%26volume%3D10%26spage%3D443%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-ref4_1"><span><span class="NLM_contrib-group">Akamizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kangawa, K.</span><span> </span><span class="NLM_article-title">Emerging results of anticatabolic therapy with ghrelin</span> <span class="citation_source-journal">Curr. Opin. Clin. Nutr. Metab. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/ref4_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1097%2FMCO.0b013e3280fa8208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/ref4_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=17414495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/ref4_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtFemu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=278-283&author=T.+Akamizuauthor=K.+Kangawa&title=Emerging+results+of+anticatabolic+therapy+with+ghrelin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref4_1R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging results of anticatabolic therapy with ghrelin</span></div><div class="casAuthors">Akamizu, Takashi; Kangawa, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">278-283</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review: This review summarizes recent developments in research into anticatabolic therapies with ghrelin.  Potential conditions in which ghrelin treatment may be useful include cachexia, anorexia and ageing.  We highlight a no. of intriguing basic topics related to the anticatabolic effects of ghrelin.  Recent finding: Repeated administration of ghrelin to patients with congestive heart failure or chronic obstructive pulmonary disease improved appetite, body compn., muscle wasting and functional capacity in open-label pilot studies.  An acute, randomized, placebo-controlled, crossover clin. trial of cancer patients with anorexia revealed marked increases in energy intake following treatment.  The effects of ghrelin treatment in patients with anorexia nervosa are controversial.  Basic research studies have extended our understanding of the upstream regulation of neuropeptide Y/agouti-related protein signalling and the central control of adipocyte metab.  In addn., alterations in fat-free mass may play a role in ghrelin regulation.  Summary: A no. of studies are currently evaluating the anticatabolic effects of ghrelin in the treatment of various diseases, including cachexia, anorexia and age-related disorders.  These studies will hopefully lead to the development of novel clin. applications for ghrelin treatment.  These studies have also facilitated a better understanding of the mol. basis of the anticatabolic effects of ghrelin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnaNFQmg05OrVg90H21EOLACvtfcHk0lhvTQSCI80RUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtFemu7Y%253D&md5=0e2dff9dac044a0ef5e41f7c5c50c852</span></div><a href="/servlet/linkout?suffix=ref4_1&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e3280fa8208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e3280fa8208%26sid%3Dliteratum%253Aachs%26aulast%3DAkamizu%26aufirst%3DT.%26aulast%3DKangawa%26aufirst%3DK.%26atitle%3DEmerging%2520results%2520of%2520anticatabolic%2520therapy%2520with%2520ghrelin%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2007%26volume%3D10%26spage%3D278%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-ref5_1"><span><span class="NLM_contrib-group">Deboer, M. D.</span><span> </span><span class="NLM_article-title">Melanocortin interventions in cachexia: how soon from bench to bedside</span> <span class="citation_source-journal">Curr. Opin. Clin. Nutr. Metab. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/ref5_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1097%2FMCO.0b013e328108f441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/ref5_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=17563464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/ref5_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotl2lsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=457-462&author=M.+D.+Deboer&title=Melanocortin+interventions+in+cachexia%3A+how+soon+from+bench+to+bedside"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref5_1R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Melanocortin interventions in cachexia: how soon from bench to bedside?</span></div><div class="casAuthors">DeBoer, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Clinical Nutrition and Metabolic Care</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">457-462</span>CODEN:
                <span class="NLM_cas:coden">COCMF3</span>;
        ISSN:<span class="NLM_cas:issn">1363-1950</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review Cachexia is a condition of anorexia and wasting that accompanies many diseases including cancer, heart failure, and renal failure.  One key center that is probably involved in the propagation of symptoms of cachexia is the melanocortin system in the hypothalamus and brainstem.  This review focuses on cachexia treatment interventions that act via melanocortin antagonism, by direct or indirect means.  Recent findings Recent reports include a description of the physiol. of the melanocortin system and its responsiveness to inflammatory cytokines.  Regarding treatment potential, multiple reports describe the effectiveness of small mol. antagonists of the melanocortin-4 receptor in animal models of cachexia.  These melanocortin antagonists, given by peripheral injection, improve food intake and lean body mass retention in the setting of cancer and renal failure.  Addnl. reports provide evidence of melanocortin antagonism following treatment of cachexia using ghrelin and eicosanoic acid.  Summary Cachexia is a serious condition that accompanies various disease states and currently does not have effective treatments.  The melanocortin system may play a direct role in producing symptoms of cachexia, making antagonism of this system a logical objective for ameliorating these symptoms.  Thus far, however, no data on human application have been published.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMys3_l7XJJ7Vg90H21EOLACvtfcHk0lhvTQSCI80RUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotl2lsbY%253D&md5=40acd523630c355b2a099b7b305aeba8</span></div><a href="/servlet/linkout?suffix=ref5_1&amp;dbid=16384&amp;doi=10.1097%2FMCO.0b013e328108f441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMCO.0b013e328108f441%26sid%3Dliteratum%253Aachs%26aulast%3DDeboer%26aufirst%3DM.%2BD.%26atitle%3DMelanocortin%2520interventions%2520in%2520cachexia%253A%2520how%2520soon%2520from%2520bench%2520to%2520bedside%26jtitle%3DCurr.%2520Opin.%2520Clin.%2520Nutr.%2520Metab.%2520Care%26date%3D2007%26volume%3D10%26spage%3D457%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-ref6_1"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span> </span><span class="NLM_article-title">Structural mimicry in G-protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2001&pages=1-19&author=J.+A.+Ballesterosauthor=L.+Shiauthor=J.+A.+Javitch&title=Structural+mimicry+in+G-protein-coupled+receptors%3A+Implications+of+the+high-resolution+structure+of+rhodopsin+for+structure-function+analysis+of+rhodopsin-like+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref6_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26atitle%3DStructural%2520mimicry%2520in%2520G-protein-coupled%2520receptors%253A%2520Implications%2520of%2520the%2520high-resolution%2520structure%2520of%2520rhodopsin%2520for%2520structure-function%2520analysis%2520of%2520rhodopsin-like%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D60%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-ref7_1"><span><span class="NLM_contrib-group">Goodfellow, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">The melanocortin system and its role in obesity and cachexia</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">883</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/ref7_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.2174%2F1568026033452212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/ref7_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=12678837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/ref7_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFClsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=855-883&author=V.+S.+Goodfellowauthor=J.+Saunders&title=The+melanocortin+system+and+its+role+in+obesity+and+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref7_1R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The melanocortin system and its role in obesity and cachexia</span></div><div class="casAuthors">Goodfellow, Val S.; Saunders, John</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">855-883</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Melanocortin receptors (MC-R) activated by one of several peptides derived from the proopiomelanocortin (POMC) precursor have become leading contenders for a pivotal role in controlling food intake.  Evidence has emerged over the last decade to implicate primarily the MC4-R and, to a lesser extent, MC3-R as the key sub-types involved and both are strategically located in those regions within the hypothalamus known to be assocd. with feeding.  The receptors are within class A of the GPCR superfamily and the key electrostatic interaction with the pos. charged peptide (Arg8) has been mapped to one or more Asp or Glu residues located on helixes II and III of the seven helical bundle characteristic of this class of receptor.  Sites for secondary interactions from which sub-type selectivity may be derived have also been located in the extracellular and helical domains.  Unique amongst GPCRs is the presence of endogenous antagonist peptides, Agouti and Agouti-related peptide (AGRP), which confer an extra level of control on the system.  Recently, several reports of potent and selective non-peptide ligands have been published and these are seen as prototypic mols. from which drugs may emerge to treat obesity (agonists) and cachexia (antagonists).  The role played by the melanocortin system is the subject of this review and advances in our understanding of the structure of the endogenous ligand(s), non-peptide, small mol. ligands and the receptors at which they interact will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQwzaktjSlVLVg90H21EOLACvtfcHk0lhvTQSCI80RUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFClsr8%253D&md5=49aba14cf21093bab1e60d68aaac1aff</span></div><a href="/servlet/linkout?suffix=ref7_1&amp;dbid=16384&amp;doi=10.2174%2F1568026033452212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033452212%26sid%3Dliteratum%253Aachs%26aulast%3DGoodfellow%26aufirst%3DV.%2BS.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DThe%2520melanocortin%2520system%2520and%2520its%2520role%2520in%2520obesity%2520and%2520cachexia%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D855%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-ref8_1"><span><span class="NLM_contrib-group">Wilczynski, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskell-Luevano, C.</span><span> </span><span class="NLM_article-title">Current trends in the structure−activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/ref8_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1002%2Fmed.20037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/ref8_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16044415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/ref8_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGiurfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=545-556&author=A.+M.+Wilczynskiauthor=C.+G.+Josephauthor=C.+Haskell-Luevano&title=Current+trends+in+the+structure%E2%88%92activity+relationship+studies+of+the+endogenous+agouti-related+protein+%28AGRP%29+melanocortin+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref8_1R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Current trends in the structure-activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist</span></div><div class="casAuthors">Wilczynski, Andrzej M.; Joseph, Christine G.; Haskell-Luevano, Carrie</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Agouti-related protein (AGRP) is an endogenous antagonist of the melanocortin-3 and -4 (MC3R and MC4) G-protein coupled receptors.  The 87 - 132 amino acid C-terminal domain of hAGRP possesses five disulfide bridges and a well-defined three-dimensional structure that displays full biol. activity as compared to the full-length protein.  Based on the NMR structure of the C-terminal AGRP(87 - 132), a novel mini-protein, referred to as "Mini-AGRP" was designed that exhibited receptor binding affinity and antagonism similar to that of the parent hAGRP(87 - 132) protein.  It was demonstrated that this new-engineered protein autonomously folds to the inhibitor cystine knot (ICK) motif.  As this AGRP is a novel mammalian protein involved in energy homeostasis and possibly other physiol. functions remaining to be identified, structure-function studies are starting to emerge toward the understanding of how this unique protein putatively interacts with the melanocortin receptors with the objective of designing potential therapeutic agents for in vivo physiol. studies.  This article summarizes the progress to date of AGRP-based structure-activity relationships and putative ligand-receptor interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0QnlstAeNrVg90H21EOLACvtfcHk0lgp4VQOqiLZrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGiurfO&md5=5e8fd6aa056c12e764dc42476d3e8361</span></div><a href="/servlet/linkout?suffix=ref8_1&amp;dbid=16384&amp;doi=10.1002%2Fmed.20037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20037%26sid%3Dliteratum%253Aachs%26aulast%3DWilczynski%26aufirst%3DA.%2BM.%26aulast%3DJoseph%26aufirst%3DC.%2BG.%26aulast%3DHaskell-Luevano%26aufirst%3DC.%26atitle%3DCurrent%2520trends%2520in%2520the%2520structure%25E2%2588%2592activity%2520relationship%2520studies%2520of%2520the%2520endogenous%2520agouti-related%2520protein%2520%2528AGRP%2529%2520melanocortin%2520receptor%2520antagonist%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D545%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-ref9_1"><span><span class="NLM_contrib-group">Cone, R. D.</span><span> </span><span class="NLM_article-title">The central melanocortin system and energy homeostasis</span> <span class="citation_source-journal">Trends Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/ref9_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1016%2FS1043-2760%2899%2900153-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/ref9_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=10407394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/ref9_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKkt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=211-216&author=R.+D.+Cone&title=The+central+melanocortin+system+and+energy+homeostasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref9_1R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The central melanocortin system and energy homeostasis</span></div><div class="casAuthors">Cone, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">TENME4</span>;
        ISSN:<span class="NLM_cas:issn">1043-2760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 53 refs.  Obesity is a significant health problem owing to increased risk for diabetes and cardiovascular disease, and several lines of evidence suggest that alterations in the central melanocortin system might account for some of the genetic contribution to obesity in humans.  First, the phenotypic aspects and dominant inheritance of the melanocortin obesity syndromes in the mouse are more like human obesity than other murine obesity syndromes.  Second, studies recently published present two rare cases of familial obesity resulting from null alleles of the proopiomelanocortin (POMC) gene, providing the first evidence that the melanocortin pathway in humans subserves the same function in regulation of energy homeostasis as it does in the rodent.  Addnl. studies suggest that heterozygous mutations in the melanocortin 4 receptor might be a common reason for genetic predisposition to obesity in children.  Research on the central melanocortin system in rodents suggests that this system might be a fundamental component of the adipostat, the mechanism by which energy stores are held relatively const., and this hypothesis will be the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZOl70E49pTLVg90H21EOLACvtfcHk0lgp4VQOqiLZrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKkt7w%253D&md5=0f180e7a29e3b0664630e4f255f28da7</span></div><a href="/servlet/linkout?suffix=ref9_1&amp;dbid=16384&amp;doi=10.1016%2FS1043-2760%2899%2900153-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-2760%252899%252900153-8%26sid%3Dliteratum%253Aachs%26aulast%3DCone%26aufirst%3DR.%2BD.%26atitle%3DThe%2520central%2520melanocortin%2520system%2520and%2520energy%2520homeostasis%26jtitle%3DTrends%2520Endocrinol.%2520Metab.%26date%3D1999%26volume%3D10%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-ref10_1"><span><span class="NLM_contrib-group">Tao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segaloff, D. L.</span><span> </span><span class="NLM_article-title">Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">5632</span><span class="NLM_x">–</span> <span class="NLM_lpage">5638</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/ref10_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1210%2Fjc.2005-0519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/ref10_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16030156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/ref10_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWjt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2005&pages=5632-5638&author=Y.+X.+Taoauthor=D.+L.+Segaloff&title=Functional+analyses+of+melanocortin-4+receptor+mutations+identified+from+patients+with+binge+eating+disorder+and+nonobese+or+obese+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref10_1R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects</span></div><div class="casAuthors">Tao, Ya-Xiong; Segaloff, Deborah L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5632-5638</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Context: Whether mutations in the melanocortin-4 receptor (MC4R) are the cause of binge eating disorder was controversial.  In addn., the penetrance of mutations in the MC4R in causing obesity was debated.  Objective: We investigated whether MC4R variants identified from obese patients with binge eating disorder (T11A, F51L, T112M, and M200V) and variants identified in nonobese (I102T, F202L, and N240S) or obese (I102S, A154D, and S295P) subjects cause loss-of-function and what are the defects.  Design: Variant or wild-type MC4Rs were expressed in HEK293 cells and examd. for their pharmacol. characteristics.  Setting: The study setting was in vitro bench-top lab. expts.  Main Outcome Measures: Ligand binding, signaling, and cell surface expression of the variant MC4Rs were compared with wild-type MC4R.  Results: Our data clearly show a loss-of-function phenotype in vitro for I102T and N240S variants identified in nonobese individuals.  Furthermore, not all MC4R variants identified in obese subjects exhibit a loss-of-function phenotype in vitro.  Finally, the MC4R variants T11A, F51L, T112M, and M200V identified from patients with binge eating disorder displayed normal function with regards to the parameters measured in our study.  Conclusions: Patients harboring loss-of-function MC4R mutations do not always exhibit obesity.  Novel MC4R variant identified from an obese patient cannot be assumed to be the cause of obesity without demonstrating a loss-of-function phenotype in vitro for the variant MC4R.  Whether MC4R mutations are involved in the pathogenesis of binge eating disorder needs addnl. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohWlYPNtUm2rVg90H21EOLACvtfcHk0lgp4VQOqiLZrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWjt73J&md5=e088d4991bfd6f238f09505cc2f5d0f4</span></div><a href="/servlet/linkout?suffix=ref10_1&amp;dbid=16384&amp;doi=10.1210%2Fjc.2005-0519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2005-0519%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DY.%2BX.%26aulast%3DSegaloff%26aufirst%3DD.%2BL.%26atitle%3DFunctional%2520analyses%2520of%2520melanocortin-4%2520receptor%2520mutations%2520identified%2520from%2520patients%2520with%2520binge%2520eating%2520disorder%2520and%2520nonobese%2520or%2520obese%2520subjects%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2005%26volume%3D90%26spage%3D5632%26epage%3D5638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-ref11_1"><span><span class="NLM_contrib-group">MacKenzie, R. G.</span><span> </span><span class="NLM_article-title">Obesity-associated mutations in the human melanocortin-4 receptor gene</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=395-403&author=R.+G.+MacKenzie&title=Obesity-associated+mutations+in+the+human+melanocortin-4+receptor+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref11_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DR.%2BG.%26atitle%3DObesity-associated%2520mutations%2520in%2520the%2520human%2520melanocortin-4%2520receptor%2520gene%26jtitle%3DPeptides%26date%3D2006%26volume%3D27%26spage%3D395%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-ref12_1"><span><span class="NLM_contrib-group">Boyce, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duhl, D. M.</span><span> </span><span class="NLM_article-title">Melanocortin-4 receptor agonists for the treatment of obesity</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1063</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1063-1071&author=R.+S.+Boyceauthor=D.+M.+Duhl&title=Melanocortin-4+receptor+agonists+for+the+treatment+of+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref12_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DR.%2BS.%26aulast%3DDuhl%26aufirst%3DD.%2BM.%26atitle%3DMelanocortin-4%2520receptor%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D1063%26epage%3D1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-ref13_1"><span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joppa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleck, B. A.</span><span> </span><span class="NLM_article-title">Body weight regulation by selective MC4 receptor agonists and antagonists</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">994</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=994&publication_year=2003&pages=103-110&author=A.+C.+Fosterauthor=M.+Joppaauthor=S.+Markisonauthor=K.+R.+Gogasauthor=B.+A.+Fleck&title=Body+weight+regulation+by+selective+MC4+receptor+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref13_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DJoppa%26aufirst%3DM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DGogas%26aufirst%3DK.%2BR.%26aulast%3DFleck%26aufirst%3DB.%2BA.%26atitle%3DBody%2520weight%2520regulation%2520by%2520selective%2520MC4%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D994%26spage%3D103%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-ref14_1"><span><span class="NLM_contrib-group">DeBoer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, D. L.</span><span> </span><span class="NLM_article-title">Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease</span> <span class="citation_source-journal">Nat. Clin. Pract. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/ref14_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1038%2Fncpendmet0221" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/ref14_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16932335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/ref14_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xosl2ht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=459-466&author=M.+D.+DeBoerauthor=D.+L.+Marks&title=Therapy+insight%3A+Use+of+melanocortin+antagonists+in+the+treatment+of+cachexia+in+chronic+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref14_1R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Therapy insight: use of melanocortin antagonists in the treatment of cachexia in chronic disease</span></div><div class="casAuthors">DeBoer, Mark D.; Marks, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">NCPEDB</span>;
        ISSN:<span class="NLM_cas:issn">1745-8366</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cachexia is a process that accompanies many chronic diseases, and consists of a combination of wasting of lean body mass, increased energy expenditure, and a paradoxical loss of appetite.  Cachexia both worsens quality of life and neg. affects treatment of the underlying disease.  Conditions as diverse as cancer, renal failure, and heart failure show a remarkable similarity in their assocd. cachexia, exhibiting changes in metab. and endocrinol., including marked increases in levels of cytokines that accompany these diseases.  So far, it has been difficult to treat disease-assocd. cachexia successfully.  One treatment that has shown promise in animal trials, however, involves antagonism of the central melanocortin system, an anorexigenic pathway in the hypothalamus and brainstem.  Humans who have genetic mutations involving pro-opiomelanocortin or the melanocortin 4 receptor in this pathway exhibit increased appetite and increased lean body mass.  Recent research has shown that in rodent models of cancer and renal failure, administration of melanocortin 4 receptor antagonists results in an attenuation of symptoms of cachexia, including maintenance of appetite, lean body mass, and basal energy expenditure.  Although this research needs to be substantiated in humans, it provides a promising direction for treating the wasting that is assocd. with a variety of disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfRZFaKLBcrbVg90H21EOLACvtfcHk0lh9vtG4mH0O5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xosl2ht78%253D&md5=646f63ecd6116216781fcd9939a71df8</span></div><a href="/servlet/linkout?suffix=ref14_1&amp;dbid=16384&amp;doi=10.1038%2Fncpendmet0221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncpendmet0221%26sid%3Dliteratum%253Aachs%26aulast%3DDeBoer%26aufirst%3DM.%2BD.%26aulast%3DMarks%26aufirst%3DD.%2BL.%26atitle%3DTherapy%2520insight%253A%2520Use%2520of%2520melanocortin%2520antagonists%2520in%2520the%2520treatment%2520of%2520cachexia%2520in%2520chronic%2520disease%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Endocrinol.%2520Metab.%26date%3D2006%26volume%3D2%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-ref15_1"><span><span class="NLM_contrib-group">Li, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hruby, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. D.</span><span> </span><span class="NLM_article-title">Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5182</span><span class="NLM_x">–</span> <span class="NLM_lpage">5188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/ref15_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1523%2FJNEUROSCI.16-16-05182.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/ref15_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=8756446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/ref15_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADyaK28XkvFaht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=5182-5188&author=S.+J.+Liauthor=K.+Vargaauthor=P.+Archerauthor=V.+J.+Hrubyauthor=S.+D.+Sharma&title=Melanocortin+antagonists+define+two+distinct+pathways+of+cardiovascular+control+by+alpha-+and+gamma-melanocyte-stimulating+hormones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref15_1R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Melanocortin antagonists define two distinct pathways of cardiovascular control by α- and γ-melanocyte-stimulating hormones</span></div><div class="casAuthors">Li, Si-Jai; Varga, Karoly; Archer, Phillip; Hruby, Victor J.; Sharama, Shubh D.; Kesterson, Robert A.; Cong, Roger D.; Kunos, George</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5182-5188</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Melanocortin peptides and at least two subtypes of melanocortin receptors (MC3-R and MC4-R) are present in brain regions involved in cardiovascular regulation.  In urethane-anesthetized rats, unilateral microinjection of α-MSH into the medullary dorsal-vagal complex (DVC) causes dose-dependent (125-250 pmol) hypotension and bradycardia, whereas γ-MSH is less effective.  The effects of α-MSH are inhibited by microinjection to the same site of the novel MC4-R/MC3-R antagonist SHU9119 (2-100 pmol) but not naloxone (270 pmol), whereas the similar effects of intra-DVC injection of β-endorphin (1 pmol) are inhibited by naloxone and not by SHU9119.  Hypotensive and bradycardic responses to elec. stimulation of the arcuate nucleus also are inhibited by ipsilateral intra-DVC microinjection of SHU9119.  γ-MSH and ACTH(4-10), but not α-MSH, elicit dose-dependent (0.1-12.5 nmol) pressor tachycardic effects, which are much more pronounced after intracarotid than after i.v. administration.  The effects of γ-MSH (1.25 nmol) are not inhibited by the intracarotid injection of SHU9119 (1.25-12.5 nmol) or the novel MC3-R antagonist SHU9005 (1.25-12.5 nmol).  We conclude that the hypotension and bradycardia elicited by the release of α-MSH from arcuate neurons is mediated by neural melanocortin receptors (MC4-R/MC3-R) located in the DVC, whereas the similar effects of β-endorphin, a peptide derived from the same precursor, are mediated by opiate receptors at the same site.  In contrast, neither MC3-R nor MC4-R is involved in the centrally mediated pressor and tachycardic actions of γ-MSH, which, likely, are mediated by an as yet unidentified receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm9gwh_Mtut7Vg90H21EOLACvtfcHk0lh9vtG4mH0O5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFaht7g%253D&md5=64873dfb90c5d6777a36cb4c55bb730f</span></div><a href="/servlet/linkout?suffix=ref15_1&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.16-16-05182.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.16-16-05182.1996%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%2BJ.%26aulast%3DVarga%26aufirst%3DK.%26aulast%3DArcher%26aufirst%3DP.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DSharma%26aufirst%3DS.%2BD.%26atitle%3DMelanocortin%2520antagonists%2520define%2520two%2520distinct%2520pathways%2520of%2520cardiovascular%2520control%2520by%2520alpha-%2520and%2520gamma-melanocyte-stimulating%2520hormones%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D5182%26epage%3D5188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-ref16_1"><span><span class="NLM_contrib-group">Wisse, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frayo, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, D. E.</span><span> </span><span class="NLM_article-title">Reversal of cancer anorexia by blockade of central melanocortin receptors in rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">3292</span><span class="NLM_x">–</span> <span class="NLM_lpage">3301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2001&pages=3292-3301&author=B.+E.+Wisseauthor=R.+S.+Frayoauthor=M.+W.+Schwartzauthor=D.+E.+Cummings&title=Reversal+of+cancer+anorexia+by+blockade+of+central+melanocortin+receptors+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref16_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWisse%26aufirst%3DB.%2BE.%26aulast%3DFrayo%26aufirst%3DR.%2BS.%26aulast%3DSchwartz%26aufirst%3DM.%2BW.%26aulast%3DCummings%26aufirst%3DD.%2BE.%26atitle%3DReversal%2520of%2520cancer%2520anorexia%2520by%2520blockade%2520of%2520central%2520melanocortin%2520receptors%2520in%2520rats%26jtitle%3DEndocrinology%26date%3D2001%26volume%3D142%26spage%3D3292%26epage%3D3301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-ref17_1"><span><span class="NLM_contrib-group">Marks, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookhart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cone, R. D.</span><span> </span><span class="NLM_article-title">Differential role of melanocortin receptor subtypes in cachexia</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">1513</span><span class="NLM_x">–</span> <span class="NLM_lpage">1523</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/ref17_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1210%2Fen.2002-221099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/ref17_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=12639936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/ref17_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXisVegtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2003&pages=1513-1523&author=D.+L.+Marksauthor=A.+A.+Butlerauthor=R.+Turnerauthor=G.+Brookhartauthor=R.+D.+Cone&title=Differential+role+of+melanocortin+receptor+subtypes+in+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref17_1R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential role of melanocortin receptor subtypes in cachexia</span></div><div class="casAuthors">Marks, Daniel L.; Butler, Andrew A.; Turner, Renn; Brookhart, Gregor; Cone, Roger D.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1513-1523</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Animals and humans respond to starvation with a complex neuroendocrine response that ultimately leads to an increase in appetite, a sparing of lean body mass (LBM) and burning of fat, and an overall decrease in basal metabolic rate.  In contrast, cachexia is a pathol. state of malnutrition assocd. with many infections and chronic diseases, wherein appetite is diminished concomitant with an increase in metabolic rate, and a relative wasting of LBM.  In previous studies, we demonstrated that anorexia and wt. loss in mouse cachexia models induced by lipopolysaccharide (LPS) administration and by tumor growth are ameliorated by central melanocortin-4 (MC4) receptor (MC4-R) blockade.  In contrast to the results seen with MC4 blockade, melanocortin-3 (MC3) receptor knockout (MC3-RKO) mice show illness-induced anorexia and wt. loss with LPS administration and with cytokine administration, and they have similar decreases in mobility.  Both MC3-RKOs and MC4-RKOs have an intact corticosterone response and fever with LPS injection.  In tumor models, we show that MC4-RKO mice resist the loss of LBM brought about by tumor growth, whereas MC3-RKO animals show enhanced tissue wasting.  These data underscore the importance of central melanocortin signaling in wt. homeostasis and demonstrate differential effects of MC3-R and MC4-R blockade on the development of cachexia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwfaUe64Rgt7Vg90H21EOLACvtfcHk0lh9vtG4mH0O5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXisVegtrs%253D&md5=5ae36664febda3d0f09baccebcb46abc</span></div><a href="/servlet/linkout?suffix=ref17_1&amp;dbid=16384&amp;doi=10.1210%2Fen.2002-221099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2002-221099%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DD.%2BL.%26aulast%3DButler%26aufirst%3DA.%2BA.%26aulast%3DTurner%26aufirst%3DR.%26aulast%3DBrookhart%26aufirst%3DG.%26aulast%3DCone%26aufirst%3DR.%2BD.%26atitle%3DDifferential%2520role%2520of%2520melanocortin%2520receptor%2520subtypes%2520in%2520cachexia%26jtitle%3DEndocrinology%26date%3D2003%26volume%3D144%26spage%3D1513%26epage%3D1523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-ref18_1"><span><span class="NLM_contrib-group">Joppa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span> </span><span class="NLM_article-title">Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83–132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">636</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=636-642&author=M.+A.+Joppaauthor=K.+R.+Gogasauthor=A.+C.+Fosterauthor=S.+Markison&title=Central+infusion+of+the+melanocortin+receptor+antagonist+agouti-related+peptide+%28AgRP%2883%E2%80%93132%29%29+prevents+cachexia-related+symptoms+induced+by+radiation+and+colon-26+tumors+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref18_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJoppa%26aufirst%3DM.%2BA.%26aulast%3DGogas%26aufirst%3DK.%2BR.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DMarkison%26aufirst%3DS.%26atitle%3DCentral%2520infusion%2520of%2520the%2520melanocortin%2520receptor%2520antagonist%2520agouti-related%2520peptide%2520%2528AgRP%252883%25E2%2580%2593132%2529%2529%2520prevents%2520cachexia-related%2520symptoms%2520induced%2520by%2520radiation%2520and%2520colon-26%2520tumors%2520in%2520mice%26jtitle%3DPeptides%26date%3D2007%26volume%3D28%26spage%3D636%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-ref19_1"><span><span class="NLM_contrib-group">Foster, A. C.; Chen, C. Melanocortin-4 receptor antagonists as potential therapeutics in the treatment of cachexia</span>.  <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span><div class="note"><p class="first last"><i>7</i>, 1131–1136</p></div> .</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Foster%2C+A.+C.%3B+Chen%2C+C.+Melanocortin-4+receptor+antagonists+as+potential+therapeutics+in+the+treatment+of+cachexia.+Curr.+Top.+Med.+Chem.+2007%2C+7%2C+1131%E2%80%931136+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref19_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DA.%2BC.%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-ref20_1"><span><span class="NLM_contrib-group">Marks, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cone, R. D.</span><span> </span><span class="NLM_article-title">The role of the melanocortin-3 receptor in cachexia</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">994</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=994&publication_year=2003&pages=258-266&author=D.+L.+Marksauthor=R.+D.+Cone&title=The+role+of+the+melanocortin-3+receptor+in+cachexia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref20_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DD.%2BL.%26aulast%3DCone%26aufirst%3DR.%2BD.%26atitle%3DThe%2520role%2520of%2520the%2520melanocortin-3%2520receptor%2520in%2520cachexia%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D994%26spage%3D258%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-ref21_1"><span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caracoti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, C. A.</span><span> </span><span class="NLM_article-title">Identification of 2-[2-[2-(5-bromo-2- methoxyphenyl)-ethyl]-3-fluorophenyl]-4,5-dihydro-1<i>H</i>-imidazole (ML00253764), a small molecule melanocortin 4 receptor antagonist that effectively reduces tumor-induced weight loss in a mouse model</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1602</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034244g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1602-1604&author=T.+J.+Vosauthor=A.+Caracotiauthor=J.+L.+Cheauthor=M.+Daiauthor=C.+A.+Farrer&title=Identification+of+2-%5B2-%5B2-%285-bromo-2-+methoxyphenyl%29-ethyl%5D-3-fluorophenyl%5D-4%2C5-dihydro-1H-imidazole+%28ML00253764%29%2C+a+small+molecule+melanocortin+4+receptor+antagonist+that+effectively+reduces+tumor-induced+weight+loss+in+a+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref21_1&amp;dbid=16384&amp;doi=10.1021%2Fjm034244g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034244g%26sid%3Dliteratum%253Aachs%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DCaracoti%26aufirst%3DA.%26aulast%3DChe%26aufirst%3DJ.%2BL.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DFarrer%26aufirst%3DC.%2BA.%26atitle%3DIdentification%2520of%25202-%255B2-%255B2-%25285-bromo-2-%2520methoxyphenyl%2529-ethyl%255D-3-fluorophenyl%255D-4%252C5-dihydro-1H-imidazole%2520%2528ML00253764%2529%252C%2520a%2520small%2520molecule%2520melanocortin%25204%2520receptor%2520antagonist%2520that%2520effectively%2520reduces%2520tumor-induced%2520weight%2520loss%2520in%2520a%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1602%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-ref22_1"><span><span class="NLM_contrib-group">Nicholson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaerer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyermann, P.</span><span> </span><span class="NLM_article-title">Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/ref22_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1124%2Fjpet.105.097725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/ref22_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=16436498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/ref22_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=771-777&author=J.+R.+Nicholsonauthor=G.+Kohlerauthor=F.+Schaererauthor=C.+Sennauthor=P.+Weyermann&title=Peripheral+administration+of+a+melanocortin+4-receptor+inverse+agonist+prevents+loss+of+lean+body+mass+in+tumor-bearing+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref22_1R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice</span></div><div class="casAuthors">Nicholson, Janet R.; Kohler, Gotz; Schaerer, Florian; Senn, Claudia; Weyermann, Philipp; Hofbauer, Karl G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">771-777</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cachexia affects many different chronically ill patient populations, including those with cancer.  It results in loss of body wt., particularly of lean body mass (LBM), and is estd. to be responsible for over 20% of all cancer-related deaths.  Currently, available drugs are ineffective, and new therapies are urgently needed.  Melanocortin 4-receptor (MC4-R) blockade has been shown recently to be effective in preventing cancer cachexia in rodent models.  In the present study, we have tested a MC4-R blocker, ML00253764 [2-{2-[2-(5-bromo-2-methoxyphenyl)-ethyl]-3-fluorophenyl}-4,5-dihydro-1H-imidazolium hydrochloride], in vitro and in vivo.  In membranes of human embryonic kidney 293 cells expressing human MC4-R, ML00253764 displaced [Nle4, D-Phe7]-α-MSH binding with an IC50 of 0.32 μM.  At concns. above 1 μM, ML00253764 decreased cAMP accumulation (maximal redn. of -20%) indicative of inverse agonist activity.  ML00253764 was administered twice daily (15 mg/kg s.c.) for 13 days to C57BL6 mice bearing s.c. Lewis lung carcinoma tumors.  Food intake and body wt. were measured, and body compn. was assessed using magnetic resonance relaxometry.  ML00253764 stimulated light-phase food intake relative to vehicle-treated controls (p < 0.05), although no effect was obsd. on 24-h food intake.  During the 21 days of the expt., the LBM of tumor vehicle-treated mice decreased (p < 0.05).  In contrast, the tumor-bearing mice treated with ML00253764 maintained their LBM.  These data support the view that MC4-R blockade may be a suitable approach for the treatment of cancer cachexia and that MC4-R inverse agonists may have potential as drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR75n3KXNhM7Vg90H21EOLACvtfcHk0li2YDWBa5ZtSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamu7o%253D&md5=b2a4319a2dac210cdfee31238030476e</span></div><a href="/servlet/linkout?suffix=ref22_1&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097725%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DJ.%2BR.%26aulast%3DKohler%26aufirst%3DG.%26aulast%3DSchaerer%26aufirst%3DF.%26aulast%3DSenn%26aufirst%3DC.%26aulast%3DWeyermann%26aufirst%3DP.%26atitle%3DPeripheral%2520administration%2520of%2520a%2520melanocortin%25204-receptor%2520inverse%2520agonist%2520prevents%2520loss%2520of%2520lean%2520body%2520mass%2520in%2520tumor-bearing%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D771%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-ref23_1"><span><span class="NLM_contrib-group">Tucci, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joppa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J. A.</span><span> </span><span class="NLM_article-title">Potent and orally active nonpeptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4389-4395&author=F.+C.+Tucciauthor=N.+S.+Whiteauthor=S.+Markisonauthor=M.+Joppaauthor=J.+A.+Tran&title=Potent+and+orally+active+nonpeptide+antagonists+of+the+human+melanocortin-4+receptor+based+on+a+series+of+trans-2-disubstituted+cyclohexylpiperazines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref23_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTucci%26aufirst%3DF.%2BC.%26aulast%3DWhite%26aufirst%3DN.%2BS.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoppa%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DJ.%2BA.%26atitle%3DPotent%2520and%2520orally%2520active%2520nonpeptide%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor%2520based%2520on%2520a%2520series%2520of%2520trans-2-disubstituted%2520cyclohexylpiperazines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4389%26epage%3D4395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-ref24_1"><span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brookhart, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesse, A.</span><span> </span><span class="NLM_article-title">The regulation of feeding and metabolic rate and the prevention of murine cancer cachexia with a small-molecule melanocortin-4 receptor antagonist</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">2766</span><span class="NLM_x">–</span> <span class="NLM_lpage">2773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=2766-2773&author=S.+Markisonauthor=A.+C.+Fosterauthor=C.+Chenauthor=G.+B.+Brookhartauthor=A.+Hesse&title=The+regulation+of+feeding+and+metabolic+rate+and+the+prevention+of+murine+cancer+cachexia+with+a+small-molecule+melanocortin-4+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref24_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DBrookhart%26aufirst%3DG.%2BB.%26aulast%3DHesse%26aufirst%3DA.%26atitle%3DThe%2520regulation%2520of%2520feeding%2520and%2520metabolic%2520rate%2520and%2520the%2520prevention%2520of%2520murine%2520cancer%2520cachexia%2520with%2520a%2520small-molecule%2520melanocortin-4%2520receptor%2520antagonist%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26spage%3D2766%26epage%3D2773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-ref25_1"><span><span class="NLM_contrib-group">Foster, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, D. L.</span><span> </span><span class="NLM_article-title">MC4 receptor antagonists: A potential treatment for cachexia</span> <span class="citation_source-journal">IDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=15800806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/ref25_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFOrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=314-319&author=A.+C.+Fosterauthor=C.+Chenauthor=S.+Markisonauthor=D.+L.+Marks&title=MC4+receptor+antagonists%3A+A+potential+treatment+for+cachexia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref25_1R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">MC4 receptor antagonists: a potential treatment for cachexia</span></div><div class="casAuthors">Foster, Alan C.; Chen, Chen; Markison, Stacy; Marks, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">IDrugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">314-319</span>CODEN:
                <span class="NLM_cas:coden">IDRUFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-7056</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Cachexia (involuntary wt. loss) is a devastating syndrome assocd. with many chronic diseases including cancer, and heart, lung, kidney and liver failure.  There are currently no effective treatments capable of reversing the loss of lean body mass that is believed to be a major contributor to morbidity and mortality in these chronic diseases.  Recent findings strongly indicate that blockade of central melanocortin signaling through the MC4 receptor subtype attenuates cachexia.  This review summarizes the evidence supporting the role of MC4 receptors in cachexia, and highlights the progress achieved in the development of small-mol. MC4 antagonists, which have recently proved to be effective in animal models of cachexia.  MC4 antagonists are an attractive therapeutic approach for cachexia that may ameliorate the loss of lean body mass in cachectic patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFP6R2JMJEXbVg90H21EOLACvtfcHk0lhb9oXhNRvNRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFOrtL8%253D&md5=2402516fd0a9ad4573baae4191882edb</span></div><a href="/servlet/linkout?suffix=ref25_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DA.%2BC.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMarks%26aufirst%3DD.%2BL.%26atitle%3DMC4%2520receptor%2520antagonists%253A%2520A%2520potential%2520treatment%2520for%2520cachexia%26jtitle%3DIDrugs%26date%3D2005%26volume%3D8%26spage%3D314%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-ref26_1"><span><span class="NLM_contrib-group">Nozawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakinuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1989</span><span class="NLM_x">–</span> <span class="NLM_lpage">2005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1989-2005&author=D.+Nozawaauthor=T.+Okuboauthor=T.+Ishiiauthor=H.+Kakinumaauthor=S.+Chaki&title=Structure%E2%88%92activity+relationships+of+novel+piperazines+as+antagonists+for+the+melanocortin-4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref26_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNozawa%26aufirst%3DD.%26aulast%3DOkubo%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DKakinuma%26aufirst%3DH.%26aulast%3DChaki%26aufirst%3DS.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520novel%2520piperazines%2520as%2520antagonists%2520for%2520the%2520melanocortin-4%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D1989%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-ref27_1"><span><span class="NLM_contrib-group">Nozawa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span> </span><span class="NLM_article-title">Novel piperazines: Potent melanocortin-4 receptor antagonists with anxiolytic-like activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2375</span><span class="NLM_x">–</span> <span class="NLM_lpage">2385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2375-2385&author=D.+Nozawaauthor=T.+Okuboauthor=T.+Ishiiauthor=K.+Takamoriauthor=S.+Chaki&title=Novel+piperazines%3A+Potent+melanocortin-4+receptor+antagonists+with+anxiolytic-like+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref27_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNozawa%26aufirst%3DD.%26aulast%3DOkubo%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DTakamori%26aufirst%3DK.%26aulast%3DChaki%26aufirst%3DS.%26atitle%3DNovel%2520piperazines%253A%2520Potent%2520melanocortin-4%2520receptor%2520antagonists%2520with%2520anxiolytic-like%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D2375%26epage%3D2385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-ref28_1"><span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danca, M. D.</span><span> </span><span class="NLM_article-title">Identification and structure−activity relationships of a new series of melanocortin-4 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2302</span><span class="NLM_x">–</span> <span class="NLM_lpage">2305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2302-2305&author=T.+J.+Vosauthor=S.+Balaniauthor=C.+Blackburnauthor=R.+W.+Chauauthor=M.+D.+Danca&title=Identification+and+structure%E2%88%92activity+relationships+of+a+new+series+of+melanocortin-4+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref28_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DBalani%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DChau%26aufirst%3DR.%2BW.%26aulast%3DDanca%26aufirst%3DM.%2BD.%26atitle%3DIdentification%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520a%2520new%2520series%2520of%2520melanocortin-4%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2302%26epage%3D2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-ref29_1"><span><span class="NLM_contrib-group">Poitout, L.; Brault, V.; Sackur, C.; Bernetiere, S.; Camara, J.; et al.</span><span> </span><span class="NLM_article-title">Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=L.+Poitout&author=V.+Brault&author=C.+Sackur&author=S.+Bernetiere&author=J.+Camara+et+al.&title=Identification+of+a+novel+series+of+benzimidazoles+as+potent+and+selective+antagonists+of+the+human+melanocortin-4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref29_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoitout%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520a%2520novel%2520series%2520of%2520benzimidazoles%2520as%2520potent%2520and%2520selective%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-ref30_1"><span><span class="NLM_contrib-group">Chen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucci, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arellano, M.</span><span> </span><span class="NLM_article-title">Propionylpiperazines as human melanocortin-4 receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4800</span><span class="NLM_x">–</span> <span class="NLM_lpage">4803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4800-4803&author=C.+W.+Chenauthor=J.+A.+Tranauthor=W.+Jiangauthor=F.+C.+Tucciauthor=M.+Arellano&title=Propionylpiperazines+as+human+melanocortin-4+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref30_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%2BW.%26aulast%3DTran%26aufirst%3DJ.%2BA.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DTucci%26aufirst%3DF.%2BC.%26aulast%3DArellano%26aufirst%3DM.%26atitle%3DPropionylpiperazines%2520as%2520human%2520melanocortin-4%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4800%26epage%3D4803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-ref31_1"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. W.</span><span> </span><span class="NLM_article-title">Practical asymmetric synthesis of alpha-branched 2-piperazinylbenzylamines by 1,2-additions of organometallic reagents to <i>N</i>-<i>tert</i>-butanesulfinyl imines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">8924</span><span class="NLM_x">–</span> <span class="NLM_lpage">8931</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo051514p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=8924-8931&author=W.+Jiangauthor=C.+Chenauthor=D.+Marinkovicauthor=J.+A.+Tranauthor=C.+W.+Chen&title=Practical+asymmetric+synthesis+of+alpha-branched+2-piperazinylbenzylamines+by+1%2C2-additions+of+organometallic+reagents+to+N-tert-butanesulfinyl+imines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref31_1&amp;dbid=16384&amp;doi=10.1021%2Fjo051514p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo051514p%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DMarinkovic%26aufirst%3DD.%26aulast%3DTran%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DC.%2BW.%26atitle%3DPractical%2520asymmetric%2520synthesis%2520of%2520alpha-branched%25202-piperazinylbenzylamines%2520by%25201%252C2-additions%2520of%2520organometallic%2520reagents%2520to%2520N-tert-butanesulfinyl%2520imines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D8924%26epage%3D8931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-ref32_1"><span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucci, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arellano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, J. A.</span><span> </span><span class="NLM_article-title">Arylpropionylpiperazines as antagonists of the human melanocortin-4 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4674</span><span class="NLM_x">–</span> <span class="NLM_lpage">4678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4674-4678&author=W.+Jiangauthor=F.+C.+Tucciauthor=C.+W.+Chenauthor=M.+Arellanoauthor=J.+A.+Tran&title=Arylpropionylpiperazines+as+antagonists+of+the+human+melanocortin-4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref32_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DTucci%26aufirst%3DF.%2BC.%26aulast%3DChen%26aufirst%3DC.%2BW.%26aulast%3DArellano%26aufirst%3DM.%26aulast%3DTran%26aufirst%3DJ.%2BA.%26atitle%3DArylpropionylpiperazines%2520as%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4674%26epage%3D4678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-ref33_1"><span><span class="NLM_contrib-group">Tran, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucci, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinkovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. W.</span><span> </span><span class="NLM_article-title">Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5166</span><span class="NLM_x">–</span> <span class="NLM_lpage">5176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5166-5176&author=J.+A.+Tranauthor=F.+C.+Tucciauthor=W.+Jiangauthor=D.+Marinkovicauthor=C.+W.+Chen&title=Pyrrolidinones+as+orally+bioavailable+antagonists+of+the+human+melanocortin-4+receptor+with+anti-cachectic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref33_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DJ.%2BA.%26aulast%3DTucci%26aufirst%3DF.%2BC.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DMarinkovic%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DC.%2BW.%26atitle%3DPyrrolidinones%2520as%2520orally%2520bioavailable%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor%2520with%2520anti-cachectic%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5166%26epage%3D5176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-ref34_1"><span><span class="NLM_contrib-group">Kotake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajesh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takiguchi, Y.</span><span> </span><span class="NLM_article-title">Design and synthesis of a new polymer-supported Evans-type oxazolidinone: An efficient chiral auxiliary in the solid-phase asymmetric alkylation reactions</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3819</span><span class="NLM_x">–</span> <span class="NLM_lpage">3844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=3819-3844&author=T.+Kotakeauthor=Y.+Hayashiauthor=S.+Rajeshauthor=Y.+Mukaiauthor=Y.+Takiguchi&title=Design+and+synthesis+of+a+new+polymer-supported+Evans-type+oxazolidinone%3A+An+efficient+chiral+auxiliary+in+the+solid-phase+asymmetric+alkylation+reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref34_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKotake%26aufirst%3DT.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DRajesh%26aufirst%3DS.%26aulast%3DMukai%26aufirst%3DY.%26aulast%3DTakiguchi%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520new%2520polymer-supported%2520Evans-type%2520oxazolidinone%253A%2520An%2520efficient%2520chiral%2520auxiliary%2520in%2520the%2520solid-phase%2520asymmetric%2520alkylation%2520reactions%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D3819%26epage%3D3844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-ref35_1"><span><span class="NLM_contrib-group">Numata, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, T.</span><span> </span><span class="NLM_article-title">General synthetic method for naphthyridines and their N-oxides containing isoquinolinic nitrogen</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1999&pages=311&author=A.+Numataauthor=Y.+Kondoauthor=T.+Sakamoto&title=General+synthetic+method+for+naphthyridines+and+their+N-oxides+containing+isoquinolinic+nitrogen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref35_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNumata%26aufirst%3DA.%26aulast%3DKondo%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DT.%26atitle%3DGeneral%2520synthetic%2520method%2520for%2520naphthyridines%2520and%2520their%2520N-oxides%2520containing%2520isoquinolinic%2520nitrogen%26jtitle%3DSynthesis%26date%3D1999%26volume%3D306%26spage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-ref36_1"><span><span class="NLM_contrib-group">Nickolls, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cismowski, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conlon, P. J.</span><span> </span><span class="NLM_article-title">Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">1217</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/ref36_1&amp;dbid=16&amp;doi=10.1021%2Fjm701137s&amp;key=10.1124%2Fjpet.102.044974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/ref36_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=12604699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/ref36_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1eis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2003&pages=1217-1227&author=S.+A.+Nickollsauthor=M.+I.+Cismowskiauthor=X.+Wangauthor=M.+Wolffauthor=P.+J.+Conlon&title=Molecular+determinants+of+melanocortin+4+receptor+ligand+binding+and+MC4%2FMC3+receptor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref36_1R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity</span></div><div class="casAuthors">Nickolls, Sarah A.; Cismowski, Mary I.; Wang, Xiaochuan; Wolff, Meira; Conlon, Paul J.; Maki, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1217-1227</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The mol. basis of ligand recognition by the melanocortin 4 receptor (MC4R) has not been fully defined.  In this study, we investigated the mol. determinants of MC4R ligand binding, employing a large array of ligands, using three approaches.  First; mol. modeling of the receptor was used to identify Phe284, in transmembrane (TM) 7, as a potential site of ligand interaction.  Mutation of Phe284 to alanine reduced binding affinity and potency of peptides contg. L-Phe by up to 71-fold but did not appreciably affect binding of linear peptides contg. D-Phe, consistent with a hydrophobic interaction between the Phe7 of α-MSH and Phe284.  Second, we examd. the effect of a naturally occurring mutation in TM3 (I137T) that is linked to obesity.  This mutation decreased affinity and potency of cyclic, rigid peptides but not more flexible peptides, consistent with an indirect effect of the mutation on the tertiary structure of the receptor.  Third, we examd. the residues that support ligand selectivity for the MC4R over the MC3R.  Mutation of lle125 (TM3) of the MC4R to the equiv. residue of the MC3R (phenylalanine) selectively decreased affinity and potency of MC4R-selective ligands.  This effect was mirrored by the reciprocal MC3R mutation F157I.  The magnitude of this effect indicates that this locus is not of major importance.  However, it is considered that an isoleucine/phenylalanine mutation may affect the orientation of Asp122, which has been identified as a major determinant of ligand binding affinity.  Thus, this study provides further characterization of the MC4R binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-46mcgWzdLLVg90H21EOLACvtfcHk0lgqnsa1as2Ysw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1eis7c%253D&md5=d41f83b8dbc4db2ccee2349cd2f2d7e2</span></div><a href="/servlet/linkout?suffix=ref36_1&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.044974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.044974%26sid%3Dliteratum%253Aachs%26aulast%3DNickolls%26aufirst%3DS.%2BA.%26aulast%3DCismowski%26aufirst%3DM.%2BI.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DConlon%26aufirst%3DP.%2BJ.%26atitle%3DMolecular%2520determinants%2520of%2520melanocortin%25204%2520receptor%2520ligand%2520binding%2520and%2520MC4%252FMC3%2520receptor%2520selectivity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D304%26spage%3D1217%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-ref37_1"><span><span class="NLM_contrib-group">Loscher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potschka, H.</span><span> </span><span class="NLM_article-title">Blood−brain barrier active efflux transporters: ATP-binding cassette gene family</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=86-98&author=W.+Loscherauthor=H.+Potschka&title=Blood%E2%88%92brain+barrier+active+efflux+transporters%3A+ATP-binding+cassette+gene+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref37_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLoscher%26aufirst%3DW.%26aulast%3DPotschka%26aufirst%3DH.%26atitle%3DBlood%25E2%2588%2592brain%2520barrier%2520active%2520efflux%2520transporters%253A%2520ATP-binding%2520cassette%2520gene%2520family%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D86%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-ref38_1"><span><span class="NLM_contrib-group">Jiang, J.; Tucci, F. C.; Tran, J. A.; Fleck, B. A.; Wen, J.</span> et al. <span> </span><span class="NLM_article-title">Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor.</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5610</span><span class="NLM_x">–</span> <span class="NLM_lpage">5613</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5610-5613&author=J.+Jiang&author=F.+C.+Tucci&author=J.+A.+Tran&author=B.+A.+Fleck&author=J.+Wen&title=Pyrrolidinones+as+potent+functional+antagonists+of+the+human+melanocortin-4+receptor."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref38_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DJ.%26atitle%3DPyrrolidinones%2520as%2520potent%2520functional%2520antagonists%2520of%2520the%2520human%2520melanocortin-4%2520receptor.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5610%26epage%3D5613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-ref39_1"><span><span class="NLM_contrib-group">Konturek, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konturek, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brzozowski, T.</span><span> </span><span class="NLM_article-title">Brain−gut axis and its role in the control of food intake</span> <span class="citation_source-journal">J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/ref39_1&amp;dbid=8&amp;doi=10.1021%2Fjm701137s&amp;key=15082874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/ref39_1&amp;dbid=32&amp;doi=10.1021%2Fjm701137s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1Orurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=137-154&author=S.+J.+Konturekauthor=J.+W.+Konturekauthor=T.+Pawlikauthor=T.+Brzozowski&title=Brain%E2%88%92gut+axis+and+its+role+in+the+control+of+food+intake"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref39_1R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-gut axis and its role in the control of food intake</span></div><div class="casAuthors">Konturek, S. J.; Konturek, J. W.; Pawlik, T.; Brzozowki, T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1, Pt. 2</span>),
    <span class="NLM_cas:pages">137-154</span>CODEN:
                <span class="NLM_cas:coden">JPHPEI</span>;
        ISSN:<span class="NLM_cas:issn">0867-5910</span>.
    
            (<span class="NLM_cas:orgname">Polish Physiological Society</span>)
        </div><div class="casAbstract">A review.  Gastrointestinal tract (GIT) and nervous system, both central (CNS) and enteric (ENS), are involved in 2-way extrinsic communication by parasympathetic and sympathetic nerves, each comprising efferents fibers such as cholinergic and noradrenergic, resp., and afferent sensory fibers required for gut-brain signaling.  Afferent nerves are equipped with numerous sensors at their terminals in the gut related to visceral mechano- chemo- and noci-receptors, whose excitations may trigger a variety of visceral reflexes regulating GIT functions, including the appetitive behavior.  Food intake depends upon various influences from the CNS as well as from the body energy stores (adipocytes) that express and release the product of Ob gene, leptin, in proportion to fat stored and acting in long-term regulation of food intake.  Leptin acts through receptors (Ob-R) present in afferent visceral nerves and hypothalamic arcuate nucleus (ARC), whose neurons are capable of expressing and releasing neuropeptide Y (NPY) and agouti related protein (AgRP) that activate the ingestive behavior through paraventricular nucleus (PVN) ("feeding center").  In addn., to this long-term regulation, a short-term regulation, on meal-to-meal basis, is secured by several gut hormones, such as cholecystokinin (CCK), peptides YY (PYY) and oxyntomodulin (OXM), released from the endocrine intestinal cells and acting via G-protein coupled receptors (GPCR) either on afferent nerves or directly on ARC neurons, which in turn inhibit expression and release of food-intake stimulating NPY and AgRP, thereby inducing satiety through inhibition of PVN.  In contrast, during fasting, the GIT, esp. oxyntic mucosa, expresses and releases appetite stimulating (orexigenic) factors such as ghrelin and orexins (OX) -A and OX-B, and cannabinoid CB1 agonist.  Ghrelin activates growth-hormone secretagogue receptor (GHS-R) in hypothalamic ARC and stimulates growth hormone (GH) release and in vagal afferents to promote the expression and release of hypothalamic NPY and AgRP stimulating PVN and driving ingestive behavior.  The balance and interaction between anorexigenic (CCK, PYY, OXM) and orexigenic (ghrelin and OX) factors originating from GIT appears to play an important role in short-term regulation of food intake and growth hormone (GH) release.  An impairment of this balance may result in disorders of feeding behavior and wt. gain (obesity) or wt. loss (cachexia).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKLXDDB_IWw7Vg90H21EOLACvtfcHk0li-ysugVH4U3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1Orurc%253D&md5=0ef9dff0a2329bcfaa0598c24e587376</span></div><a href="/servlet/linkout?suffix=ref39_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKonturek%26aufirst%3DS.%2BJ.%26aulast%3DKonturek%26aufirst%3DJ.%2BW.%26aulast%3DPawlik%26aufirst%3DT.%26aulast%3DBrzozowski%26aufirst%3DT.%26atitle%3DBrain%25E2%2588%2592gut%2520axis%2520and%2520its%2520role%2520in%2520the%2520control%2520of%2520food%2520intake%26jtitle%3DJ.%2520Physiol.%2520Pharmacol.%26date%3D2004%26volume%3D55%26spage%3D137%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-ref40_1"><span><span class="NLM_contrib-group">Ferorelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiodice, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tortorella, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amoroso, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettoni, G.</span><span> </span><span class="NLM_article-title">Isosteres of chiral clofibric acid analogs: synthesis, resolution, absolute configuration and HPLC detection of the optical purity</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1999&pages=367-374&author=S.+Ferorelliauthor=F.+Loiodiceauthor=V.+Tortorellaauthor=R.+Amorosoauthor=G.+Bettoni&title=Isosteres+of+chiral+clofibric+acid+analogs%3A+synthesis%2C+resolution%2C+absolute+configuration+and+HPLC+detection+of+the+optical+purity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=ref40_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerorelli%26aufirst%3DS.%26aulast%3DLoiodice%26aufirst%3DF.%26aulast%3DTortorella%26aufirst%3DV.%26aulast%3DAmoroso%26aufirst%3DR.%26aulast%3DBettoni%26aufirst%3DG.%26atitle%3DIsosteres%2520of%2520chiral%2520clofibric%2520acid%2520analogs%253A%2520synthesis%252C%2520resolution%252C%2520absolute%2520configuration%2520and%2520HPLC%2520detection%2520of%2520the%2520optical%2520purity%26jtitle%3DFarmaco%26date%3D1999%26volume%3D52%26spage%3D367%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a href="/doi/suppl/10.1021/jm701137s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_72421"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedure for the preparation of compound <b>6c</b>, analytic data of key compounds, and description of pharmacokinetic studies and protocol for the murine cachexia model. This material is available free of charge via the Internet at <a class="extLink" href="http://http:/pubs.acs.org">http:/pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701137s/suppl_file/jm701137s-file003.pdf">jm701137s-file003.pdf (113.44 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701137s&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Fjm701137s%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2007.50.issue-25%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701137s" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                438KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999122690d3d7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
